Table of Contents

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

x

Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

For the Quarterly Period Ended November 30, 2013

 

o

Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Commission File Number: 1-33376

 

SARATOGA INVESTMENT CORP.

(Exact name of registrant as specified in its charter)

 

Maryland

 

20-8700615

(State or other jurisdiction of
incorporation or organization)

 

(I.R.S. Employer
Identification No.)

 

535 Madison Avenue
New York, New York

 

10022

(Address of principal executive office)

 

(Zip Code)

 

(212) 906-7800

(Registrant’s telephone number, including area code)

 

Not applicable

(Former Name, Former Address and Former Fiscal Year, if Changed Since Last Report)

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days.  Yes x No o

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).  Yes o No o

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company.  See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.  (check one):

 

Large Accelerated Filer o

 

Accelerated Filer o

 

 

 

Non-Accelerated Filer x

 

Smaller Reporting Company o

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  Yes o No x

 

The number of shares of the registrant’s common stock, $0.001 par value, outstanding as of January 14, 2014 was 5,379,616.

 

 

 



Table of Contents

 

TABLE OF CONTENTS

 


 

 

 

Page

 

 

 

PART I

FINANCIAL INFORMATION

3

 

 

 

Item 1.

Financial Statements

3

 

 

 

 

Consolidated Statements of Assets and Liabilities as of November 30, 2013 (unaudited) and February 28, 2013

3

 

 

 

 

Consolidated Statements of Operations for the three and nine months ended November 30, 2013 and 2012 (unaudited)

4

 

 

 

 

Consolidated Schedules of Investments as of November 30, 2013 (unaudited) and February 28, 2013

5

 

 

 

 

Consolidated Statements of Changes in Net Assets for the nine months ended November 30, 2013 and 2012 (unaudited)

11

 

 

 

 

Consolidated Statements of Cash Flows for the nine months ended November 30, 2013 and 2012 (unaudited)

12

 

 

 

 

Notes to Consolidated Financial Statements as of November 30, 2013 (unaudited)

13

 

 

 

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

36

 

 

 

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

52

 

 

 

Item 4.

Controls and Procedures

53

 

 

 

PART II

OTHER INFORMATION

53

 

 

 

Item 1.

Legal Proceedings

53

 

 

 

Item 1A.

Risk Factors

53

 

 

 

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

53

 

 

 

Item 3.

Defaults upon Senior Securities

53

 

 

 

Item 4.

Mine Safety Disclosures

54

 

 

 

Item 5.

Other Information

54

 

 

 

Item 6.

Exhibits

54

 

 

 

Signatures

 

55

 

2



Table of Contents

 

PART I FINANCIAL INFORMATION

 

Item 1. Financial Statements

 

Saratoga Investment Corp.

 

Consolidated Statements of Assets and Liabilities

 

 

 

As of

 

 

 

November 30, 2013

 

February 28, 2013

 

 

 

(unaudited)

 

 

 

ASSETS

 

 

 

 

 

 

 

 

 

 

 

Investments at fair value

 

 

 

 

 

Non-control/non-affiliate investments (amortized cost of $180,323,606 and $130,465,086, respectively)

 

$

179,759,938

 

$

129,563,428

 

Control investments (cost of $16,555,808 and $18,944,966 respectively)

 

19,018,842

 

25,516,959

 

Total investments at fair value (amortized cost of $196,879,414 and $149,410,052 respectively)

 

198,778,780

 

155,080,387

 

Cash and cash equivalents

 

3,359,983

 

149,025

 

Cash and cash equivalents, reserve accounts

 

1,599,132

 

12,086,142

 

Interest receivable, (net of reserve of $310,146 and $53,543, respectively)

 

2,751,138

 

2,889,358

 

Due from manager

 

4,929

 

 

Deferred debt financing costs, net

 

4,008,926

 

2,090,184

 

Management fee receivable

 

166,682

 

215,853

 

Other assets

 

99,597

 

83,407

 

Receivable from unsettled trades

 

 

1,817,074

 

Total assets

 

$

210,769,167

 

$

174,411,430

 

 

 

 

 

 

 

LIABILITIES

 

 

 

 

 

Revolving credit facility

 

$

4,000,000

 

$

24,300,000

 

SBA debentures payable

 

40,000,000

 

36,000,000

 

Notes payable

 

48,300,000

 

 

Dividend payable

 

2,507,112

 

 

Management and incentive fees payable

 

3,587,061

 

4,509,322

 

Accounts payable and accrued expenses

 

381,485

 

435,038

 

Interest and debt fees payable

 

514,333

 

257,796

 

Due to manager

 

273,083

 

222,513

 

Total liabilities

 

$

99,563,074

 

$

65,724,669

 

 

 

 

 

 

 

NET ASSETS

 

 

 

 

 

Common stock, par value $.001, 100,000,000 common shares authorized, 5,379,616 and 4,730,116 common shares issued and outstanding, respectively

 

$

5,380

 

$

4,730

 

Capital in excess of par value

 

184,851,122

 

174,824,076

 

Distribution in excess of net investment income

 

(29,418,170

)

(24,522,951

)

Accumulated net realized loss from investments and derivatives

 

(46,131,603

)

(47,289,427

)

Net unrealized appreciation on investments and derivatives

 

1,899,364

 

5,670,333

 

Total Net Assets

 

111,206,093

 

108,686,761

 

 

 

 

 

 

 

Total liabilities and Net Assets

 

$

210,769,167

 

$

174,411,430

 

 

 

 

 

 

 

NET ASSET VALUE PER SHARE

 

$

20.67

 

$

22.98

 

 

See accompanying notes to consolidated financial statements.

 

3



Table of Contents

 

Saratoga Investment Corp.

 

Consolidated Statements of Operations

 

(unaudited)

 

 

 

For the three months ended
November 30

 

For the nine months ended
November 30

 

 

 

2013

 

2012

 

2013

 

2012

 

 

 

 

 

 

 

 

 

 

 

INVESTMENT INCOME

 

 

 

 

 

 

 

 

 

Interest from investments

 

 

 

 

 

 

 

 

 

Non-control/Non-affiliate investments

 

$

4,279,445

 

$

2,190,350

 

$

11,534,271

 

$

6,129,508

 

Payment-in-kind interest income from Non-control/Non-affiliate investments

 

161,485

 

276,245

 

634,408

 

821,830

 

Control investments

 

556,291

 

1,046,285

 

2,791,830

 

3,186,751

 

Total interest income

 

4,997,221

 

3,512,880

 

14,960,509

 

10,138,089

 

Interest from cash and cash equivalents

 

1,316

 

731

 

7,181

 

5,368

 

Management fee income

 

421,198

 

500,454

 

1,400,039

 

1,500,519

 

Other income

 

381,480

 

19,750

 

838,956

 

172,310

 

Total investment income

 

5,801,215

 

4,033,815

 

17,206,685

 

11,816,286

 

 

 

 

 

 

 

 

 

 

 

EXPENSES

 

 

 

 

 

 

 

 

 

Interest and debt financing expenses

 

1,611,221

 

529,858

 

4,342,657

 

1,808,586

 

Base management fees

 

876,345

 

528,735

 

2,424,167

 

1,492,345

 

Professional fees

 

312,992

 

347,459

 

879,247

 

986,781

 

Administrator expenses

 

250,000

 

250,000

 

750,000

 

750,000

 

Incentive management fees

 

(561,539

)

(412,654

)

219,813

 

887,020

 

Insurance

 

117,955

 

128,891

 

357,184

 

389,506

 

Directors fees and expenses

 

35,978

 

53,705

 

131,978

 

155,705

 

General & administrative

 

251,058

 

117,357

 

440,844

 

265,720

 

Other expense

 

9,172

 

1,311

 

21,207

 

4,434

 

Total expenses

 

2,903,182

 

1,544,662

 

9,567,097

 

6,740,097

 

 

 

 

 

 

 

 

 

 

 

NET INVESTMENT INCOME

 

2,898,033

 

2,489,153

 

7,639,588

 

5,076,189

 

 

 

 

 

 

 

 

 

 

 

REALIZED AND UNREALIZED GAIN (LOSS) ON INVESTMENTS:

 

 

 

 

 

 

 

 

 

Net realized gain from investments

 

82,882

 

95,372

 

1,157,824

 

542,720

 

Net realized loss from derivatives

 

 

 

 

(131,000

)

Net unrealized appreciation (depreciation) on investments

 

(1,713,025

)

(1,838,957

)

(3,770,968

)

3,188,543

 

Net unrealized appreciation on derivatives

 

 

 

 

130,925

 

Net gain (loss) on investments

 

(1,630,143

)

(1,743,585

)

(2,613,144

)

3,731,188

 

 

 

 

 

 

 

 

 

 

 

NET INCREASE IN NET ASSETS RESULTING FROM OPERATIONS

 

$

1,267,890

 

$

745,568

 

$

5,026,444

 

$

8,807,377

 

 

 

 

 

 

 

 

 

 

 

WEIGHTED AVERAGE - BASIC AND DILUTED EARNINGS PER COMMON SHARE

 

$

0.26

 

$

0.19

 

$

1.05

 

$

2.25

 

 

 

 

 

 

 

 

 

 

 

WEIGHTED AVERAGE COMMON STOCK OUTSTANDING - BASIC AND DILUTED

 

4,851,451

 

3,970,447

 

4,770,267

 

3,907,696

 

 

See accompanying notes to consolidated financial statements.

 

4



Table of Contents

 

Saratoga Investment Corp.

 

Consolidated Schedule of Investments

 

November 30, 2013

 

(unaudited)

 

Company (a)

 

Industry

 

Investment Interest Rate / Maturity

 

Principal/
Number of Shares

 

Cost

 

Fair Value (c)

 

% of
Net Assets

 

Non-control/Non-affiliated investments - 161.6% (b)

 

 

 

 

 

 

 

 

 

 

 

 

 

PATS Aircraft, LLC (d, g)

 

Aerospace

 

Common Stock

 

51,813

 

89,636

 

89,636

 

0.1

%

PATS Aircraft, LLC (d)

 

Aerospace

 

First Lien Term Loan 8.50% Cash, 10/6/2016

 

$

 

254,598

 

$

254,598

 

$

254,598

 

0.2

%

 

 

 

 

Total Aerospace

 

 

 

344,234

 

344,234

 

0.3

%

National Truck Protection Co., Inc. (d, g)

 

Automotive

 

Common Stock

 

1,116

 

1,000,000

 

1,120,330

 

1.0

%

National Truck Protection Co., Inc. (d)

 

Automotive

 

First Lien Term Loan 15.50% (13.50% Cash/2.00% PIK), 9/13/2018

 

$

 

8,250,000

 

8,250,000

 

8,250,000

 

7.4

%

Take 5 Oil Change, L.L.C. (d, g)

 

Automotive

 

Common Stock

 

7,128

 

712,800

 

1,091,154

 

1.0

%

 

 

 

 

Total Automotive

 

 

 

9,962,800

 

10,461,484

 

9.4

%

Legacy Cabinets Holdings (d, g)

 

Building Products

 

Common Stock Voting A-1

 

2,535

 

220,900

 

302,020

 

0.3

%

Legacy Cabinets Holdings (d, g)

 

Building Products

 

Common Stock Voting B-1

 

1,600

 

139,424

 

190,624

 

0.2

%

Legacy Cabinets, Inc. (d)

 

Building Products

 

First Lien Term Loan 7.25% (1.00% Cash/6.25% PIK), 5/3/2014

 

$

 

260,521

 

260,521

 

260,521

 

0.2

%

 

 

 

 

Total Building Products

 

 

 

620,845

 

753,165

 

0.7

%

ARSloane Acquistion, LLC (d)

 

Business Services

 

First Lien Term Loan 7.50% Cash, 10/1/2019

 

$

 

1,000,000

 

990,265

 

1,001,300

 

0.9

%

BMC Software, Inc. (d)

 

Business Services

 

First Lien Term Loan 5.00% Cash, 9/10/2020

 

$

 

6,000,000

 

5,941,650

 

6,051,000

 

5.4

%

Dispensing Dynamics International (d)

 

Business Services

 

Senior Secured Note 12.50% Cash, 1/1/2018

 

$

 

7,000,000

 

6,877,686

 

7,385,000

 

6.7

%

Easy Ice, LLC (d)

 

Business Services

 

First Lien Term Loan 14.00% (11.00% Cash 3.00% PIK), 3/29/2018

 

$

 

7,451,002

 

7,324,751

 

7,451,002

 

6.7

%

Emily Street Enterprises, L.L.C. (d)

 

Business Services

 

Senior Secured Note 14.00% (13.00% Cash/1.00% PIK), 12/28/2017

 

$

 

5,753,427

 

5,660,528

 

5,753,427

 

5.2

%

Emily Street Enterprises, L.L.C. (d, g)

 

Business Services

 

Warrant Membership Interests

 

49,318

 

400,000

 

488,741

 

0.4

%

Help/Systems Holdings, Inc.(Help/Systems, LLC) (d)

 

Business Services

 

First Lien Term Loan 5.50% Cash, 6/28/2019

 

$

 

4,000,000

 

3,962,643

 

3,990,000

 

3.6

%

Help/Systems Holdings, Inc.(Help/Systems, LLC) (d)

 

Business Services

 

Second Lien Term Loan 9.50% Cash, 6/28/2020

 

$

 

2,000,000

 

1,971,697

 

2,000,000

 

1.8

%

Knowland Technology Holdings, L.L.C. (d)

 

Business Services

 

First Lien Term Loan 11.00% Cash, 11/29/2017

 

$

 

6,200,000

 

6,100,922

 

6,200,000

 

5.6

%

Trinet HR Corporation (SOI Holdings, Inc.) (d)

 

Business Services

 

First Lien Term Loan 5.00% Cash, 8/20/2020

 

$

 

5,000,000

 

4,951,958

 

5,000,000

 

4.5

%

Trinet HR Corporation (SOI Holdings, Inc.) (d)

 

Business Services

 

Second Lien Term Loan 8.75% Cash, 2/20/2021

 

$

 

2,500,000

 

2,451,490

 

2,472,000

 

2.2

%

Vector Controls Holding Co., LLC (d)

 

Business Services

 

First Lien Term Loan, 14.00% (12.00% Cash, 2.00% PIK), 3/6/2018

 

$

 

9,554,517

 

9,394,118

 

9,554,517

 

8.6

%

Vector Controls Holding Co., LLC (d, g)

 

Business Services

 

Warrants to Purchase Limited Liability Company Interests

 

101

 

 

 

0.0

%

 

 

 

 

Total Business Services

 

 

 

56,027,708

 

57,346,987

 

51.6

%

Targus Group International, Inc. (d)

 

Consumer Products

 

First Lien Term Loan 11.00% Cash, 5/24/2016

 

$

 

3,776,785

 

3,738,991

 

3,635,156

 

3.3

%

Targus Holdings, Inc. (d, g)

 

Consumer Products

 

Common Stock

 

62,413

 

566,765

 

680,302

 

0.6

%

Targus Holdings, Inc. (d)

 

Consumer Products

 

Unsecured Note 10.00% PIK, 6/14/2019

 

$

 

1,914,341

 

1,914,341

 

1,320,582

 

1.2

%

Targus Holdings, Inc. (d)

 

Consumer Products

 

Unsecured Note 16.00% Cash, 10/26/2018

 

$

 

371,073

 

366,112

 

345,148

 

0.3

%

 

 

 

 

Total Consumer Products

 

 

 

6,586,209

 

5,981,188

 

5.4

%

CFF Acquisition L.L.C. (d)

 

Consumer Services

 

First Lien Term Loan 7.50% Cash, 7/31/2015

 

$

 

1,606,766

 

1,540,599

 

1,606,766

 

1.4

%

Expedited Travel L.L.C. (d)

 

Consumer Services

 

First Lien Term Loan 12.00% Cash, 12/28/2017

 

$

 

4,642,500

 

4,557,379

 

4,642,500

 

4.2

%

PrePaid Legal Services, Inc. (d)

 

Consumer Services

 

First Lien Term Loan 6.25% Cash, 7/1/2019

 

$

 

4,596,774

 

4,553,840

 

4,596,774

 

4.1

%

PrePaid Legal Services, Inc. (d)

 

Consumer Services

 

Second Lien Term Loan 9.75% Cash, 7/1/2020

 

$

 

5,000,000

 

4,929,239

 

5,000,000

 

4.5

%

 

 

 

 

Total Consumer Services

 

 

 

15,581,057

 

15,846,040

 

14.2

%

M/C Acquisition Corp., L.L.C. (d, g)

 

Education

 

Class A Common Stock

 

544,761

 

30,241

 

 

0.0

%

 

5



Table of Contents

 

Company (a)

 

Industry

 

Investment Interest Rate / Maturity

 

Principal/
Number of Shares

 

Cost

 

Fair Value (c)

 

% of
Net Assets

 

M/C Acquisition Corp., L.L.C. (d)

 

Education

 

First Lien Term Loan 1.00% Cash, 3/13/14

 

$

2,519,667

 

1,365,733

 

90,426

 

0.1

%

 

 

 

 

Total Education

 

 

 

1,395,974

 

90,426

 

0.1

%

Group Dekko, Inc. (d)

 

Electronics

 

Second Lien Term Loan 11.00% (10.00% Cash/1.00% PIK), 5/1/2016

 

$

6,883,558

 

6,883,558

 

6,752,082

 

6.1

%

 

 

 

 

Total Electronics

 

 

 

6,883,558

 

6,752,082

 

6.1

%

USS Parent Holding Corp. (d, g)

 

Environmental

 

Non Voting Common Stock

 

765

 

133,002

 

192,577

 

0.2

%

USS Parent Holding Corp. (d, g)

 

Environmental

 

Voting Common Stock

 

17,396

 

3,025,798

 

4,381,122

 

3.9

%

 

 

 

 

Total Environmental

 

 

 

3,158,800

 

4,573,699

 

4.1

%

DS Waters of America, Inc. (d)

 

Food and Beverage

 

First Lien Term Loan 5.25% Cash, 8/30/2020

 

$

2,500,000

 

2,475,815

 

2,512,500

 

2.2

%

HOA Restaurant Group, L.L.C. (d)

 

Food and Beverage

 

Senior Secured Note 11.25% Cash, 4/1/2017

 

$

4,000,000

 

3,912,548

 

4,220,000

 

3.8

%

TB Corp. (d)

 

Food and Beverage

 

First Lien Term Loan 5.75% Cash, 6/19/2018

 

$

5,114,855

 

5,093,700

 

5,080,585

 

4.6

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

TB Corp. (d)

 

Food and Beverage

 

Unsecured Note 13.50% (12.00% Cash/1.50% PIK), 12/20/2018

 

$

2,533,219

 

2,501,656

 

2,533,219

 

2.3

%

TM Restaurant Group L.L.C. (d)

 

Food and Beverage

 

First Lien Term Loan 7.75% Cash, 7/16/2017

 

$

2,864,440

 

2,848,866

 

2,850,118

 

2.6

%

 

 

 

 

Total Food and Beverage

 

 

 

16,832,585

 

17,196,422

 

15.5

%

Bristol Hospice, LLC (d)

 

Healthcare Services

 

First Lien Term Loan 11.00%(10.00% Cash/1.00% PIK), 11/29/2018

 

$

5,500,000

 

5,390,120

 

5,500,000

 

4.9

%

Oceans Acquisition, Inc. (d)

 

Healthcare Services

 

First Lien Term Loan 10.75% Cash, 12/27/2017

 

$

6,500,000

 

6,391,338

 

6,500,000

 

5.8

%

Smile Brands Group Inc. (d)

 

Healthcare Services

 

First Lien Term Loan 7.50% Cash, 8/16/2019

 

$

4,500,000

 

4,413,884

 

4,421,250

 

4.0

%

Surgical Specialties Corporation (US), Inc. (d)

 

Healthcare Services

 

First Lien Term Loan 7.25% Cash, 8/22/2018

 

$

2,468,750

 

2,445,338

 

2,474,922

 

2.2

%

Zest Holdings, LLC (d)

 

Healthcare Services

 

First Lien Term Loan 6.50% Cash, 8/16/2020

 

$

4,500,000

 

4,412,915

 

4,432,500

 

4.0

%

 

 

 

 

Total Healthcare Services

 

 

 

23,053,595

 

23,328,672

 

20.9

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

McMillin Companies L.L.C. (d, g)

 

Homebuilding

 

Senior Secured Note 0% Cash, 12/31/2013

 

$

550,000

 

556,046

 

375,705

 

0.3

%

 

 

 

 

Total Homebuilding

 

 

 

556,046

 

375,705

 

0.3

%

Keystone Automotive Operations, Inc. (d)

 

Logistics

 

First Lien Term Loan 7.00% Cash, 8/15/2019

 

$

5,000,000

 

4,928,468

 

5,056,500

 

4.5

%

 

 

 

 

Total Logistics

 

 

 

4,928,468

 

5,056,500

 

4.5

%

Distribution International, Inc.  (d)

 

Manufacturing

 

First Lien Term Loan 7.50% Cash, 7/16/2019

 

$

5,985,000

 

5,928,481

 

5,955,075

 

5.4

%

 

 

 

 

Total Manufacturing

 

 

 

5,928,481

 

5,955,075

 

5.4

%

Elyria Foundry Company, L.L.C. (d)

 

Metals

 

Senior Secured Note 17.00% (13.00% Cash/4.00% PIK), 9/14/2014

 

$

8,859,614

 

8,859,614

 

6,685,465

 

6.0

%

Elyria Foundry Company, L.L.C. (d, g)

 

Metals

 

Warrants to Purchase Limited Liability Company Interests (2008)

 

7,000

 

20

 

 

0.0

%

Elyria Foundry Company, L.L.C. (d, g)

 

Metals

 

Warrants to Purchase Limited Liability Company Interests (2013)

 

18,227

 

 

 

0.0

%

 

 

 

 

Total Metals

 

 

 

8,859,634

 

6,685,465

 

6.0

%

Network Communications, Inc. (d, g)

 

Publishing

 

Common Stock

 

380,572

 

 

 

0.0

%

Network Communications, Inc. (d)

 

Publishing

 

Unsecured Notes 8.60% PIK, 1/14/2020

 

$

2,553,597

 

2,142,163

 

1,179,794

 

1.1

%

 

 

 

 

Total Publishing

 

 

 

2,142,163

 

1,179,794

 

1.1

%

Community Investors, Inc. (d, g)

 

Software

 

Common Stock

 

1,282

 

1,282

 

1,564

 

0.0

%

Community Investors, Inc. (d)

 

Software

 

First Lien Term Loan 9.75% Cash, 5/9/2018

 

$

6,150,000

 

6,040,876

 

6,150,000

 

5.5

%

Community Investors, Inc. (d)

 

Software

 

Revolver

 

$

166,667

 

 

 

0.0

%

Community Investors, Inc. (d, g)

 

Software

 

Preferred Stock

 

148,718

 

148,718

 

181,436

 

0.2

%

Pen-Link, Ltd. (d)

 

Software

 

Second Lien Term Loan 12.50% Cash, 5/26/2019

 

$

11,500,000

 

11,270,573

 

11,500,000

 

10.3

%

 

 

 

 

Total Software

 

 

 

17,461,449

 

17,833,000

 

16.0

%

Sub Total Non-control/Non-affiliated investments

 

 

 

 

 

 

 

180,323,606

 

179,759,938

 

161.6

%

Control investments - 17.1% (b)

 

 

 

 

 

 

 

 

 

 

 

 

 

Saratoga Investment Corp. CLO 2013-1, Ltd. (d, e, f)

 

Structured Finance Securities

 

Other/Structured Finance Securities 14.78%, 10/17/2023

 

$

30,000,000

 

16,555,808

 

19,018,842

 

17.1

%

Sub Total Control investments

 

 

 

 

 

 

 

16,555,808

 

19,018,842

 

17.1

%

TOTAL INVESTMENTS - 178.7% (b)

 

 

 

 

 

 

 

$

196,879,414

 

$

198,778,780

 

178.7

%

 

6



Table of Contents

 


(a)       All of our equity and debt investments are issued by eligible portfolio companies, as defined in the Investment Company Act of 1940, except Saratoga Investment Corp. CLO 2013-1, Ltd.

(b)       Percentages are based on net assets of $111,206,093 as of November 30, 2013.

(c)       Because there is no readily available market value for these investments, the fair value of these investments is approved in good faith by our board of directors. (see Note 3 to the consolidated financial statements).

(d)       These securities are pledged as collateral under a senior secured revolving credit facility (see Note 6 to the consolidated financial statements).

(e)       14.78% represents the modeled effective interest rate that is expected to be earned over the life of the investment.

(f)        As defined in the Investment Company Act, we “Control” this portfolio company because we own more than 25% of the portfolio company’s outstanding voting securities. Transactions during the period in which the issuer was both an Affiliate and a portfolio company that we Control are as follows:

 

 

 

 

 

 

 

 

 

Interest

 

Management

 

Net Realized

 

Net Unrealized

 

Company

 

Purchases

 

Redemptions

 

Sales (cost)

 

Income

 

fee income

 

gains/(losses)

 

gains/(losses)

 

Saratoga Investment Corp. CLO 2013-1, Ltd.

 

$

 

$

 

$

 

$

2,791,830

 

$

1,400,039

 

$

 

$

2,463,034

 

 


(g) Non-income producing at November 30, 2013.

 

7



Table of Contents

 

Saratoga Investment Corp.

 

Consolidated Schedule of Investments

 

February 28, 2013

 

Company (a)

 

Industry

 

Investment Interest Rate / Maturity

 

Principal/
Number of Shares

 

Cost

 

Fair Value (c)

 

% of
Net Assets

 

Non-control/Non-affiliated investments - 119.2% (b)

 

 

 

 

 

 

 

 

 

 

 

 

 

Coast Plating, Inc. (d)

 

Aerospace

 

First Lien Term Loan 11.70% Cash, 9/13/2014

 

$

2,550,000

 

$

2,550,000

 

$

2,550,000

 

2.3

%

Coast Plating, Inc. (d)

 

Aerospace

 

First Lien Term Loan 13.20% Cash, 9/13/2014

 

$

950,000

 

950,000

 

950,000

 

0.9

%

 

 

 

 

Total Aerospace

 

 

 

3,500,000

 

3,500,000

 

3.2

%

National Truck Protection Co., Inc. (d), (h)

 

Automotive

 

Common Stock

 

589

 

500,000

 

591,827

 

0.5

%

National Truck Protection Co., Inc. (d)

 

Automotive

 

First Lien Term Loan 15.50% Cash 8/10/2017

 

$

5,500,000

 

5,500,000

 

5,500,000

 

5.1

%

Take 5 Oil Change, L.L.C. (d)

 

Automotive

 

First Lien Term Loan 9.00% Cash, 11/28/2016

 

$

6,000,000

 

6,000,000

 

6,000,000

 

5.5

%

Take 5 Oil Change, L.L.C. (d)

 

Automotive

 

First Lien Term Loan 13.00% Cash, 11/28/2016

 

$

2,000,000

 

1,961,761

 

2,000,000

 

1.8

%

Take 5 Oil Change, L.L.C. (d), (h)

 

Automotive

 

Common Stock

 

7,128

 

712,800

 

712,800

 

0.7

%

 

 

 

 

Total Automotive

 

 

 

14,674,561

 

14,804,627

 

13.6

%

Legacy Cabinets Holdings (d), (h)

 

Building Products

 

Common Stock Voting A-1

 

2,535

 

220,900

 

 

0.0

%

Legacy Cabinets Holdings (d), (h)

 

Building Products

 

Common Stock Voting B-1

 

1,600

 

139,424

 

 

0.0

%

Legacy Cabinets, Inc. (d)

 

Building Products

 

First Lien Term Loan 7.25% (1.00% Cash/6.25% PIK), 5/3/2014

 

$

332,229

 

332,229

 

267,378

 

0.2

%

 

 

 

 

Total Building Products

 

 

 

692,553

 

267,378

 

0.2

%

Emily Street Enterprises, L.L.C. (d)

 

Business Services

 

Senior Secured Note 14.00% (13.00% Cash/1.00% PIK), 12/28/2017

 

$

5,705,384

 

5,595,317

 

5,705,384

 

5.2

%

Emily Street Enterprises, L.L.C. (d), (h)

 

Business Services

 

Warrant Membership Interests

 

49,318

 

400,000

 

399,969

 

0.4

%

Dispensing Dynamics International (d)

 

Business Services

 

Senior Secured Note 12.50% Cash, 1/1/2018

 

$

7,000,000

 

6,860,186

 

7,000,000

 

6.4

%

Knowland Technology Holdings, L.L.C. (d)

 

Business Services

 

First Lien Term Loan 11.00% Cash, 11/29/2017

 

$

6,200,000

 

6,082,248

 

6,200,000

 

5.7

%

Sourcehov LLC (d)

 

Business Services

 

Second Lien Term Loan 10.50% Cash, 4/29/2018

 

$

3,000,000

 

2,648,298

 

2,850,000

 

2.6

%

 

 

 

 

Total Business Services

 

 

 

21,586,049

 

22,155,353

 

20.3

%

C.H.I. Overhead Doors, Inc. (d)

 

Consumer Products

 

First Lien Term Loan 7.25% Cash, 8/17/2017

 

$

4,974,747

 

4,930,481

 

5,024,495

 

4.7

%

Targus Group International, Inc. (d)

 

Consumer Products

 

First Lien Term Loan 11.00% Cash, 5/24/2016

 

$

3,940,003

 

3,888,460

 

3,956,551

 

3.6

%

Targus Holdings, Inc. (d)

 

Consumer Products

 

Unsecured Note 10.00% PIK, 6/14/2019

 

$

1,914,341

 

1,914,341

 

1,116,252

 

1.0

%

Targus Holdings, Inc. (d)

 

Consumer Products

 

Unsecured Note 16.00% Cash, 10/26/2018

 

$

332,500

 

326,320

 

305,334

 

0.3

%

Targus Holdings, Inc. (d), (h)

 

Consumer Products

 

Common Stock

 

62,413

 

566,765

 

3,324,741

 

3.1

%

 

 

 

 

Total Consumer Products

 

 

 

11,626,367

 

13,727,373

 

12.7

%

CFF Acquisition L.L.C. (d)

 

Consumer Services

 

First Lien Term Loan 7.50% Cash, 7/31/2015

 

$

2,161,391

 

2,032,060

 

2,154,475

 

2.0

%

Expedited Travel L.L.C. (d)

 

Consumer Services

 

First Lien Term Loan 12.00% Cash, 12/28/2017

 

$

5,500,000

 

5,380,520

 

5,500,000

 

5.0

%

PrePaid Legal Services, Inc. (d)

 

Consumer Services

 

First Lien Term Loan 11.00% Cash, 12/31/2016

 

$

3,000,000

 

2,936,860

 

3,000,000

 

2.8

%

 

 

 

 

Total Consumer Services

 

 

 

10,349,440

 

10,654,475

 

9.8

%

 

8



Table of Contents

 

Company (a)

 

Industry

 

Investment Interest Rate / Maturity

 

Principal/
Number of Shares

 

Cost

 

Fair Value (c)

 

% of
Net Assets

 

M/C Acquisition Corp., L.L.C. (d)

 

Education

 

First Lien Term Loan 1.00% Cash, 12/31/2012

 

$

2,740,780

 

1,586,846

 

291,893

 

0.3

%

M/C Acquisition Corp., L.L.C. (d), (h)

 

Education

 

Class A Common Stock

 

544,761

 

30,242

 

 

0.0

%

 

 

 

 

Total Education

 

 

 

1,617,088

 

291,893

 

0.3

%

Group Dekko, Inc. (d)

 

Electronics

 

Second Lien Term Loan 11.00% (10.00% Cash/1.00% PIK), 5/1/2016

 

$

6,824,717

 

6,824,717

 

6,720,981

 

6.2

%

 

 

 

 

Total Electronics

 

 

 

6,824,717

 

6,720,981

 

6.2

%

USS Parent Holding Corp. (d), (h)

 

Environmental

 

Non Voting Common Stock

 

765

 

133,002

 

125,981

 

0.1

%

USS Parent Holding Corp. (d), (h)

 

Environmental

 

Voting Common Stock

 

17,396

 

3,025,798

 

2,866,065

 

2.7

%

 

 

 

 

Total Environmental

 

 

 

3,158,800

 

2,992,046

 

2.8

%

DS Waters of America, Inc. (d)

 

Food and Beverage

 

First Lien Term Loan 10.50% Cash, 8/29/2017

 

$

3,970,000

 

3,994,704

 

4,049,400

 

3.7

%

HOA Restaurant Group, L.L.C. (d)

 

Food and Beverage

 

Senior Secured Note 11.25% Cash, 4/1/2017

 

$

4,000,000

 

3,897,940

 

3,560,000

 

3.3

%

TB Corp. (d)

 

Food and Beverage

 

First Lien Term Loan 5.81% Cash, 6/19/2018

 

$

5,153,506

 

5,128,662

 

5,140,622

 

4.7

%

TB Corp. (d)

 

Food and Beverage

 

Unsecured Note 13.50% (12.00% Cash/1.50% PIK), 2/19/2017

 

$

2,504,585

 

2,468,317

 

2,492,062

 

2.3

%

TM Restaurant Group L.L.C. (d)

 

Food and Beverage

 

First Lien Term Loan 7.75% Cash, 7/17/2017

 

$

2,962,500

 

2,943,045

 

2,956,871

 

2.7

%

 

 

 

 

Total Food and Beverage

 

 

 

18,432,668

 

18,198,955

 

16.7

%

Oceans Acquisition, Inc. (d)

 

Healthcare Services

 

First Lien Term Loan 10.75% Cash, 12/27/2017

 

$

7,500,000

 

7,351,433

 

7,500,000

 

6.9

%

Maverick Healthcare Group (d)

 

Healthcare Services

 

First Lien Term Loan 10.75% Cash, 12/31/2016

 

$

4,900,000

 

4,835,389

 

4,900,000

 

4.5

%

 

 

 

 

Total Healthcare Services

 

 

 

12,186,822

 

12,400,000

 

11.4

%

McMillin Companies L.L.C. (d), (h)

 

Homebuilding

 

Senior Secured Note 0% Cash, 12/31/2013

 

$

550,000

 

536,764

 

315,370

 

0.3

%

 

 

 

 

Total Homebuilding

 

 

 

536,764

 

315,370

 

0.3

%

Capstone Logistics, L.L.C. (d)

 

Logistics

 

First Lien Term Loan 7.50% Cash, 9/16/2016

 

$

899,769

 

889,798

 

908,766

 

0.8

%

Capstone Logistics, L.L.C. (d)

 

Logistics

 

First Lien Term Loan 13.50% Cash, 9/16/2016

 

$

3,693,369

 

3,652,443

 

3,767,236

 

3.5

%

Worldwide Express Operations, L.L.C. (d)

 

Logistics

 

First Lien Term Loan 7.50% Cash, 6/30/2013

 

$

6,527,979

 

6,461,295

 

6,504,478

 

6.0

%

 

 

 

 

Total Logistics

 

 

 

11,003,536

 

11,180,480

 

10.3

%

Elyria Foundry Company, L.L.C. (d)

 

Metals

 

Senior Secured Note 17.00% (13.00% Cash/4.00% PIK), 3/1/2013

 

$

7,728,566

 

7,728,566

 

6,723,852

 

6.2

%

Elyria Foundry Company, L.L.C. (d), (h)

 

Metals

 

Warrants to Purchase Limited Liability Company Interests

 

3,000

 

 

 

0.0

%

 

 

 

 

Total Metals

 

 

 

7,728,566

 

6,723,852

 

6.2

%

Network Communications, Inc. (d)

 

Publishing

 

Unsecured Note 8.60% PIK, 1/14/2020

 

$

2,500,198

 

2,049,660

 

960,827

 

0.9

%

Network Communications, Inc. (d), (h)

 

Publishing

 

Common Stock

 

211,429

 

 

 

0.0

%

Penton Media, Inc. (d)

 

Publishing

 

First Lien Term Loan 6.00% (4.00% Cash/2.00% PIK), 8/1/2014

 

$

4,839,189

 

4,497,495

 

4,669,818

 

4.3

%

 

 

 

 

Total Publishing

 

 

 

6,547,155

 

5,630,645

 

5.2

%

 

9



Table of Contents

 

Company (a)

 

Industry

 

Investment Interest Rate / Maturity

 

Principal/
Number of Shares

 

Cost

 

Fair Value (c)

 

% of
Net Assets

 

Sub Total Non-control/Non-affiliated investments

 

 

 

 

 

 

 

130,465,086

 

129,563,428

 

119.2

%

Control investments - 23.5% (b)

 

 

 

 

 

 

 

 

 

 

 

 

 

GSC Partners CDO GP III, LP (g), (h) 

 

Financial Services

 

100% General Partnership Interest

 

 

 

 

0.0

%

GSC Investment Corp. CLO 2007 LTD. (d), (e), (g) 

 

Structured Finance Securities

 

Other/Structured Finance Securities 23.06%, 1/21/2020

 

$

30,000,000

 

18,944,966

 

25,516,959

 

23.5

%

Sub Total Control investments

 

 

 

 

 

 

 

18,944,966

 

25,516,959

 

23.5

%

Affiliate investments - 0.0% (b)

 

 

 

 

 

 

 

 

 

 

 

 

 

GSC Partners CDO GP III, LP (f), (h) 

 

Financial Services

 

6.24% Limited Partnership Interest

 

 

 

 

0.0

%

Sub Total Affiliate investments

 

 

 

 

 

 

 

 

 

0.0

%

TOTAL INVESTMENTS - 142.7% (b)

 

 

 

 

 

 

 

$

149,410,052

 

$

155,080,387

 

142.7

%

 


(a)

 

All of our equity and debt investments are issued by eligible portfolio companies, as defined in the Investment Company Act of 1940, except GSC Investment Corp. CLO 2007 Ltd. and GSC Partners CDO GP III, LP.

(b)

 

Percentages are based on net assets of $108,686,761 as of February 28, 2013.

(c)

 

Because there is no readily available market value for these investments, the fair value of these investments is approved in good faith by our board of directors. (see Note 3 to the consolidated financial statements).

(d)

 

These securities are pledged as collateral under a senior secured revolving credit facility (see Note 6 to the consolidated financial statements).

(e)

 

23.06% represents the modeled effective interest rate that is expected to be earned over the life of the investment.

(f)

 

As defined in the Investment Company Act, we are an “Affiliate” of this portfolio company because we own 5% or more of the portfolio company’s outstanding voting securities. Transactions during the period in which the issuer was an Affiliate are as follows:

 

 

 

 

 

 

 

 

 

Interest

 

Management

 

Net Realized

 

Net Unrealized

 

Company

 

Purchases

 

Redemptions

 

Sales (cost)

 

Income

 

fee income

 

gains/(losses)

 

gains/(losses)

 

GSC Partners CDO GP III, LP

 

$

 

$

 

$

 

$

 

$

 

$

 

$

 

 

(g)

 

As defined in the Investment Company Act, we “Control” this portfolio company because we own more than 25% of the portfolio company’s outstanding voting securities. Transactions during the period in which the issuer was both an Affiliate and a portfolio company that we Control are as follows:

 

 

 

 

 

 

 

 

 

Interest

 

Management

 

Net Realized

 

Net Unrealized

 

Company

 

Purchases

 

Redemptions

 

Sales (cost)

 

Income

 

fee income

 

gains/(losses)

 

gains/(losses)

 

GSC Investment Corp. CLO 2007 LTD.

 

$

 

$

 

$

 

$

4,205,509

 

$

2,000,072

 

$

 

$

6,571,992

 

GSC Partners CDO GP III, LP

 

$

 

$

 

$

 

$

 

$

 

$

 

$

 

 

(h)

 

Non-income producing at February 28, 2013.

 

10



Table of Contents

 

Saratoga Investment Corp.

 

Consolidated Statements of Changes in Net Assets

 

(unaudited)

 

 

 

For the nine months ended
November 30, 2013

 

For the nine months ended
November 30, 2012

 

INCREASE FROM OPERATIONS:

 

 

 

 

 

Net investment income

 

$

7,639,588

 

$

5,076,189

 

Net realized gain from investments

 

1,157,824

 

542,720

 

Net realized loss from derivatives

 

 

(131,000

)

Net unrealized appreciation (depreciation) on investments

 

(3,770,968

)

3,188,543

 

Net unrealized appreciation on derivatives

 

 

130,925

 

Net increase in net assets from operations

 

5,026,444

 

8,807,377

 

DECREASE FROM SHAREHOLDER DISTRIBUTIONS:

 

 

 

 

 

Distributions declared

 

(12,534,807

)

(16,475,809

)

Net decrease in net assets from shareholder distributions

 

(12,534,807

)

(16,475,809

)

CAPITAL SHARE TRANSACTIONS:

 

 

 

 

 

Stock dividend distribution

 

10,027,695

 

13,180,503

 

Net increase in net assets from capital share transactions

 

10,027,695

 

13,180,503

 

 

 

 

 

 

 

Total increase in net assets

 

2,519,332

 

5,512,071

 

Net assets at beginning of period

 

108,686,761

 

97,380,150

 

Net assets at end of period

 

$

111,206,093

 

$

102,892,221

 

 

 

 

 

 

 

Net asset value per common share

 

$

20.67

 

$

21.75

 

Common shares outstanding at end of period

 

5,379,616

 

4,730,116

 

 

 

 

 

 

 

Distribution in excess of net investment income

 

$

(29,418,170

)

$

(25,319,688

)

 

See accompanying notes to consolidated financial statements.

 

11



Table of Contents

 

Saratoga Investment Corp.

 

Consolidated Statements of Cash Flows

 

(unaudited)

 

 

 

For the nine months
ended November 30,
2013

 

For the nine months
ended November 30,
2012

 

Operating activities

 

 

 

 

 

NET INCREASE IN NET ASSETS FROM OPERATIONS

 

$

5,026,444

 

$

8,807,377

 

ADJUSTMENTS TO RECONCILE NET INCREASE IN NET ASSETS FROM OPERATIONS TO NET CASH PROVIDED BY (USED BY) OPERATING ACTIVITIES:

 

 

 

 

 

Paid-in-kind interest income

 

(634,408

)

(821,830

)

Net accretion of discount on investments

 

(543,999

)

(710,418

)

Amortization of deferred debt financing costs

 

660,568

 

342,505

 

Net realized gain from investments

 

(1,157,824

)

(542,720

)

Net realized loss from derivatives

 

 

131,000

 

Net unrealized (appreciation) depreciation on investments

 

3,770,968

 

(3,188,543

)

Net unrealized appreciation on derivatives

 

 

(130,925

)

Proceeds from sale and redemption of investments

 

64,989,332

 

15,990,963

 

Purchase of investments

 

(110,122,464

)

(34,658,367

)

(Increase) decrease in operating assets:

 

 

 

 

 

Cash and cash equivalents, reserve accounts

 

10,487,010

 

21,747,012

 

Interest receivable

 

138,220

 

(216,782

)

Due from manager

 

(4,929

)

 

Management fee receivable

 

49,171

 

10,634

 

Other assets

 

(16,190

)

75,850

 

Receivable from unsettled trades

 

1,817,074

 

59,511

 

Increase (decrease) in operating liabilities:

 

 

 

 

 

Payable for unsettled trades

 

 

(4,072,500

)

Management and incentive fees payable

 

(922,261

)

479,049

 

Accounts payable and accrued expenses

 

(53,553

)

(196,907

)

Interest and debt fees payable

 

256,537

 

87,162

 

Due to manager

 

50,570

 

(276,217

)

NET CASH PROVIDED BY (USED BY) OPERATING ACTIVITIES

 

(26,209,734

)

2,915,854

 

 

 

 

 

 

 

Financing activities

 

 

 

 

 

Borrowings on debt

 

8,000,000

 

7,350,000

 

Paydowns on debt

 

(24,300,000

)

(8,500,000

)

Issuance of notes

 

48,300,000

 

 

Debt financing cost

 

(2,579,308

)

(597,000

)

NET CASH PROVIDED BY (USED BY) FINANCING ACTIVITIES

 

29,420,692

 

(1,747,000

)

 

 

 

 

 

 

NET INCREASE IN CASH AND CASH EQUIVALENTS

 

3,210,958

 

1,168,854

 

CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD

 

149,025

 

1,325,698

 

CASH AND CASH EQUIVALENTS, END OF PERIOD

 

$

3,359,983

 

$

2,494,552

 

 

 

 

 

 

 

Supplemental Information:

 

 

 

 

 

Interest paid during the period

 

$

3,425,552

 

$

1,378,919

 

 

 

 

 

 

 

Supplemental non-cash information:

 

 

 

 

 

Paid-in-kind interest income

 

$

634,408

 

$

821,830

 

Net accretion of discount on investments

 

$

543,999

 

$

710,418

 

Amortization of deferred debt financing costs

 

$

660,568

 

$

342,505

 

Stock dividend distribution

 

$

10,027,695

 

$

13,180,503

 

Cash dividend payable

 

$

2,507,112

 

$

3,295,306

 

 

See accompanying notes to consolidated financial statements.

 

12



Table of Contents

 

SARATOGA INVESTMENT CORP.

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

November 30, 2013

 

(unaudited)

 

Note 1. Organization and Basis of Presentation

 

Saratoga Investment Corp. (the “Company”, “we”, “our” and “us”) is a non-diversified closed end management investment company incorporated in Maryland that has elected to be treated and is regulated as a business development company (“BDC”) under the Investment Company Act of 1940 (the “1940 Act”). We commenced operations on March 23, 2007 as GSC Investment Corp. and completed our initial public offering (“IPO”) on March 28, 2007. We have elected to be treated as a regulated investment company (“RIC”) under subchapter M of the Internal Revenue Code (the “Code”). We expect to continue to qualify and to elect to be treated for tax purposes as a RIC. Our investment objective is to generate current income and, to a lesser extent, capital appreciation from our investments.

 

GSC Investment, LLC (the “LLC”) was organized in May 2006 as a Maryland limited liability company. As of February 28, 2007, the LLC had not yet commenced its operations and investment activities.

 

On March 21, 2007, the Company was incorporated and concurrently therewith the LLC was merged with and into the Company, with the Company as the surviving entity, in accordance with the procedure for such merger in the LLC’s limited liability company agreement and Maryland law. In connection with such merger, each outstanding limited liability company interest of the LLC was converted into a share of common stock of the Company.

 

On July 30, 2010, the Company changed its name from “GSC Investment Corp.” to “Saratoga Investment Corp.” in conjunction with the transaction described in “Note 12. Recapitalization Transaction” below.

 

We are externally managed and advised by our investment adviser, Saratoga Investment Advisors, LLC (the “Manager”), pursuant to an investment advisory and management agreement. Prior to July 30, 2010, we were managed and advised by GSCP (NJ), L.P.

 

On March 28, 2012, our wholly-owned subsidiary, Saratoga Investment Corp. SBIC, LP (“SBIC LP”), received a Small Business Investment Company (“SBIC”) license from the Small Business Administration (“SBA”).

 

The accompanying consolidated financial statements have been prepared on the accrual basis of accounting in conformity with U.S. generally accepted accounting principles (“GAAP”) and include the accounts of the Company, its special purpose financing subsidiary, Saratoga Investment Funding, LLC (previously known as GSC Investment Funding LLC), and SBIC LP. All intercompany accounts and transactions have been eliminated in consolidation. All references made to the “Company,” “we,” and “us” herein include Saratoga Investment Corp. and its consolidated subsidiaries, except as stated otherwise.

 

Note 2. Summary of Significant Accounting Policies

 

Use of Estimates in the Preparation of Financial Statements

 

The preparation of the accompanying consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and disclosure of contingent assets and liabilities at the date of the financial statements, and income, gains (losses) and expenses during the period reported. Actual results could differ materially from those estimates.

 

Cash and Cash Equivalents

 

Cash and cash equivalents include short-term, liquid investments in a money market fund. Cash and cash equivalents are carried at cost which approximates fair value. Per section 12(d)(1)(A) of the 1940 Act, the Company may not invest in another registered investment company, such as a money market fund, if such investment would cause the Company to exceed any of the following limitations:

 

·                  we were to own more than 3.0% of the total outstanding voting stock of the money market fund;

 

13



Table of Contents

 

·                  we were to hold securities in the money market fund having an aggregate value in excess of 5.0% of the value of our total assets; or

 

·                  we were to hold securities in money market funds and other registered investment companies and BDCs having an aggregate value in excess of 10.0% of the value of our total assets.

 

Cash and Cash Equivalents, Reserve Accounts

 

Cash and cash equivalents, reserve accounts include amounts held in designated bank accounts in the form of cash and short-term liquid investments in money market funds representing payments received on secured investments or other reserved amounts associated with our $45.0 million senior secured revolving credit facility with Madison Capital Funding LLC. The Company is required to use these amounts to pay interest expense, reduce borrowings, or pay other amounts in accordance with the terms of the senior secured revolving credit facility.

 

Investment Classification

 

The Company classifies its investments in accordance with the requirements of the 1940 Act. Under the 1940 Act, “Control Investments” are defined as investments in companies which we own more than 25.0% of the voting securities or maintain greater than 50.0% of the board representation. Under the 1940 Act, “Affiliated Investments” are defined as those non-control investments in companies in which we own between 5.0% and 25.0% of the voting securities. Under the 1940 Act, “Non-affiliated Investments” are defined as investments that are neither Control Investments nor Affiliated Investments.

 

Investment Valuation

 

The Company accounts for its investments at fair value in accordance with the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 820, Fair Value Measurements and Disclosures (“ASC 820”). ASC 820 defines fair value, establishes a framework for measuring fair value, establishes a fair value hierarchy based on the quality of inputs used to measure fair value and enhances disclosure requirements for fair value measurements. ASC 820 requires the Company to assume that its investments are to be sold at the statement of assets and liabilities date in the principal market to independent market participants, or in the absence of a principal market, in the most advantageous market, which may be a hypothetical market. Market participants are defined as buyers and sellers in the principal or most advantageous market that are independent, knowledgeable, and willing and able to transact.

 

Investments for which market quotations are readily available are fair valued at such market quotations obtained from independent third party pricing services and market makers subject to any decision by our board of directors to approve a fair value determination to reflect significant events affecting the value of these investments. We value investments for which market quotations are not readily available at fair value as approved, in good faith, by our board of directors based on input from our Manager, the audit committee of our board of directors and a third party independent valuation firm. Determinations of fair value may involve subjective judgments and estimates. The types of factors that may be considered in determining the fair value of our investments include the nature and realizable value of any collateral, the portfolio company’s ability to make payments, market yield trend analysis, the markets in which the portfolio company does business, comparison to publicly traded companies, discounted cash flow and other relevant factors.

 

We undertake a multi-step valuation process each quarter when valuing investments for which market quotations are not readily available, as described below:

 

·                  Each investment is initially valued by the responsible investment professionals of our Manager and preliminary valuation conclusions are documented and discussed with the senior management of our Manager; and

 

·                  An independent valuation firm engaged by our board of directors reviews approximately one quarter of these preliminary valuations each quarter so that the valuation of each investment for which market quotes are not readily available is reviewed by the independent valuation firm at least annually.

 

In addition, all our investments are subject to the following valuation process:

 

·                  The audit committee of our board of directors reviews each preliminary valuation and our Manager and independent valuation firm (if applicable) will supplement the preliminary valuation to reflect any comments provided by the audit committee; and

 

14



Table of Contents

 

·                  Our board of directors discusses the valuations and approves the fair value of each investment, in good faith, based on the input of our Manager, independent valuation firm (to the extent applicable) and the audit committee of our board of directors.

 

Our investment in Saratoga Investment Corp. CLO 2013-1, Ltd. (“Saratoga CLO”) is carried at fair value, which is based on a discounted cash flow model that utilizes prepayment, re-investment and loss assumptions based on historical experience and projected performance, economic factors, the characteristics of the underlying cash flow, and comparable yields for equity interests in collateralized loan obligation funds similar to Saratoga CLO, when available, as determined by our Manager and recommended to our board of directors. Specifically, we use Intex cash flow models, or an appropriate substitute, to form the basis for the valuation of our investment in Saratoga CLO. The models use a set of assumptions including projected default rates, recovery rates, reinvestment rate and prepayment rates in order to arrive at estimated valuations. The assumptions are based on available market data and projections provided by third parties as well as management estimates. We use the output from the Intex models (i.e., the estimated cash flows) to perform a discounted cash flows analysis on expected future cash flows to determine a valuation for our investment in Saratoga CLO.

 

Because such valuations, and particularly valuations of private investments and private companies, are inherently uncertain, they may fluctuate over short periods of time and may be based on estimates. The determination of fair value may differ materially from the values that would have been used if a ready market for these investments existed. Our net asset value could be materially affected if the determinations regarding the fair value of our investments were materially higher or lower than the values that we ultimately realize upon the disposal of such investments.

 

Derivative Financial Instruments

 

We account for derivative financial instruments in accordance with ASC Topic 815, Derivatives and Hedging (“ASC 815”). ASC 815 requires recognizing all derivative instruments as either assets or liabilities on the consolidated statements of assets and liabilities at fair value. The Company values derivative contracts at the closing fair value provided by the counterparty. Changes in the values of derivative contracts are included in the consolidated statements of operations.

 

Investment Transactions and Income Recognition

 

Purchases and sales of investments and the related realized gains or losses are recorded on a trade-date basis. Interest income, adjusted for amortization of premium and accretion of discount, is recorded on an accrual basis to the extent that such amounts are expected to be collected. The Company stops accruing interest on its investments when it is determined that interest is no longer collectible. Discounts and premiums on investments purchased are accreted/amortized over the life of the respective investment using the effective yield method. The amortized cost of investments represents the original cost adjusted for the accretion of discounts and amortizations of premium on investments.

 

Loans are generally placed on non-accrual status when there is reasonable doubt that principal or interest will be collected. Accrued interest is generally reserved when a loan is placed on non-accrual status. Interest payments received on non-accrual loans may be recognized as a reduction in principal depending upon management’s judgment regarding collectability. Non-accrual loans are restored to accrual status when past due principal and interest is paid and, in management’s judgment, are likely to remain current, although we may make exceptions to this general rule if the loan has sufficient collateral value and is in the process of collection.

 

Interest income on our investment in Saratoga CLO is recorded using the effective interest method in accordance with the provisions of ASC Topic 325-40, Investments-Other, Beneficial Interests in Securitized Financial Assets, based on the anticipated yield and the estimated cash flows over the projected life of the investment. Yields are revised when there are changes in actual or estimated cash flows due to changes in prepayments and/or re-investments, credit losses or asset pricing. Changes in estimated yield are recognized as an adjustment to the estimated yield over the remaining life of the investment from the date the estimated yield was changed.

 

Paid-in-Kind Interest

 

The Company holds debt investments in its portfolio that contain a payment-in-kind (“PIK”) interest provision. The PIK interest, which represents contractually deferred interest added to the investment balance that is generally due at maturity, is generally recorded on the accrual basis to the extent such amounts are expected to be collected. We stop accruing PIK interest if we do not expect the issuer to be able to pay all principal and interest when due.

 

15



Table of Contents

 

Deferred Debt Financing Costs

 

Financing costs incurred in connection with our credit facility, SBA debentures and notes offering are deferred and amortized using the straight line method, which approximates the effective interest method, over the life of their respective debt instrument.

 

Contingencies

 

In the ordinary course of its business, the Company may enter into contracts or agreements that contain indemnifications or warranties. Future events could occur that lead to the execution of these provisions against the Company. Based on its history and experience, management feels that the likelihood of such an event is remote.

 

In the ordinary course of business, the Company may directly or indirectly be a defendant or plaintiff in legal actions with respect to bankruptcy, insolvency or other types of proceedings. Such lawsuits may involve claims that could adversely affect the value of certain financial instruments owned by the Company.

 

Income Taxes

 

The Company has filed an election to be treated for tax purposes as a RIC under Subchapter M of the Code and, among other things, intends to make the requisite distributions to its stockholders which will relieve the Company from federal income taxes. Therefore, no provision has been recorded for federal income taxes.

 

In order to qualify as a RIC, among other requirements, the Company is required to timely distribute to its stockholders at least 90.0% of its investment company taxable income, as defined by the Code, for each fiscal tax year. The Company will be subject to a nondeductible U.S. federal excise tax of 4.0% on undistributed income if it does not distribute at least 98.0% of its ordinary income in any calendar year and 98.2% of its capital gain net income for each one-year period ending on October 31.

 

Depending on the level of taxable income earned in a tax year, the Company may choose to carry forward taxable income in excess of current year dividend distributions into the next tax year and pay a 4.0% excise tax on such income, as required. To the extent that the Company determines that its estimated current year annual taxable income will be in excess of estimated current year dividend distributions for excise tax purposes, the Company accrues excise tax, if any, on estimated excess taxable income as taxable income is earned.

 

In accordance with certain applicable Treasury regulations and private letter rulings issued by the Internal Revenue Service, a RIC may treat a distribution of its own stock as fulfilling its RIC distribution requirements if each stockholder may elect to receive his or her entire distribution in either cash or stock of the RIC subject to a limitation on the aggregate amount of cash to be distributed to all stockholders, which limitation must be at least 20.0% of the aggregate declared distribution. If too many stockholders elect to receive cash, each stockholder electing to receive cash will receive a pro rata amount of cash (with the balance of the distribution paid in stock). In no event will any stockholder, electing to receive cash, receive less than 20.0% of his or her entire distribution in cash. If these and certain other requirements are met, for U.S federal income tax purposes, the amount of the dividend paid in stock will be equal to the amount of cash that could have been received instead of stock.

 

ASC 740, Income Taxes, (“ASC 740”), provides guidance for how uncertain tax positions should be recognized, measured, presented and disclosed in the financial statements. ASC 740 requires the evaluation of tax positions taken or expected to be taken in the course of preparing the Company’s tax returns to determine whether the tax positions are “more-likely-than-not” of being sustained by the applicable tax authority. Tax positions deemed to meet a “more-likely-than-not” threshold would be recorded as a tax benefit or expense in the current period. The Company recognizes interest and penalties, if any, related to unrecognized tax benefits as income tax expense in the consolidated statements of operations. As of November 30, 2013 and February 28, 2013, there were no uncertain tax positions.

 

Dividends

 

Dividends to common stockholders are recorded on the ex-dividend date. The amount to be paid out as a dividend is determined by the board of directors. Net realized capital gains, if any, are generally distributed at least annually, although we may decide to retain such capital gains for reinvestment.

 

We have adopted a dividend reinvestment plan that provides for reinvestment of our dividend distributions on behalf of our stockholders unless a stockholder elects to receive cash. As a result, if our board of directors authorizes, and we declare, a cash dividend, then our stockholders who have not “opted out” of our dividend reinvestment plan will have their cash dividends automatically reinvested in additional shares of our common stock, rather than receiving the cash dividends. If our common stock is

 

16



Table of Contents

 

trading below net asset value at the time of valuation, the plan administrator may receive the dividend or distribution in cash and purchase common stock in the open market, on the New York Stock Exchange or elsewhere, for the account of each participant in our dividend reinvestment plan.

 

Capital Gains Incentive Fee

 

The Company records an expense accrual in the consolidated statements of operations relating to the capital gains incentive fee payable by the Company to its investment adviser when the unrealized gains on its investments exceed all realized capital losses on its investments given the fact that a capital gains incentive fee would be owed to the investment adviser if the Company were to liquidate its investment portfolio at such time. The actual incentive fee payable to the Company’s investment adviser related to capital gains will be determined and payable in arrears at the end of each fiscal year and will include only realized capital gains for the period.

 

Risk Management

 

In the ordinary course of its business, the Company manages a variety of risks, including market risk and credit risk. Market risk is the risk of potential adverse changes to the value of investments because of changes in market conditions such as interest rate movements and volatility in investment prices.

 

Credit risk is the risk of default or non-performance by portfolio companies, equivalent to the investment’s carrying amount.

 

The Company is also exposed to credit risk related to maintaining all of its cash and cash equivalents, including those in reserve accounts, at a major financial institution and credit risk related to any of its derivative counterparties.

 

The Company has investments in lower rated and comparable quality unrated high yield bonds and bank loans. Investments in high yield investments are accompanied by a greater degree of credit risk. The risk of loss due to default by the issuer is significantly greater for holders of high yield securities because such investments are generally unsecured and are often subordinated to other creditors of the issuer.

 

Note 3. Investments

 

As noted above, the Company values all investments in accordance with ASC 820. ASC 820 requires enhanced disclosures about assets and liabilities that are measured and reported at fair value. As defined in ASC 820, fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date.

 

ASC 820 establishes a hierarchal disclosure framework which prioritizes and ranks the level of market price observability of inputs used in measuring investments at fair value. Market price observability is affected by a number of factors, including the type of investment and the characteristics specific to the investment. Investments with readily available active quoted prices or for which fair value can be measured from actively quoted prices generally will have a higher degree of market price observability and a lesser degree of judgment used in measuring fair value.

 

Based on the observability of the inputs used in the valuation techniques, the Company is required to provide disclosures on fair value measurements according to the fair value hierarchy. The fair value hierarchy ranks the observability of the inputs used to determine fair values. Investments carried at fair value are classified and disclosed in one of the following three categories:

 

·                  Level 1—Valuations based on quoted prices in active markets for identical assets or liabilities that the Company has the ability to access.

 

·                  Level 2—Valuations based on inputs other than quoted prices in active markets, which are either directly or indirectly observable.

 

·                  Level 3—Valuations based on inputs that are unobservable and significant to the overall fair value measurement. The inputs used in the determination of fair value may require significant management judgment or estimation. Such information may be the result of consensus pricing information or broker quotes which include a disclaimer that the broker would not be held to such a price in an actual transaction. The non-binding nature of consensus pricing and/or quotes accompanied by disclaimer would result in classification as a Level 3 asset, assuming no additional corroborating evidence.

 

In addition to using the above inputs in investment valuations, the Company continues to employ the valuation policy approved by the board of directors that is consistent with ASC 820 and the 1940 Act (see Note 2). Consistent with our Company’s

 

17



Table of Contents

 

valuation policy, we evaluate the source of inputs, including any markets in which our investments are trading, in determining fair value.

 

The following table presents fair value measurements of investments, by major class, as of November 30, 2013 (dollars in thousands), according to the fair value hierarchy:

 

 

 

Fair Value Measurements

 

 

 

Level 1

 

Level 2

 

Level 3

 

Total

 

Middle market loans

 

$

 

$

 

$

37,381

 

$

37,381

 

First lien term loans

 

 

 

70,637

 

70,637

 

Second lien term loans

 

 

 

27,724

 

27,724

 

Senior secured notes

 

 

 

29,920

 

29,920

 

Unsecured notes

 

 

 

5,379

 

5,379

 

Structured finance securities

 

 

 

19,019

 

19,019

 

Equity interest

 

 

 

8,719

 

8,719

 

Total

 

$

 

$

 

$

198,779

 

$

198,779

 

 

The following table presents fair value measurements of investments, by major class, as of February 28, 2013 (dollars in thousands), according to the fair value hierarchy:

 

 

 

Fair Value Measurements

 

 

 

Level 1

 

Level 2

 

Level 3

 

Total

 

First lien term loans

 

$

 

$

 

$

83,792

 

$

83,792

 

Second lien term loans

 

 

 

9,571

 

9,571

 

Senior secured notes

 

 

 

23,305

 

23,305

 

Unsecured notes

 

 

 

4,874

 

4,874

 

Structured finance securities

 

 

 

25,517

 

25,517

 

Equity interest

 

 

 

8,021

 

8,021

 

Total

 

$

 

$

 

$

155,080

 

$

155,080

 

 

The following table provides a reconciliation of the beginning and ending balances for investments that use Level 3 inputs for the nine months ended November 30, 2013 (dollars in thousands):

 

 

 

Middle
market
loans

 

First lien
term loans

 

Second lien
term loans

 

Senior
secured
notes

 

Unsecured
notes

 

Structured
finance
securities

 

Common
stock/equities

 

Total

 

Balance as of February 28, 2013

 

$

 

$

83,792

 

$

9,571

 

$

23,305

 

$

4,874

 

$

25,517

 

$

8,021

 

$

155,080

 

Net unrealized gains (losses)

 

396

 

(452

)

120

 

(23

)

339

 

(4,109

)

(42

)

(3,771

)

Purchases and other adjustments to cost

 

37,031

 

38,305

 

20,693

 

14,366

 

166

 

 

740

 

111,301

 

Sales and redemptions

 

(46

)

(51,667

)

(3,031

)

(7,728

)

 

(2,389

)

(128

)

(64,989

)

Net realized gains from investments

 

 

659

 

371

 

 

 

 

128

 

1,158

 

Balance as of November 30, 2013

 

$

37,381

 

$

70,637

 

$

27,724

 

$

29,920

 

$

5,379

 

$

19,019

 

$

8,719

 

$

198,779

 

 

The following table provides a reconciliation of the beginning and ending balances for investments that use Level 3 inputs for the nine months ended November 30, 2012 (dollars in thousands):

 

 

 

First lien
term loans

 

Second lien
term loans

 

Senior
secured
notes

 

Senior
unsecured
loans

 

Unsecured
notes

 

Structured
finance
securities

 

Common
stock/equities

 

Total

 

Balance as of February 29, 2012

 

$

36,196

 

$

8,914

 

$

10,706

 

$

6,000

 

$

2,008

 

$

25,846

 

$

5,690

 

$

95,360

 

Net unrealized gains (losses)

 

1,194

 

161

 

(679

)

(148

)

(197

)

1,974

 

884

 

3,189

 

Purchases and other adjustments to cost

 

31,069

 

2,908

 

464

 

107

 

430

 

 

1,212

 

36,190

 

Sales and redemptions

 

(4,544

)

(2,032

)

 

(6,090

)

 

(3,179

)

(146

)

(15,991

)

Net realized gain from investments

 

179

 

87

 

 

131

 

 

 

146

 

543

 

Balance as of November 30, 2012

 

$

64,094

 

$

10,038

 

$

10,491

 

$

 

$

2,241

 

$

24,641

 

$

7,786

 

$

119,291

 

 

18



Table of Contents

 

Purchases and other adjustments to cost include purchases of new investments at cost, effects of refinancing/restructuring, accretion/amortization of income from discount/premium on debt securities, and PIK.

 

Sales and redemptions represent net proceeds received from investments sold, and principal paydowns received, during the period.

 

The net change in unrealized gain/(loss) on investments held for the nine months ended November 30, 2013 and 2012, was $(3,890,205) and $3,318,830, respectively, and is included in net unrealized appreciation (depreciation) on investments in the consolidated statements of operations.

 

The valuation techniques and significant unobservable inputs used in recurring Level 3 fair value measurements of assets as of November 30, 2013 were as follows (dollars in thousands):

 

 

 

Fair Value

 

Valuation Technique

 

Unobservable Input

 

Range

 

Weighted
Average Yield

 

First lien term loans

 

$

108,018

 

Market Comparables

 

Market Yield (%)

 

5.4% - 15.5%

 

10.2

%

 

 

 

 

 

 

EBITDA Multiples (x)

 

3.0x – 4.0x

 

4.0x

 

 

 

 

 

 

 

Third-Party Bid

 

85.0% - 101.1%

 

98.8

%

Second lien term loans

 

27,724

 

Market Comparables

 

Market Yield (%)

 

9.5% - 12.2%

 

11.5

%

 

 

 

 

 

 

Third-Party Bid

 

98.9% - 100.0%

 

99.4

%

Senior secured notes

 

29,920

 

Market Comparables

 

Market Yield (%)

 

9.9% - 42.5%

 

12.5

%

 

 

 

 

 

 

EBITDA Multiples (x)

 

5.0x

 

5.0x

 

 

 

 

 

 

 

Third-Party Bid

 

105.5%

 

105.5

%

Unsecured notes

 

5,379

 

Market Comparables

 

Market Yield (%)

 

8.0% - 23.0%

 

14.4

%

Structured finance securities

 

19,019

 

Discounted Cash Flow

 

Discount Rate (%)

 

10.0%

 

10.0

%

Equity interests

 

8,719

 

Market Comparables

 

EBITDA Multiples (x)

 

4.0x – 8.0x

 

7.3x

 

 

The valuation techniques and significant unobservable inputs used in recurring Level 3 fair value measurements of assets as of February 28, 2013 were as follows (dollars in thousands):

 

 

 

Fair Value

 

Valuation Technique

 

Unobservable Input

 

Range

 

Weighted
Average Yield

 

First lien term loans

 

$

83,792

 

Market Comparables

 

Market Yield (%)

 

5.8% - 26.9%

 

10.0

%

 

 

 

 

 

 

EBITDA Multiples (x)

 

3.0x

 

3.0x

 

 

 

 

 

 

 

Third-Party Bid

 

96.5 - 102.0

 

100.1

 

Second lien term loans

 

9,571

 

Market Comparables

 

Market Yield (%)

 

11.5%

 

11.5

%

 

 

 

 

 

 

Third-Party Bid

 

90.5

 

90.5

 

Senior secured notes

 

23,305

 

Market Comparables

 

Market Yield (%)

 

14.0% - 42.5%

 

20.4

%

 

 

 

 

 

 

EBITDA Multiples (x)

 

5.5x

 

5.5x

 

 

 

 

 

 

 

Third-Party Bid

 

89.0 – 101.0

 

97.0

 

Unsecured notes

 

4,874

 

Market Comparables

 

Market Yield (%)

 

13.6% - 23.8%

 

17.4

%

Structured finance securities

 

25,517

 

Discounted Cash Flow

 

Discount Rate (%)

 

13.0%

 

13.0

%

Equity interests

 

8,021

 

Market Comparables

 

EBITDA Multiples (x)

 

3.0x – 8.9x

 

6.6x

 

 

For investments utilizing a market comparables valuation technique, a significant increase (decrease) in the market yield, in isolation, would result in a significantly lower (higher) fair value measurement, and a significant increase (decrease) in any of the EBITDA valuation multiples, in isolation, would result in a significantly higher (lower) fair value measurement. For investments utilizing a discounted cash flow valuation technique, a significant increase (decrease) in the discount rate, in isolation, would result in a significantly lower (higher) fair value measurement.

 

19



Table of Contents

 

The composition of the Company’s investments as of November 30, 2013, at amortized cost and fair value were as follows (dollars in thousands):

 

 

 

Investments at
Amortized Cost

 

Amortized Cost
Percentage of
Total Portfolio

 

Investments at
Fair Value

 

Fair Value
Percentage of
Total Portfolio

 

Middle market loans

 

$

36,985

 

18.8

%

$

37,381

 

18.8

%

First lien term loans

 

71,182

 

36.1

 

70,637

 

35.5

 

Second lien term loans

 

27,507

 

14.0

 

27,724

 

13.9

 

Senior secured notes

 

31,257

 

15.9

 

29,920

 

15.1

 

Unsecured notes

 

6,924

 

3.5

 

5,379

 

2.7

 

Structured finance securities

 

16,556

 

8.4

 

19,019

 

9.6

 

Equity interest

 

6,468

 

3.3

 

8,719

 

4.4

 

Total

 

$

196,879

 

100.0

%

$

198,779

 

100.0

%

 

The composition of the Company’s investments as of February 28, 2013, at amortized cost and fair value were as follows (dollars in thousands):

 

 

 

Investments at
Amortized Cost

 

Amortized Cost
Percentage of
Total Portfolio

 

Investments at
Fair Value

 

Fair Value
Percentage of
Total Portfolio

 

First lien term loans

 

$

83,886

 

56.2

%

$

83,792

 

54.0

%

Second lien term loans

 

9,473

 

6.3

 

9,571

 

6.2

 

Senior secured notes

 

24,619

 

16.5

 

23,305

 

15.0

 

Unsecured notes

 

6,758

 

4.5

 

4,874

 

3.1

 

Structured finance securities

 

18,945

 

12.7

 

25,517

 

16.5

 

Equity interest

 

5,729

 

3.8

 

8,021

 

5.2

 

Total

 

$

149,410

 

100.0

%

$

155,080

 

100.0

%

 

For loans and debt securities for which market quotations are not available, we determine their fair value based on third party indicative broker quotes, where available, or the assumptions that a hypothetical market participant would use to value the security in a current hypothetical sale using a market yield valuation methodology. In applying the market yield valuation methodology, we determine the fair value based on such factors as market participant assumptions including synthetic credit ratings, estimated remaining life, current market yield and interest rate spreads of similar securities as of the measurement date. If, in our judgment, the market yield methodology is not sufficient or appropriate, we may use additional methodologies such as an asset liquidation or expected recovery model.

 

For equity securities of portfolio companies, we determine the fair value based on the market approach with value then attributed to equity or equity like securities using the enterprise value waterfall valuation methodology. Under the enterprise value waterfall valuation methodology, we determine the enterprise fair value of the portfolio company and then waterfall the enterprise value over the portfolio company’s securities in order of their preference relative to one another. To estimate the enterprise value of the portfolio company, we weigh some or all of the traditional market valuation methods and factors based on the individual circumstances of the portfolio company in order to estimate the enterprise value. The methodologies for performing investments may be based on, among other things: valuations of comparable public companies, recent sales of private and public comparable companies, discounting the forecasted cash flows of the portfolio company, third party valuations of the portfolio company, considering offers from third parties to buy the company, estimating the value to potential strategic buyers and considering the value of recent investments in the equity securities of the portfolio company. For non-performing investments, we may estimate the liquidation or collateral value of the portfolio company’s assets and liabilities. We also take into account historical and anticipated financial results.

 

Our investment in Saratoga Investment Corp. CLO 2013-1, Ltd. (“Saratoga CLO”) is carried at fair value, which is based on a discounted cash flow model that utilizes prepayment, re-investment and loss assumptions based on historical experience and projected performance, economic factors, the characteristics of the underlying cash flow, and comparable yields for equity interests in collateralized loan obligation funds similar to Saratoga CLO, when available, as determined by our Manager and recommended to our board of directors. Specifically, we use Intex cash flow models, or an appropriate substitute, to form the basis for the valuation of our investment in Saratoga CLO. The models use a set of assumptions including projected default rates, recovery rates, reinvestment rate and prepayment rates in order to arrive at estimated valuations. The assumptions are based on available market data and projections provided by third parties as well as management estimates. For the quarter ended November 30, 2013, in connection with the refinancing of the Saratoga CLO liabilities, we ran Intex models based on assumptions about the refinanced Saratoga CLO’s structure, including capital structure, cost of liabilities and reinvestment period. We use the output from the Intex models (i.e., the estimated cash flows) to perform a discounted cash flows analysis on expected future cash flows to determine a valuation for our investment in Saratoga CLO at November 30, 2013. The significant inputs for the valuation model include:

 

20



Table of Contents

 

·                  Default rates: 2.0%

 

·                  Recovery rates: 35-75%

 

·                  Prepayment rate: 25.0%

 

·                  Reinvestment rate / price: L+375bps / $99.75

 

Note 4. Investment in Saratoga Investment Corp. CLO 2013-1, Ltd. (“Saratoga CLO”)

 

On January 22, 2008, we invested $30 million in all of the outstanding subordinated notes of GSC Investment Corp. CLO 2007, Ltd., a collateralized loan obligation fund managed by us that invests primarily in senior secured loans. Additionally, we entered into a collateral management agreement with GSC Investment Corp. CLO 2007, Ltd. pursuant to which we act as collateral manager to it. The Saratoga CLO was refinanced in October 2013 and its reinvestment period ends in October 2016.  The Saratoga CLO remains 100% owned and managed by Saratoga Investment Corp.  We receive a senior collateral management fee of 0.25% and a subordinate collateral management fee of 0.25% of the outstanding principal amount of Saratoga CLO’s assets, paid quarterly to the extent of available proceeds.  We are also entitled to an incentive management fee equal to 20.0% of excess cash flow to the extent the Saratoga CLO subordinated notes receive an internal rate of return equal to or greater than 12.0%. For the nine months ended November 30, 2013 and November 30, 2012, we accrued $1.4 million and $1.5 million in management fee income, respectively, and $2.8 million and $3.2 million in interest income, respectively, from Saratoga CLO. We did not accrue any amounts related to the incentive management fee as the 12.0% hurdle rate has not yet been achieved.

 

At November 30, 2013, the Company determined that the fair value of its investment in the subordinated notes of Saratoga CLO was $19.0 million. The Company determines the fair value of its investment in the subordinated notes of Saratoga CLO based on the present value of the projected future cash flows of the subordinated notes over the life of Saratoga CLO. At November 30, 2013, Saratoga CLO had investments with a principal balance of $300.6 million and a weighted average spread over LIBOR of 4.2%, and had debt with a principal balance of $284.9 million with a weighted average spread over LIBOR of 1.8%. As a result, Saratoga CLO earns a “spread” between the interest income it receives on its investments and the interest expense it pays on its debt and other operating expenses, which is distributed quarterly to the Company as the holder of its subordinated notes. At November 30, 2013, the total “spread”, or projected future cash flows of the subordinated notes, over the life of Saratoga CLO was $24.8 million, which had a present value of approximately $19.3 million, using a 10.0% discount rate.

 

Below is certain financial information from the separate unaudited financial statements of Saratoga CLO as of November 30, 2013 and February 28, 2013 and for the three and nine months ended November 30, 2013 and November 30, 2012.

 

21



Table of Contents

 

Saratoga Investment Corp. CLO 2013-1, Ltd.

 

Statements of Assets and Liabilities

 

 

 

As of

 

 

 

November 30, 2013

 

February 28, 2013

 

 

 

(unaudited)

 

 

 

ASSETS

 

 

 

 

 

 

 

 

 

 

 

Investments

 

 

 

 

 

Fair Value Loans

 

$

299,763,643

 

$

362,494,006

 

Fair Value Other/Structured finance securities

 

 

11,925,973

 

Total investments at fair value

 

299,763,643

 

374,419,979

 

Cash and cash equivalents

 

15,744,170

 

28,804,871

 

Receivable from open trades

 

503,125

 

5,131,538

 

Interest receivable

 

1,635,813

 

1,584,985

 

Other assets

 

84,909

 

 

Deferred bond issuance

 

2,222,893

 

2,092,787

 

Total assets

 

$

319,954,553

 

$

412,034,160

 

 

 

 

 

 

 

LIABILITIES

 

 

 

 

 

 

 

 

 

 

 

Interest payable

 

$

728,357

 

$

666,121

 

Payable from open trades

 

15,430,312

 

16,346,250

 

Accounts payable and accrued expenses

 

72,927

 

 

Accrued senior collateral monitoring fee

 

83,341

 

43,171

 

Accrued subordinate collateral monitoring fee

 

83,341

 

172,682

 

Class A notes - GSCIC CLO 2007, Ltd.

 

 

296,000,000

 

Class B notes - GSCIC CLO 2007, Ltd.

 

 

22,000,000

 

Discount on class B notes - GSCIC CLO 2007, Ltd.

 

 

(417,011

)

Class C notes - GSCIC CLO 2007, Ltd.

 

 

14,000,000

 

Class D notes - GSCIC CLO 2007, Ltd.

 

 

16,000,000

 

Discount on class D notes - GSCIC CLO 2007, Ltd.

 

 

(441,136

)

Class E notes - GSCIC CLO 2007, Ltd.

 

 

17,960,044

 

Discount on class E notes - GSCIC CLO 2007, Ltd.

 

 

(1,134,778

)

Class X Notes - SIC CLO 2013-1, Ltd.

 

2,500,000

 

 

Class A-1 Notes - SIC CLO 2013-1, Ltd.

 

170,000,000

 

 

Discount on Class A-1 Notes - SIC CLO 2013-1, Ltd.

 

(1,715,276

)

 

Class A-2 Notes - SIC CLO 2013-1, Ltd.

 

20,000,000

 

 

Discount on Class A-2 Notes - SIC CLO 2013-1, Ltd.

 

(177,800

)

 

Class B Notes - SIC CLO 2013-1, Ltd.

 

44,800,000

 

 

Discount on Class B Notes - SIC CLO 2013-1, Ltd.

 

(1,154,989

)

 

Class C Notes - SIC CLO 2013-1, Ltd.

 

16,000,000

 

 

Discount on Class C Notes - SIC CLO 2013-1, Ltd.

 

(719,102

)

 

Class D Notes - SIC CLO 2013-1, Ltd.

 

14,000,000

 

 

Discount on Class D Notes - SIC CLO 2013-1, Ltd.

 

(933,450

)

 

Class E Notes - SIC CLO 2013-1, Ltd.

 

13,100,000

 

 

Discount on Class E Notes - SIC CLO 2013-1, Ltd.

 

(1,759,825

)

 

Class F Notes - SIC CLO 2013-1, Ltd.

 

4,500,000

 

 

Discount on Class F Notes - SIC CLO 2013-1, Ltd.

 

(640,080

)

 

Subordinated Notes

 

30,000,000

 

30,000,000

 

Total liabilities

 

$

324,197,756

 

$

411,195,343

 

 

 

 

 

 

 

NET ASSETS

 

 

 

 

 

 

 

 

 

 

 

Ordinary equity, par value $1.00, 250 ordinary shares authorized, 250 and 250 issued and outstanding, respectively

 

$

250

 

$

250

 

Accumulated gain (loss)

 

838,567

 

(5,963,092

)

Net income

 

(5,082,020

)

6,801,659

 

Total Net Assets

 

(4,243,203

)

838,817

 

 

 

 

 

 

 

Total liabilities and net assets

 

$

319,954,553

 

$

412,034,160

 

 

22



Table of Contents

 

Saratoga Investment Corp. CLO 2013-1, Ltd.

 

Statements of Operations

(unaudited)

 

 

 

For the three months ended
November 30

 

For the nine months ended
November 30

 

 

 

2013

 

2012

 

2013

 

2012

 

INVESTMENT INCOME

 

 

 

 

 

 

 

 

 

Interest from investments

 

$

3,552,429

 

$

4,843,433

 

$

12,160,257

 

$

14,699,180

 

Interest from cash and cash equivalents

 

2,030

 

2,718

 

6,481

 

13,550

 

Other income

 

214,092

 

292,475

 

891,358

 

607,648

 

Total investment income

 

3,768,551

 

5,138,626

 

13,058,096

 

15,320,378

 

 

 

 

 

 

 

 

 

 

 

EXPENSES

 

 

 

 

 

 

 

 

 

Interest expense

 

6,906,431

 

8,076,898

 

9,944,427

 

11,652,383

 

Professional fees

 

62,452

 

46,134

 

387,380

 

293,392

 

Misc. Fee Expense

 

4,198

 

15,494

 

164,989

 

83,081

 

Senior collateral monitoring fee

 

134,244

 

100,091

 

330,012

 

300,104

 

Subordinate collateral monitoring fee

 

286,953

 

400,363

 

1,070,026

 

1,200,415

 

Trustee expenses

 

21,012

 

25,778

 

69,383

 

75,646

 

Amortization expense

 

3,692,220

 

253,635

 

4,201,074

 

762,489

 

Total expenses

 

11,107,510

 

8,918,393

 

16,167,291

 

14,367,510

 

 

 

 

 

 

 

 

 

 

 

NET INVESTMENT INCOME

 

(7,338,959

)

(3,779,767

)

(3,109,195

)

952,868

 

 

 

 

 

 

 

 

 

 

 

REALIZED AND UNREALIZED GAIN (LOSS) ON INVESTMENTS:

 

 

 

 

 

 

 

 

 

Net realized gain/(loss) on investments

 

(9,292,595

)

269,472

 

(8,840,995

)

1,681,602

 

Net unrealized appreciation on investments

 

10,367,981

 

782,564

 

6,868,170

 

2,091,233

 

Net gain/(loss) on investments

 

1,075,386

 

1,052,036

 

(1,972,825

)

3,772,835

 

 

 

 

 

 

 

 

 

 

 

NET INCREASE (DECREASE) IN NET ASSETS RESULTING FROM OPERATIONS

 

$

(6,263,573

)

$

(2,727,731

)

$

(5,082,020

)

$

4,725,703

 

 

23



Table of Contents

 

GSC Investment Corp.

 

Schedule of Investments

 

November 30, 2013

 

(unaudited)

 

Issuer Name

 

Industry

 

Asset Name

 

Asset Type

 

Current Rate

 

Maturity Date

 

Principal / Number
of Shares

 

Cost

 

Fair Value

 

Elyria Foundry Company, LLC

 

Industrial Equipment

 

Preferred Warrants (2013)

 

Equity

 

0.00

%

 

 

7,291

 

$

 

$

 

OLD AII, Inc (fka Aleris International Inc.)

 

Conglomerate

 

Common

 

Equity

 

0.00

%

 

 

2,624

 

224,656

 

 

Academy, LTD.

 

Retailers (Except Food and Drugs)

 

Initial Term Loan (2012)

 

Loan

 

4.50

%

8/3/2018

 

$

1,965,150

 

1,953,154

 

1,974,150

 

Acosta, Inc.

 

Food Products

 

Term D Loan

 

Loan

 

5.00

%

3/2/2018

 

$

4,173,199

 

4,107,534

 

4,171,113

 

Aderant North America, Inc.

 

Business Equipment and Services

 

Term Loan (First Lien)

 

Loan

 

6.25

%

12/20/2018

 

$

3,482,500

 

3,478,743

 

3,473,794

 

Aeroflex Incorporated

 

Aerospace and Defense

 

Tranche B-1 Term Loan

 

Loan

 

4.50

%

11/9/2019

 

$

3,208,854

 

3,194,077

 

3,227,754

 

Akorn, Inc.

 

Healthcare

 

Term Loan B

 

Loan

 

4.50

%

11/13/2020

 

$

500,000

 

497,500

 

501,565

 

Alcatel-Lucent USA Inc.

 

Telecommunications/Cellular

 

US Term Loan

 

Loan

 

7.25

%

1/30/2019

 

$

1,066,938

 

1,062,273

 

1,075,612

 

Alere Inc. (fka IM US Holdings, LLC)

 

Healthcare

 

Incremental B-1 Term Loan

 

Loan

 

4.25

%

6/30/2017

 

$

1,965,000

 

1,933,308

 

1,976,456

 

Aptalis Pharma, Inc. (fka Axcan Intermediate Holdings Inc.)

 

Drugs

 

Term B-1 Loan

 

Loan

 

5.50

%

2/10/2017

 

$

1,945,000

 

1,935,496

 

1,963,847

 

Aramark Corporation

 

Food Products

 

LC-2 Facility

 

Loan

 

3.69

%

7/26/2016

 

$

79,187

 

79,187

 

79,328

 

Aramark Corporation

 

Food Products

 

LC-3 Facility

 

Loan

 

3.69

%

7/26/2016

 

$

43,961

 

43,961

 

44,039

 

Aramark Corporation

 

Food Products

 

U.S. Term B Loan (Extending)

 

Loan

 

3.69

%

7/26/2016

 

$

977,380

 

977,380

 

979,120

 

Aramark Corporation

 

Food Products

 

U.S. Term C Loan

 

Loan

 

3.75

%

7/26/2016

 

$

2,545,700

 

2,545,700

 

2,550,231

 

ARG IH Corporation

 

Food Services

 

Term Loan

 

Loan

 

5.00

%

11/15/2020

 

$

500,000

 

498,753

 

501,875

 

Asurion, LLC (fka Asurion Corporation)

 

Insurance

 

Incremental Tranche B-1 Term Loan

 

Loan

 

4.50

%

5/24/2019

 

$

5,616,648

 

5,567,444

 

5,612,772

 

Auction.Com, LLC

 

Business Equipment and Services

 

Term Loan A-4

 

Loan

 

4.20

%

2/28/2017

 

$

993,333

 

992,400

 

985,884

 

Autotrader.com, Inc.

 

Automotive

 

Tranche B-1 Term Loan

 

Loan

 

4.00

%

12/15/2016

 

$

3,801,525

 

3,801,525

 

3,825,285

 

Avantor Performance Materials Holdings, Inc.

 

Chemicals/Plastics

 

Term Loan

 

Loan

 

5.25

%

6/24/2017

 

$

4,887,500

 

4,872,855

 

4,887,500

 

AZ Chem US Inc.

 

Chemicals/Plastics

 

Term Loan

 

Loan

 

5.25

%

12/22/2017

 

$

1,415,023

 

1,386,045

 

1,423,867

 

Bass Pro Group, LLC

 

Retailers (Except Food and Drugs)

 

New Term Loan

 

Loan

 

3.75

%

11/20/2019

 

$

500,000

 

499,375

 

501,795

 

Biomet, Inc.

 

Healthcare

 

Dollar Term B-1 Loan

 

Loan

 

3.97

%

7/25/2017

 

$

1,975,087

 

1,975,087

 

1,989,585

 

BJ’s Wholesale Club, Inc.

 

Food/Drug Retailers

 

New 2013 (November) Replacement Loan (First Lien)

 

Loan

 

4.50

%

9/26/2019

 

$

500,000

 

497,500

 

501,455

 

Bombardier Recreational Products Inc.

 

Leisure Goods/Activities/Movies

 

Term B Loan

 

Loan

 

4.00

%

1/30/2019

 

$

754,285

 

747,769

 

755,900

 

Brock Holdings III, Inc.

 

Industrial Equipment

 

Term Loan (First Lien)

 

Loan

 

6.01

%

3/16/2017

 

$

1,983,998

 

2,002,588

 

1,988,958

 

Burlington Coat Factory Warehouse Corporation

 

Retailers (Except Food and Drugs)

 

Term B-2 Loan

 

Loan

 

4.25

%

2/23/2017

 

$

2,762,958

 

2,755,664

 

2,777,768

 

C.H.I. Overhead Doors, Inc. (CHI)

 

Home Furnishings

 

Term Loan (First Lien)

 

Loan

 

5.50

%

3/18/2019

 

$

2,870,466

 

2,819,817

 

2,874,054

 

Camp International Holding Company

 

Aerospace and Defense

 

Refinanced Term Loan (First Lien)

 

Loan

 

5.25

%

5/31/2019

 

$

990,000

 

981,827

 

992,475

 

Capital Automotive L.P.

 

Conglomerate

 

Tranche B-1 Term Loan Facility

 

Loan

 

4.00

%

4/10/2019

 

$

2,143,450

 

2,148,234

 

2,153,503

 

Capstone Logistics, LLC

 

Business Equipment and Services

 

Term Note A

 

Loan

 

6.50

%

9/16/2016

 

$

2,675,560

 

2,652,296

 

2,635,578

 

Capsugel Holdings US, Inc.

 

Drugs

 

Initial Term Loan

 

Loan

 

4.75

%

8/1/2018

 

$

3,342,357

 

3,334,996

 

3,334,001

 

Celanese US Holdings LLC

 

Chemicals/Plastics

 

Dollar Term C Loan (Extended)

 

Loan

 

3.03

%

10/31/2016

 

$

2,181,792

 

2,209,793

 

2,204,700

 

Charter Communications Operating, LLC

 

Cable and Satellite Television

 

Term F Loan

 

Loan

 

3.00

%

12/31/2020

 

$

2,689,447

 

2,679,082

 

2,650,450

 

CHS/Community Health Systems, Inc.

 

Healthcare

 

Extended Term Loan

 

Loan

 

3.77

%

1/25/2017

 

$

4,064,516

 

3,983,104

 

4,083,457

 

Cinedigm Digital Funding I, LLC

 

Business Equipment and Services

 

Term Loan

 

Loan

 

3.75

%

2/28/2018

 

$

886,841

 

882,016

 

884,624

 

Covanta Energy Corporation

 

Ecological Services and Equipment

 

Term Loan

 

Loan

 

3.50

%

3/28/2019

 

$

492,500

 

490,626

 

494,347

 

CPI International Acquisition, Inc. (f/k/a Catalyst Holdings, Inc.)

 

Electronics/Electric

 

Term B Loan

 

Loan

 

5.00

%

2/13/2017

 

$

4,805,833

 

4,792,984

 

4,814,868

 

Crosby US Acquisition Corp.

 

Industrial Equipment

 

Initial Term Loan (First Lien)

 

Loan

 

4.00

%

11/23/2020

 

$

750,000

 

749,063

 

750,705

 

Crown Castle Operating Company

 

Telecommunications/Cellular

 

New Tranche B Term Loan

 

Loan

 

3.25

%

1/31/2019

 

$

1,965,129

 

1,947,580

 

1,961,160

 

Culligan International Company

 

Conglomerate

 

Dollar Loan (First Lien)

 

Loan

 

6.25

%

12/19/2017

 

$

789,663

 

736,761

 

744,257

 

Culligan International Company

 

Conglomerate

 

Dollar Loan (Second Lien)

 

Loan

 

9.50

%

6/19/2018

 

$

783,162

 

729,134

 

669,604

 

DaVita HealthCare Partners Inc. (fka DaVita Inc.)

 

Healthcare

 

Tranche B Term Loan

 

Loan

 

4.50

%

10/20/2016

 

$

3,919,395

 

3,919,395

 

3,938,013

 

DCS Business Services, Inc.

 

Financial Intermediaries

 

Term B Loan

 

Loan

 

7.25

%

3/19/2018

 

$

3,841,340

 

3,800,100

 

3,745,306

 

Del Monte Foods Company

 

Food Products

 

Initial Term Loan

 

Loan

 

4.00

%

3/8/2018

 

$

4,304,067

 

4,336,219

 

4,318,873

 

Dell International LLC

 

Retailers (Except Food and Drugs)

 

Term B Loan

 

Loan

 

4.50

%

4/29/2020

 

$

2,000,000

 

1,987,500

 

1,979,100

 

Digitalglobe, Inc.

 

Ecological Services and Equipment

 

Term Loan

 

Loan

 

3.75

%

1/31/2020

 

$

248,750

 

248,750

 

250,926

 

Drew Marine Group Inc.

 

Chemicals/Plastics

 

Term Loan (First Lien)

 

Loan

 

4.50

%

11/19/2020

 

$

500,000

 

499,375

 

503,125

 

Dunkin’ Brands, Inc.

 

Food Services

 

Term B-3 Loan

 

Loan

 

3.75

%

2/14/2020

 

$

3,967,549

 

3,958,640

 

3,973,659

 

DynCorp International Inc.

 

Aerospace and Defense

 

Term Loan

 

Loan

 

6.25

%

7/7/2016

 

$

547,845

 

543,089

 

551,270

 

Education Management LLC

 

Leisure Goods/Activities/Movies

 

Tranche C-2 Term Loan

 

Loan

 

4.31

%

6/1/2016

 

$

3,892,866

 

3,742,224

 

3,751,749

 

EIG Investors Corp.

 

Business Equipment and Services

 

Term Loan

 

Loan

 

5.00

%

11/9/2019

 

$

1,000,000

 

995,000

 

1,005,000

 

Energy Transfer Equity, L.P.

 

Oil & Gas

 

Loan

 

Loan

 

3.25

%

12/2/2019

 

$

1,000,000

 

997,500

 

997,340

 

Evergreen Acqco 1 LP

 

Retailers (Except Food and Drugs)

 

New Term Loan

 

Loan

 

5.00

%

7/9/2019

 

$

493,763

 

489,672

 

494,533

 

Federal-Mogul Corporation

 

Automotive

 

Tranche B Term Loan

 

Loan

 

2.14

%

12/29/2014

 

$

2,220,981

 

2,176,995

 

2,192,108

 

Federal-Mogul Corporation

 

Automotive

 

Tranche C Term Loan

 

Loan

 

2.14

%

12/28/2015

 

$

1,310,508

 

1,269,309

 

1,293,471

 

First Data Corporation

 

Financial Intermediaries

 

2017 New Dollar Term Loan

 

Loan

 

4.20

%

3/24/2017

 

$

2,111,028

 

2,024,861

 

2,115,545

 

First Data Corporation

 

Financial Intermediaries

 

2018 Dollar Term Loan

 

Loan

 

4.20

%

3/23/2018

 

$

2,290,451

 

2,227,784

 

2,295,032

 

FMG Resources (August 2006) Pty LTD (FMG America Finance, Inc.)

 

Nonferrous Metals/Minerals

 

Loan

 

Loan

 

4.25

%

6/28/2019

 

$

1,000,000

 

997,506

 

1,008,750

 

Garda World Security Corporation

 

Business Equipment and Services

 

Term B Delayed Draw Loan

 

Loan

 

0.50

%

11/6/2020

 

$

203,704

 

(1,015

)

 

Garda World Security Corporation

 

Business Equipment and Services

 

Term B Loan

 

Loan

 

4.00

%

11/6/2020

 

$

796,296

 

792,329

 

799,784

 

Gardner Denver, Inc.

 

Oil & Gas

 

Initial Dollar Term Loan

 

Loan

 

4.25

%

7/30/2020

 

$

1,500,000

 

1,488,750

 

1,492,065

 

Generac Power Systems, Inc.

 

Industrial Equipment

 

Term Loan B

 

Loan

 

3.50

%

5/31/2020

 

$

870,595

 

854,438

 

870,596

 

Global Tel*Link Corporation

 

Business Equipment and Services

 

Term Loan (First Lien)

 

Loan

 

5.00

%

5/23/2020

 

$

1,925,000

 

1,920,549

 

1,886,500

 

Goodyear Tire & Rubber Company, The

 

Chemicals/Plastics

 

Loan (Second Lien)

 

Loan

 

4.75

%

4/30/2019

 

$

4,000,000

 

3,938,226

 

4,035,000

 

Grifols Inc.

 

Drugs

 

New U.S. Tranche B Term Loan

 

Loan

 

4.25

%

6/1/2017

 

$

3,431,901

 

3,424,917

 

3,447,207

 

Grosvenor Capital Management Holdings, LLLP

 

Brokers/Dealers/Investment Houses

 

Term Loan B

 

Loan

 

4.19

%

1/4/2021

 

$

3,500,000

 

3,482,500

 

3,491,250

 

Grosvenor Capital Management Holdings, LLLP

 

Brokers/Dealers/Investment Houses

 

Tranche C Term Loan

 

Loan

 

4.25

%

12/5/2016

 

$

3,277,143

 

3,211,147

 

3,260,757

 

HCA Inc.

 

Healthcare

 

Tranche B-4 Term Loan

 

Loan

 

2.94

%

5/1/2018

 

$

5,734,690

 

5,384,082

 

5,735,206

 

Health Management Associates, Inc.

 

Healthcare

 

Replacement Term B Loan

 

Loan

 

3.50

%

11/16/2018

 

$

2,902,198

 

2,881,300

 

2,899,934

 

Hertz Corporation, The

 

Automotive

 

Tranche B-1 Term Loan

 

Loan

 

3.75

%

3/11/2018

 

$

2,977,500

 

3,015,577

 

2,987,058

 

HMH Holdings (Delaware) Inc.

 

Conglomerate

 

Term Loan (Exit Facility)

 

Loan

 

5.25

%

5/22/2018

 

$

985,000

 

970,072

 

987,049

 

Hologic, Inc.

 

Healthcare

 

Refinancing Tranche A Term Loan

 

Loan

 

2.19

%

8/1/2017

 

$

2,343,750

 

2,338,831

 

2,341,547

 

Hunter Defense Technologies, Inc.

 

Aerospace and Defense

 

Term Loan

 

Loan

 

3.45

%

8/22/2014

 

$

3,581,279

 

3,566,068

 

3,402,215

 

Huntsman International LLC

 

Chemicals/Plastics

 

Extended Term B Loan

 

Loan

 

2.73

%

4/19/2017

 

$

3,920,000

 

3,890,303

 

3,913,140

 

Infor (US), Inc. (fka Lawson Software Inc.)

 

Business Equipment and Services

 

Tranche B-2 Term Loan

 

Loan

 

5.34

%

4/5/2018

 

$

1,776,183

 

1,762,209

 

1,783,803

 

Inventiv Health, Inc. (fka Ventive Health, Inc)

 

Conglomerate

 

Consolidated Term Loan

 

Loan

 

7.50

%

8/4/2016

 

$

492,090

 

492,090

 

486,248

 

J. Crew Group, Inc.

 

Retailers (Except Food and Drugs)

 

Term B-1 Loan

 

Loan

 

4.00

%

3/7/2018

 

$

975,000

 

975,000

 

978,354

 

JFB Firth Rixson Inc.

 

Industrial Equipment

 

2013 Replacement Dollar Term Facility Loan

 

Loan

 

4.25

%

6/30/2017

 

$

2,570,786

 

2,560,260

 

2,579,630

 

Kinetic Concepts, Inc.

 

Healthcare

 

Dollar Term D-1 Loan

 

Loan

 

5.50

%

5/4/2018

 

$

491,291

 

475,733

 

496,081

 

Michaels Stores, Inc.

 

Retailers (Except Food and Drugs)

 

Term B Loan

 

Loan

 

3.75

%

1/28/2020

 

$

497,500

 

497,500

 

498,789

 

Microsemi Corporation

 

Electronics/Electric

 

Incremental Term Loan

 

Loan

 

3.50

%

2/19/2020

 

$

500,000

 

500,000

 

501,665

 

Microsemi Corporation

 

Electronics/Electric

 

Term Loan

 

Loan

 

3.75

%

2/19/2020

 

$

2,503,704

 

2,498,783

 

2,509,337

 

Murray Energy Corporation

 

Nonferrous Metals/Minerals

 

Term Loan

 

Loan

 

5.25

%

12/5/2019

 

$

1,000,000

 

995,000

 

1,006,560

 

National CineMedia, LLC

 

Leisure Goods/Activities/Movies

 

Term Loan (2013)

 

Loan

 

2.95

%

11/26/2019

 

$

1,086,207

 

1,052,802

 

1,082,134

 

Newsday, LLC

 

Publishing

 

Term Loan

 

Loan

 

3.69

%

10/12/2016

 

$

2,953,845

 

2,950,975

 

2,955,707

 

Novelis, Inc.

 

Conglomerate

 

Initial Term Loan

 

Loan

 

3.75

%

3/10/2017

 

$

4,870,017

 

4,881,756

 

4,890,325

 

NPC International, Inc.

 

Food Services

 

Term Loan

 

Loan

 

4.50

%

12/28/2018

 

$

490,833

 

490,833

 

492,468

 

NRG Energy, Inc.

 

Utilities

 

Term Loan (2013)

 

Loan

 

3.25

%

7/1/2018

 

$

3,910,350

 

3,883,871

 

3,902,099

 

NuSil Technology LLC.

 

Chemicals/Plastics

 

Term Loan

 

Loan

 

5.25

%

4/7/2017

 

$

811,398

 

811,398

 

795,843

 

OEP Pearl Dutch Acquisition B.V.

 

Chemicals/Plastics

 

Initial BV Term Loan

 

Loan

 

6.50

%

3/30/2018

 

$

142,785

 

140,705

 

144,034

 

On Assignment, Inc.

 

Business Equipment and Services

 

Initial Term B Loan

 

Loan

 

3.50

%

5/15/2020

 

$

1,911,364

 

1,898,879

 

1,904,196

 

Onex Carestream Finance LP

 

Healthcare

 

Term Loan (First Lien 2013)

 

Loan

 

5.00

%

2/25/2017

 

$

4,589,251

 

4,568,158

 

4,637,622

 

OpenLink International, Inc.

 

Business Equipment and Services

 

Initial Term Loan

 

Loan

 

7.75

%

10/30/2017

 

$

982,500

 

969,678

 

983,728

 

P.F. Chang’s China Bistro, Inc. (Wok Acquisition Corp.)

 

Food/Drug Retailers

 

Term Borrowing

 

Loan

 

5.25

%

6/22/2019

 

$

990,000

 

982,057

 

994,950

 

P2 Upstream Acquisition Co. (P2 Upstream Canada BC ULC)

 

Business Equipment and Services

 

Term Loan (First Lien)

 

Loan

 

5.00

%

10/30/2020

 

$

1,000,000

 

995,008

 

1,005,000

 

PetCo Animal Supplies, Inc.

 

Retailers (Except Food and Drugs)

 

New Loans

 

Loan

 

4.00

%

11/24/2017

 

$

1,488,520

 

1,486,977

 

1,494,340

 

Pharmaceutical Product Development, Inc. (Jaguar Holdings, LLC)

 

Conglomerate

 

2013 Term Loan

 

Loan

 

4.25

%

12/5/2018

 

$

1,965,150

 

1,939,872

 

1,976,037

 

Pinnacle Foods Finance LLC

 

Food Products

 

New Term Loan G

 

Loan

 

3.25

%

4/29/2020

 

$

4,975,000

 

4,963,546

 

4,967,537

 

Prestige Brands, Inc.

 

Drugs

 

Term B-1 Loan

 

Loan

 

3.75

%

1/31/2019

 

$

640,152

 

631,802

 

641,432

 

Pro Mach, Inc.

 

Industrial Equipment

 

Term Loan

 

Loan

 

5.00

%

7/6/2017

 

$

1,950,545

 

1,938,754

 

1,956,650

 

Progressive Waste Solutions Ltd.

 

Ecological Services and Equipment

 

Term B Loan

 

Loan

 

3.00

%

10/24/2019

 

$

500,000

 

500,000

 

500,000

 

Quintiles Transnational Corp.

 

Conglomerate

 

Term B-2 Loan

 

Loan

 

4.50

%

6/8/2018

 

$

3,681,541

 

3,657,766

 

3,682,682

 

Redtop Acquisitions Limited

 

Electronics/Electric

 

Initial Dollar Term Loan (First Lien)

 

Loan

 

4.50

%

12/3/2020

 

$

500,000

 

496,250

 

501,875

 

Rexnord LLC/RBS Global, Inc.

 

Industrial Equipment

 

Term B Loan

 

Loan

 

3.75

%

4/1/2018

 

$

1,667,645

 

1,667,645

 

1,666,944

 

Reynolds Group Holdings Inc.

 

Industrial Equipment

 

U.S. Term Loan

 

Loan

 

4.75

%

9/28/2018

 

$

1,980,000

 

1,980,000

 

1,992,375

 

Rocket Software, Inc.

 

Business Equipment and Services

 

Term Loan (First Lien)

 

Loan

 

5.75

%

2/8/2018

 

$

1,965,019

 

1,937,386

 

1,962,975

 

Roundy’s Supermarkets, Inc.

 

Food/Drug Retailers

 

Tranche B Term Loan

 

Loan

 

5.75

%

2/13/2019

 

$

984,711

 

973,689

 

964,249

 

Rovi Solutions Corporation / Rovi Guides, Inc.

 

Electronics/Electric

 

Tranche A-2 Loan

 

Loan

 

2.45

%

3/29/2017

 

$

1,562,552

 

1,551,261

 

1,556,692

 

Rovi Solutions Corporation / Rovi Guides, Inc.

 

Electronics/Electric

 

Tranche B-3 Term Loan

 

Loan

 

3.50

%

3/29/2019

 

$

1,344,450

 

1,339,323

 

1,332,686

 

RPI Finance Trust

 

Drugs

 

6.75 Year Term Loan(2012)

 

Loan

 

3.50

%

5/9/2018

 

$

5,321,522

 

5,295,174

 

5,334,826

 

Scitor Corporation

 

Business Equipment and Services

 

Term Loan

 

Loan

 

5.00

%

2/15/2017

 

$

463,977

 

462,736

 

453,538

 

Sensata Technology BV/Sensata Technology Finance Company, LLC

 

Electronics/Electric

 

Term Loan

 

Loan

 

3.75

%

5/12/2018

 

$

1,028,552

 

1,028,552

 

1,038,673

 

Sensus USA Inc. (fka Sensus Metering Systems)

 

Utilities

 

Term Loan (First Lien)

 

Loan

 

4.75

%

5/9/2017

 

$

1,950,000

 

1,944,392

 

1,957,313

 

ServiceMaster Company, The

 

Conglomerate

 

Tranche B Term Loan

 

Loan

 

4.45

%

1/31/2017

 

$

2,829,894

 

2,837,963

 

2,796,303

 

SI Organization, Inc., The

 

Aerospace and Defense

 

New Tranche B Term Loan

 

Loan

 

5.50

%

11/22/2016

 

$

3,890,450

 

3,871,140

 

3,773,736

 

Sonneborn, LLC

 

Chemicals/Plastics

 

Initial US Term Loan

 

Loan

 

6.50

%

3/30/2018

 

$

809,113

 

797,330

 

816,192

 

Sophia, L.P.

 

Electronics/Electric

 

Term B Loan

 

Loan

 

4.50

%

7/19/2018

 

$

930,812

 

918,936

 

937,216

 

SRA International Inc.

 

Aerospace and Defense

 

Term Loan

 

Loan

 

6.50

%

7/20/2018

 

$

3,268,571

 

3,179,811

 

3,264,486

 

SRAM, LLC

 

Industrial Equipment

 

Term Loan (First Lien)

 

Loan

 

4.01

%

4/10/2020

 

$

3,332,387

 

3,305,173

 

3,319,891

 

SS&C Technologies Holdings Europe S.A.R.L.

 

Business Equipment and Services

 

2013 Replacement Term B-2 Loan

 

Loan

 

5.00

%

6/7/2019

 

$

69,095

 

68,459

 

69,245

 

SS&C Technologies, Inc., /Sunshine Acquisition II, Inc.

 

Business Equipment and Services

 

2013 Replacement Term B-1 Loan

 

Loan

 

5.00

%

6/7/2019

 

$

667,916

 

661,768

 

669,372

 

Starwood Property Trust, Inc.

 

Financial Intermediaries

 

Term Loan (First Lien)

 

Loan

 

3.50

%

4/17/2020

 

$

1,000,000

 

995,000

 

995,000

 

SunCoke Energy, Inc.

 

Nonferrous Metals/Minerals

 

Tranche B Term Loan

 

Loan

 

4.00

%

7/26/2018

 

$

1,367,311

 

1,358,746

 

1,358,765

 

SunGard Data Systems Inc (Solar Capital Corp.)

 

Conglomerate

 

Tranche C Term Loan

 

Loan

 

3.95

%

2/28/2017

 

$

304,311

 

301,990

 

305,165

 

 

24



Table of Contents

 

SunGard Data Systems Inc (Solar Capital Corp.)

 

Conglomerate

 

Tranche E Term Loan

 

Loan

 

4.00

%

3/8/2020

 

$

4,232,479

 

4,102,130

 

4,264,223

 

SuperMedia Inc. (fka Idearc Inc.)

 

Publishing

 

Loan

 

Loan

 

11.60

%

12/30/2016

 

$

271,966

 

264,559

 

200,235

 

Syniverse Holdings, Inc.

 

Telecommunications

 

Initial Term Loan

 

Loan

 

5.00

%

4/23/2019

 

$

479,913

 

476,202

 

481,113

 

Taminco Global Chemical Corporation

 

Chemicals/Plastics

 

Tranche B-2 Dollar Term Loan

 

Loan

 

4.25

%

2/15/2019

 

$

1,477,584

 

1,469,122

 

1,482,889

 

Team Health, Inc.

 

Healthcare

 

Tranche B Term Loan

 

Loan

 

3.75

%

6/29/2018

 

$

4,398,750

 

4,384,292

 

4,398,750

 

TECTUM HOLDINGS INC

 

Industrial Equipment

 

Term Loan

 

Loan

 

7.50

%

12/3/2015

 

$

3,850,000

 

3,836,769

 

3,830,750

 

Tomkins, LLC / Tomkins, Inc. (f/k/a Pinafore, LLC / Pinafore, Inc.)

 

Conglomerate

 

Term B-2 Loan

 

Loan

 

3.75

%

9/29/2016

 

$

2,397,848

 

2,402,435

 

2,404,442

 

TransDigm Inc.

 

Aerospace and Defense

 

Tranche C Term Loan

 

Loan

 

3.75

%

2/28/2020

 

$

4,908,879

 

4,917,572

 

4,929,742

 

Tricorbraun Inc. (fka Kranson Industries, Inc.)

 

Containers/Glass Products

 

Term Loan

 

Loan

 

4.00

%

5/3/2018

 

$

1,902,083

 

1,895,039

 

1,903,282

 

Truven Health Analytics Inc. (fka Thomson Reuters (Healthcare) Inc.)

 

Healthcare

 

New Tranche B Term Loan

 

Loan

 

4.50

%

6/6/2019

 

$

493,769

 

485,612

 

495,211

 

U.S. Security Associates Holdings, Inc.

 

Business Equipment and Services

 

Delayed Draw Loan

 

Loan

 

6.00

%

7/28/2017

 

$

160,555

 

159,574

 

160,823

 

U.S. Security Associates Holdings, Inc.

 

Business Equipment and Services

 

Term B Loan

 

Loan

 

6.00

%

7/28/2017

 

$

122,808

 

122,393

 

123,013

 

U.S. Security Associates Holdings, Inc.

 

Business Equipment and Services

 

Term B Loan

 

Loan

 

6.00

%

7/28/2017

 

$

820,264

 

815,255

 

821,634

 

U.S. Silica Company

 

Nonferrous Metals/Minerals

 

Term Loan

 

Loan

 

4.75

%

6/8/2017

 

$

1,955,100

 

1,945,825

 

1,959,988

 

U.S. Xpress Enterprises, Inc.

 

Industrial Equipment

 

Extended Term Loan

 

Loan

 

9.00

%

11/13/2016

 

$

2,840,788

 

2,797,837

 

2,819,482

 

United Surgical Partners International, Inc.

 

Healthcare

 

New Tranche B Term Loan

 

Loan

 

4.75

%

4/3/2019

 

$

2,462,687

 

2,434,442

 

2,477,315

 

Univar Inc.

 

Chemicals/Plastics

 

Term B Loan

 

Loan

 

5.00

%

6/30/2017

 

$

3,894,939

 

3,894,181

 

3,830,555

 

Univision Communications Inc.

 

Telecommunications

 

2013 Converted Extended First-Lien Term Loan

 

Loan

 

4.50

%

3/1/2020

 

$

2,985,000

 

2,968,357

 

2,996,582

 

UPC Financing Partnership

 

Broadcast Radio and Television

 

Facility AF

 

Loan

 

4.00

%

1/31/2021

 

$

1,000,000

 

973,715

 

1,004,170

 

Valeant Pharmaceuticals International, Inc.

 

Drugs

 

Series D-1 Tranche B Term Loan

 

Loan

 

3.50

%

2/13/2019

 

$

2,947,688

 

2,935,872

 

2,966,494

 

Verint Systems Inc.

 

Business Equipment and Services

 

Term Loan

 

Loan

 

4.00

%

9/6/2019

 

$

1,905,600

 

1,897,155

 

1,912,269

 

Vertafore, Inc.

 

Business Equipment and Services

 

Term Loan (2013)

 

Loan

 

4.25

%

10/3/2019

 

$

2,962,285

 

2,962,285

 

2,985,747

 

Visant Corporation (fka Jostens)

 

Leisure Goods/Activities/Movies

 

Tranche B Term Loan (2011)

 

Loan

 

5.25

%

12/22/2016

 

$

3,658,446

 

3,658,446

 

3,563,948

 

Washington Inventory Service

 

Business Equipment and Services

 

U.S. Term Loan (First Lien)

 

Loan

 

5.75

%

12/20/2018

 

$

1,985,000

 

2,010,492

 

1,985,000

 

Wendy’s International, Inc

 

Food Services

 

Term B Loan

 

Loan

 

3.25

%

5/15/2019

 

$

682,179

 

675,977

 

681,968

 

West Corporation

 

Telecommunications

 

Term B-8 Loan

 

Loan

 

3.75

%

6/30/2018

 

$

2,926,111

 

2,969,883

 

2,936,674

 

Western Refining, Inc.

 

Oil & Gas

 

Term Loan 2013

 

Loan

 

4.25

%

11/12/2020

 

$

250,000

 

250,000

 

252,032

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

$

298,318,837

 

$

299,763,643

 

 

25



Table of Contents

 

GSC Investment Corp. CLO 2007

 

Schedule of Investments

 

February 28, 2013

 

Issuer Name

 

Industry

 

Asset Name

 

Asset Type

 

Current Rate

 

Maturity Date

 

Principal / Number of
Shares

 

Cost

 

Fair Value

 

Elyria Foundry Company, LLC

 

Industrial Equipment

 

Warrants

 

Equity

 

0.00

%

 

 

 

$

 

$

 

Network Communications, Inc.

 

Business Equipment and Services

 

Common

 

Equity

 

0.00

%

 

 

169,143

 

169,143

 

659,658

 

OLD AII, Inc (fka Aleris International Inc.)

 

Conglomerate

 

Common

 

Equity

 

0.00

%

 

 

2,624

 

224,656

 

128,576

 

PATS Aircraft, LLC

 

Aerospace and Defense

 

Common

 

Equity

 

0.00

%

 

 

51,813

 

282,326

 

282,329

 

SuperMedia Inc. (fka Idearc Inc.)

 

Publishing

 

Common Stock

 

Equity

 

0.00

%

 

 

10,821

 

28,784

 

5,411

 

Academy, LTD.

 

Retailers (Except Food and Drugs)

 

Initial Term Loan (2012)

 

Loan

 

4.75

%

8/3/2018

 

$

1,980,037

 

1,966,002

 

2,000,927

 

ACCO Brands Corporation

 

Conglomerate

 

Term B Loan

 

Loan

 

4.25

%

5/1/2019

 

$

351,944

 

348,847

 

354,584

 

Acosta, Inc.

 

Food Products

 

Term D Loan

 

Loan

 

5.00

%

3/2/2018

 

$

4,183,659

 

4,120,774

 

4,216,082

 

Aderant North America, Inc.

 

Business Equipment and Services

 

Term Loan (First Lien)

 

Loan

 

6.25

%

12/20/2018

 

$

3,500,000

 

3,495,662

 

3,552,500

 

Aeroflex Incorporated

 

Aerospace and Defense

 

Tranche B Term Loan

 

Loan

 

5.75

%

5/9/2018

 

$

3,345,517

 

3,333,081

 

3,369,204

 

Alcatel-Lucent USA Inc.

 

Telecommunications/Cellular

 

US Term Loan

 

Loan

 

0.00

%

1/30/2019

 

$

1,075,000

 

1,069,625

 

1,087,008

 

Alere Inc. (fka IM US Holdings, LLC)

 

Healthcare

 

Incremental B-1 Term Loan

 

Loan

 

4.75

%

6/30/2017

 

$

1,980,000

 

1,941,348

 

1,999,444

 

Aptalis Pharma, Inc. (fka Axcan Intermediate Holdings Inc.)

 

Drugs

 

Term B-1 Loan

 

Loan

 

5.50

%

2/10/2017

 

$

1,960,000

 

1,953,535

 

1,963,920

 

Aramark Corporation

 

Food Products

 

LC-2 Facility

 

Loan

 

3.45

%

7/26/2016

 

$

79,187

 

79,187

 

79,600

 

Aramark Corporation

 

Food Products

 

LC-3 Facility

 

Loan

 

3.45

%

7/26/2016

 

$

43,961

 

43,961

 

44,190

 

Aramark Corporation

 

Food Products

 

U.S. Term B Loan (Extending)

 

Loan

 

3.45

%

7/26/2016

 

$

1,204,093

 

1,204,093

 

1,210,366

 

Aramark Corporation

 

Food Products

 

U.S. Term C Loan

 

Loan

 

3.52

%

7/26/2016

 

$

2,545,700

 

2,545,700

 

2,558,963

 

Armstrong World Industries, Inc

 

Building and Development

 

Term Loan B-1

 

Loan

 

4.00

%

3/10/2018

 

$

2,122,931

 

2,109,740

 

2,124,268

 

Asurion, LLC (fka Asurion Corporation)

 

Insurance

 

Amortizing Term Loan

 

Loan

 

4.75

%

7/23/2017

 

$

968,750

 

960,226

 

973,594

 

Asurion, LLC (fka Asurion Corporation)

 

Insurance

 

Incremental Tranche B-1 Term Loan

 

Loan

 

4.50

%

5/24/2019

 

$

5,659,091

 

5,602,698

 

5,674,144

 

Auction.Com, LLC

 

Business Equipment and Services

 

Term Loan A-4

 

Loan

 

4.96

%

8/30/2016

 

$

1,018,699

 

1,017,479

 

1,013,606

 

Aurora Diagnostics, LLC

 

Conglomerate

 

Tranche B Term Loan

 

Loan

 

6.25

%

5/26/2016

 

$

3,188,889

 

3,198,281

 

3,077,278

 

Autotrader.com, Inc.

 

Automotive

 

Tranche B-1 Term Loan

 

Loan

 

4.00

%

12/15/2016

 

$

3,830,768

 

3,830,768

 

3,853,522

 

Avantor Performance Materials Holdings, Inc.

 

Chemicals/Plastics

 

Term Loan

 

Loan

 

5.25

%

6/24/2017

 

$

4,925,000

 

4,907,124

 

4,925,000

 

AZ Chem US Inc.

 

Chemicals/Plastics

 

Term Loan

 

Loan

 

5.25

%

12/22/2017

 

$

1,570,579

 

1,532,447

 

1,585,170

 

Biomet, Inc.

 

Healthcare

 

Dollar Term B-1 Loan

 

Loan

 

4.00

%

7/25/2017

 

$

1,990,013

 

1,990,013

 

2,003,445

 

Bombardier Recreational Products Inc.

 

Leisure Goods/Activities/Movies

 

Term B Loan

 

Loan

 

5.00

%

1/30/2019

 

$

1,000,000

 

990,101

 

1,007,500

 

Brock Holdings III, Inc.

 

Industrial Equipment

 

Term Loan (First Lien)

 

Loan

 

0.00

%

3/16/2017

 

$

2,000,000

 

2,022,500

 

2,013,340

 

Burlington Coat Factory Warehouse Corporation

 

Retailers (Except Food and Drugs)

 

Term B-1 Loan

 

Loan

 

5.50

%

2/23/2017

 

$

2,776,843

 

2,767,803

 

2,802,306

 

C.H.I. Overhead Doors, Inc. (CHI)

 

Home Furnishings

 

Term Loan (First Lien)

 

Loan

 

7.25

%

8/17/2017

 

$

2,976,290

 

2,931,556

 

2,983,730

 

Camp International Holding Company

 

Aerospace and Defense

 

Refinanced Term Loan (First Lien)

 

Loan

 

5.25

%

5/31/2019

 

$

997,500

 

988,136

 

1,005,400

 

Capital Automotive L.P.

 

Conglomerate

 

Tranche B Term Loan

 

Loan

 

5.25

%

3/11/2017

 

$

2,811,086

 

2,817,777

 

2,823,961

 

Capstone Logistics, LLC

 

Business Equipment and Services

 

Term Note A

 

Loan

 

7.50

%

9/16/2016

 

$

2,699,305

 

2,669,394

 

2,658,816

 

Capsugel Holdings US, Inc.

 

Drugs

 

Initial Term Loan (New)

 

Loan

 

4.75

%

8/1/2018

 

$

3,605,198

 

3,595,976

 

3,641,214

 

Celanese US Holdings LLC

 

Chemicals/Plastics

 

Dollar Term C Loan (Extended)

 

Loan

 

3.06

%

10/31/2016

 

$

2,198,534

 

2,219,212

 

2,208,911

 

Cenveo Corporation

 

Publishing

 

Term B Facility

 

Loan

 

7.00

%

12/21/2016

 

$

2,437,399

 

2,421,925

 

2,444,516

 

Charter Communications Operating, LLC

 

Cable and Satellite Television

 

Term C Loan

 

Loan

 

3.46

%

9/6/2016

 

$

2,047,547

 

2,044,048

 

2,057,785

 

Charter Communications Operating, LLC

 

Cable and Satellite Television

 

Term D Loan

 

Loan

 

4.00

%

5/15/2019

 

$

1,985,000

 

1,976,313

 

2,000,503

 

CHS/ Community Health Systems, Inc.

 

Healthcare

 

Extended Term Loan

 

Loan

 

3.79

%

1/25/2017

 

$

4,064,516

 

3,963,653

 

4,090,935

 

Cinedigm Digital Funding I, LLC

 

Business Equipment and Services

 

Term Loan

 

Loan

 

5.75

%

2/28/2018

 

$

1,066,260

 

1,059,429

 

1,068,925

 

Contec, LLC

 

Electronics/Electric

 

Second Lien Term Notes

 

Loan

 

10.00

%

11/2/2016

 

$

401,202

 

2,400,891

 

2,578,210

 

Covanta Energy Corporation

 

Ecological Services and Equipment

 

Term Loan

 

Loan

 

4.00

%

3/28/2019

 

$

496,250

 

494,095

 

501,833

 

CPI International Acquisition, Inc. (f/k/a Catalyst Holdings, Inc.)

 

Electronics/Electric

 

Term B Loan

 

Loan

 

5.00

%

2/13/2017

 

$

4,805,833

 

4,789,964

 

4,829,862

 

Crown Castle Operating Company

 

Telecommunications/Cellular

 

Tranche B Term Loan

 

Loan

 

4.00

%

1/31/2019

 

$

1,980,000

 

1,963,120

 

1,989,484

 

Culligan International Company

 

Conglomerate

 

Dollar Loan (First Lien)

 

Loan

 

6.25

%

12/19/2017

 

$

795,675

 

732,459

 

729,372

 

Culligan International Company

 

Conglomerate

 

Dollar Loan (Second Lien)

 

Loan

 

9.50

%

6/19/2018

 

$

783,162

 

720,189

 

604,343

 

DaVita HealthCare Partners Inc. (fka DaVita Inc.)

 

Healthcare

 

Tranche B Term Loan

 

Loan

 

4.50

%

10/20/2016

 

$

3,949,622

 

3,949,622

 

3,977,822

 

DCS Business Services, Inc.

 

Financial Intermediaries

 

Term B Loan

 

Loan

 

7.25

%

3/19/2018

 

$

3,970,010

 

3,919,904

 

3,910,460

 

 

26



Table of Contents

 

Del Monte Foods Company

 

Food Products

 

Initial Term Loan

 

Loan

 

4.00

%

3/8/2018

 

$

4,438,139

 

4,473,061

 

4,443,687

 

Delphi Corporation

 

Electronics/Electric

 

Tranche A Term Loan Retired 03/01/2013

 

Loan

 

4.25

%

3/31/2016

 

$

1,683,357

 

1,685,403

 

1,682,650

 

Digitalglobe, Inc.

 

Ecological Services and Equipment

 

Term Loan

 

Loan

 

0.00

%

1/31/2020

 

$

250,000

 

250,000

 

250,783

 

DS Waters of America, Inc.

 

Beverage and Tobacco

 

Term Loan (First Lien)

 

Loan

 

10.50

%

8/29/2017

 

$

2,977,500

 

2,928,511

 

3,037,050

 

Dunkin’ Brands, Inc.

 

Food Services

 

Term B-3 Loan

 

Loan

 

0.00

%

2/14/2020

 

$

4,000,000

 

3,990,000

 

3,990,000

 

DynCorp International Inc.

 

Aerospace and Defense

 

Term Loan

 

Loan

 

6.25

%

7/7/2016

 

$

574,161

 

567,732

 

577,606

 

Education Management LLC

 

Leisure

 

Tranche C-2 Term Loan

 

Loan

 

4.31

%

6/1/2016

 

$

3,925,006

 

3,727,372

 

3,263,878

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

eInstruction Corporation

 

Goods/Activities/Movies Electronics/Electric

 

Initial Term Loan

 

Loan

 

0.00

%

7/2/2013

 

$

2,997,722

 

2,931,236

 

899,317

 

Electrical Components International, Inc.

 

Electronics/Electric

 

Synthetic Revolving Loan

 

Loan

 

6.75

%

2/4/2016

 

$

117,647

 

116,611

 

117,647

 

Electrical Components International, Inc.

 

Electronics/Electric

 

Term Loan

 

Loan

 

6.75

%

2/4/2017

 

$

1,786,475

 

1,768,892

 

1,786,475

 

Evergreen Acqco 1 LP

 

Retailers (Except Food and Drugs)

 

New Term Loan

 

Loan

 

5.00

%

7/9/2019

 

$

497,503

 

492,828

 

501,702

 

Federal-Mogul Corporation

 

Automotive

 

Tranche B Term Loan

 

Loan

 

2.14

%

12/29/2014

 

$

2,589,036

 

2,498,894

 

2,467,351

 

Federal-Mogul Corporation

 

Automotive

 

Tranche C Term Loan

 

Loan

 

2.14

%

12/28/2015

 

$

1,320,937

 

1,264,234

 

1,258,853

 

First Data Corporation

 

Financial Intermediaries

 

2017 Dollar Term Loan

 

Loan

 

5.20

%

3/24/2017

 

$

2,111,028

 

2,027,434

 

2,111,914

 

First Data Corporation

 

Financial Intermediaries

 

2018 Dollar Term Loan

 

Loan

 

4.20

%

3/23/2018

 

$

2,290,451

 

2,216,829

 

2,261,591

 

Freescale Semiconductor, Inc.

 

Electronics/Electric

 

Tranche B-1 Term Loan Retired 03/01/2013

 

Loan

 

4.45

%

12/1/2016

 

$

2,534,348

 

2,450,139

 

2,535,945

 

FTD Group, Inc.

 

Retailers (Except Food and Drugs)

 

Initial Term Loan

 

Loan

 

4.75

%

6/11/2018

 

$

3,715,723

 

3,683,533

 

3,715,723

 

Generac Power Systems, Inc.

 

Industrial Equipment

 

Term Loan

 

Loan

 

6.25

%

5/30/2018

 

$

906,111

 

890,154

 

923,590

 

General Nutrition Centers, Inc.

 

Retailers (Except Food and Drugs)

 

Amended Tranche B Term Loan

 

Loan

 

3.75

%

3/2/2018

 

$

4,746,591

 

4,757,841

 

4,774,548

 

Global Tel*Link Corporation

 

Business Equipment and Services

 

Replacement Term Loan

 

Loan

 

6.00

%

12/14/2017

 

$

1,964,912

 

1,960,077

 

1,967,368

 

Goodyear Tire & Rubber Company, The

 

Chemicals/Plastics

 

Loan (Second Lien)

 

Loan

 

4.75

%

4/30/2019

 

$

4,000,000

 

3,929,629

 

4,015,000

 

Grifols Inc.

 

Drugs

 

New U.S. Tranche B Term Loan

 

Loan

 

4.25

%

6/1/2017

 

$

3,465,982

 

3,457,357

 

3,481,371

 

Grosvenor Capital Management Holdings, LLLP

 

Brokers/Dealers/Investment Houses

 

Tranche C Term Loan

 

Loan

 

4.25

%

12/5/2016

 

$

3,336,378

 

3,252,391

 

3,311,355

 

Hanger Orthopedic Group, Inc.

 

Healthcare

 

Term C Loan

 

Loan

 

4.00

%

12/1/2016

 

$

3,910,667

 

3,920,277

 

3,925,332

 

HCA Inc.

 

Healthcare

 

Tranche B-3 Term Loan

 

Loan

 

3.45

%

5/1/2018

 

$

5,734,690

 

5,440,293

 

5,764,912

 

Health Management Associates, Inc.

 

Healthcare

 

Term B Loan

 

Loan

 

4.50

%

11/16/2018

 

$

2,970,000

 

2,945,366

 

2,993,344

 

Hertz Corporation, The

 

Automotive

 

Tranche B-1 Term Loan

 

Loan

 

0.00

%

3/11/2018

 

$

3,000,000

 

3,045,000

 

3,045,000

 

HIBU PLC (fka Yell Group PLC)

 

Business Equipment and Services

 

Facility B1 - YB (USA) LLC (11/2009)

 

Loan

 

3.95

%

7/31/2014

 

$

3,030,606

 

2,983,167

 

530,356

 

HMH Holdings (Delaware) Inc.

 

Conglomerate

 

Term Loan (Exit Facility)

 

Loan

 

7.25

%

5/22/2018

 

$

992,500

 

974,925

 

997,463

 

Hologic, Inc.

 

Healthcare

 

Tranche A Term Loan

 

Loan

 

3.20

%

8/1/2017

 

$

2,437,500

 

2,432,069

 

2,439,328

 

Hunter Defense Technologies, Inc.

 

Aerospace and Defense

 

Term Loan

 

Loan

 

3.54

%

8/22/2014

 

$

3,679,939

 

3,647,610

 

3,385,544

 

Huntsman International LLC

 

Chemicals/Plastics

 

Extended Term B Loan

 

Loan

 

2.75

%

4/19/2017

 

$

3,920,000

 

3,883,690

 

3,920,000

 

Infor (US), Inc. ((fka Lawson Software Inc.)

 

Business Equipment and Services

 

Tranche B-2 Term Loan

 

Loan

 

5.25

%

4/5/2018

 

$

1,990,013

 

1,971,642

 

2,011,166

 

Inventiv Health, Inc. (fka Ventive Health, Inc)

 

Conglomerate

 

Consolidated Term Loan

 

Loan

 

7.50

%

8/4/2016

 

$

492,090

 

492,090

 

484,093

 

J. Crew Group, Inc.

 

Retailers (Except Food and Drugs)

 

Term B-1 Loan

 

Loan

 

4.00

%

3/7/2018

 

$

982,500

 

982,500

 

982,726

 

JFB Firth Rixson Inc.

 

Industrial Equipment

 

2013 Replacement Dollar Term Facility Loan

 

Loan

 

4.25

%

6/30/2017

 

$

2,590,213

 

2,577,375

 

2,598,838

 

Kalispel Tribal Economic Authority

 

Lodging and Casinos

 

Term Loan

 

Loan

 

7.50

%

2/24/2017

 

$

3,625,323

 

3,577,074

 

3,634,387

 

Kinetic Concepts, Inc.

 

Healthcare

 

Dollar Term C-1 Loan

 

Loan

 

5.50

%

5/4/2018

 

$

495,000

 

478,661

 

501,034

 

Kronos Worldwide, Inc.

 

Chemicals/Plastics

 

Initial Term Loan

 

Loan

 

7.00

%

6/13/2018

 

$

500,000

 

500,000

 

504,065

 

MetroPCS Wireless, Inc.

 

Telecommunications

 

Tranche B-2 Term Loan

 

Loan

 

4.07

%

11/3/2016

 

$

2,489,192

 

2,491,685

 

2,495,938

 

Michaels Stores, Inc.

 

Retailers (Except Food and Drugs)

 

Term B Loan

 

Loan

 

3.75

%

1/28/2020

 

$

500,000

 

500,000

 

501,110

 

Microsemi Corporation

 

Electronics/Electric

 

Term Loan

 

Loan

 

3.75

%

2/20/2020

 

$

2,688,796

 

2,682,872

 

2,697,212

 

National CineMedia, LLC

 

Leisure Goods/Activities/Movies

 

Term Loan

 

Loan

 

3.46

%

11/26/2019

 

$

1,086,207

 

1,050,910

 

1,089,607

 

Newsday, LLC

 

Publishing

 

Term Loan

 

Loan

 

3.70

%

10/12/2016

 

$

3,000,000

 

2,996,317

 

2,992,500

 

Novelis, Inc.

 

Conglomerate

 

Term B-2 Loan

 

Loan

 

4.00

%

3/10/2017

 

$

987,500

 

968,539

 

988,734

 

Novelis, Inc.

 

Conglomerate

 

Term Loan

 

Loan

 

4.00

%

3/10/2017

 

$

3,920,009

 

3,946,297

 

3,924,909

 

NPC International, Inc.

 

Food Services

 

Term Loan

 

Loan

 

4.50

%

12/28/2018

 

$

490,833

 

490,833

 

495,128

 

NRG Energy, Inc.

 

Utilities

 

Term Loan

 

Loan

 

3.25

%

7/1/2018

 

$

3,940,000

 

3,910,795

 

3,958,557

 

NuSil Technology LLC.

 

Chemicals/Plastics

 

Term Loan

 

Loan

 

5.00

%

4/7/2017

 

$

820,339

 

820,339

 

824,695

 

OEP Pearl Dutch Acquisition B.V.

 

Chemicals/Plastics

 

Initial BV Term Loan

 

Loan

 

6.50

%

3/30/2018

 

$

148,875

 

146,330

 

149,992

 

On Assignment, Inc.

 

Business Equipment and Services

 

Initial Term B Loan

 

Loan

 

5.00

%

5/15/2019

 

$

2,413,048

 

2,399,166

 

2,434,114

 

Onex Carestream Finance LP

 

Healthcare

 

Term Loan

 

Loan

 

5.00

%

2/25/2017

 

$

4,909,816

 

4,893,453

 

4,916,739

 

OpenLink International, Inc.

 

Business Equipment and Services

 

Initial Term Loan

 

Loan

 

7.75

%

10/30/2017

 

$

990,000

 

974,594

 

988,763

 

P.F. Chang’s China Bistro, Inc. (Wok Acquisition Corp.)

 

Food/Drug Retailers

 

Term Borrowing

 

Loan

 

5.25

%

6/22/2019

 

$

997,500

 

988,412

 

1,007,475

 

PATS Aircraft, LLC

 

Aerospace and Defense

 

Term Loan

 

Loan

 

8.50

%

10/6/2016

 

$

357,331

 

239,023

 

276,932

 

Penn National Gaming, Inc.

 

Lodging and Casinos

 

Term A Facility

 

Loan

 

1.72

%

7/14/2016

 

$

2,775,888

 

2,719,125

 

2,776,748

 

Penn National Gaming, Inc.

 

Lodging and Casinos

 

Term B Facility

 

Loan

 

3.75

%

7/16/2018

 

$

985,013

 

983,123

 

988,431

 

 

27



Table of Contents

 

PetCo Animal Supplies, Inc.

 

Retailers (Except Food and Drugs)

 

New Loans

 

Loan

 

4.00

%

11/24/2017

 

$

1,496,173

 

1,494,329

 

1,501,784

 

Pharmaceutical Product Development, Inc. (Jaguar Holdings, LLC)

 

Conglomerate

 

2013 Term Loan

 

Loan

 

4.25

%

12/5/2018

 

$

1,980,000

 

1,950,704

 

1,989,583

 

Physician Oncology Services, LP

 

Healthcare

 

Delayed Draw Term Loan

 

Loan

 

7.75

%

1/31/2017

 

$

51,020

 

50,682

 

50,765

 

Physician Oncology Services, LP

 

Healthcare

 

Effective Date Term Loan

 

Loan

 

7.75

%

1/31/2017

 

$

419,961

 

417,178

 

417,861

 

Pinnacle Foods Finance LLC

 

Food Products

 

Extended Initial Term Loan

 

Loan

 

3.70

%

10/2/2016

 

$

5,726,579

 

5,491,534

 

5,761,168

 

Preferred Proppants, LLC

 

Nonferrous Metals/Minerals

 

Term B Loan

 

Loan

 

7.50

%

12/15/2016

 

$

1,980,000

 

1,949,170

 

1,841,400

 

Prestige Brands, Inc.

 

Drugs

 

Term B-1 Loan

 

Loan

 

3.76

%

1/31/2019

 

$

679,545

 

669,390

 

683,507

 

Pro Mach, Inc.

 

Industrial Equipment

 

Term Loan

 

Loan

 

5.00

%

7/6/2017

 

$

1,956,155

 

1,941,853

 

1,961,045

 

Quintiles Transnational Corp.

 

Conglomerate

 

Term B-2 Loan

 

Loan

 

4.50

%

6/8/2018

 

$

3,681,541

 

3,653,803

 

3,716,810

 

Ranpak Corp.

 

Food/Drug Retailers

 

USD Term Loan (First Lien)

 

Loan

 

4.75

%

4/20/2017

 

$

2,396,012

 

2,387,700

 

2,384,032

 

Rexnord LLC/RBS Global, Inc.

 

Industrial Equipment

 

Term B Loan Refinancing

 

Loan

 

4.50

%

4/1/2018

 

$

1,995,000

 

1,995,000

 

2,005,454

 

Reynolds Group Holdings Inc.

 

Industrial Equipment

 

U.S. Term Loan

 

Loan

 

4.75

%

9/28/2018

 

$

1,995,000

 

1,995,000

 

2,017,244

 

Rocket Software, Inc.

 

Business Equipment and Services

 

Term Loan (First Lien)

 

Loan

 

5.75

%

2/8/2018

 

$

1,980,000

 

1,947,152

 

1,986,197

 

Roundy’s Supermarkets, Inc.

 

Food/Drug Retailers

 

Tranche B Term Loan

 

Loan

 

5.75

%

2/13/2019

 

$

992,500

 

979,782

 

937,297

 

Rovi Solutions Corporation / Rovi Guides, Inc.

 

Electronics/Electric

 

Tranche A-2 Loan

 

Loan

 

2.46

%

3/29/2017

 

$

1,860,226

 

1,843,739

 

1,855,576

 

Rovi Solutions Corporation / Rovi Guides, Inc.

 

Electronics/Electric

 

Tranche B-2 Loan

 

Loan

 

4.00

%

3/29/2019

 

$

1,384,706

 

1,378,679

 

1,389,899

 

Royal Adhesives and Sealants, LLC

 

Chemicals/Plastics

 

Term A Loan

 

Loan

 

7.25

%

11/29/2015

 

$

4,498,210

 

4,459,450

 

4,432,399

 

RPI Finance Trust

 

Drugs

 

6.75 Year Term Loan(2012)

 

Loan

 

3.50

%

5/9/2018

 

$

5,398,833

 

5,373,794

 

5,449,474

 

Scientific Games International Inc.

 

Electronics/Electric

 

Tranche B-1 Term Loan

 

Loan

 

3.21

%

6/30/2015

 

$

1,977,810

 

1,965,672

 

1,985,226

 

Scitor Corporation

 

Business Equipment and Services

 

Term Loan

 

Loan

 

5.00

%

2/15/2017

 

$

463,977

 

462,444

 

460,692

 

Securus Technologies Holdings, Inc (fka Securus Technologies, Inc.)

 

Telecommunications

 

Tranche 2 Term Loan (First Lien)

 

Loan

 

6.50

%

5/31/2017

 

$

1,985,000

 

1,967,961

 

1,975,075

 

Sensata Technology BV/Sensata Technology Finance Company, LLC

 

Electronics/Electric

 

Term Loan

 

Loan

 

3.75

%

5/12/2018

 

$

2,969,849

 

2,969,849

 

2,986,540

 

Sensus USA Inc. (fka Sensus Metering Systems)

 

Utilities

 

Term Loan (First Lien)

 

Loan

 

4.75

%

5/9/2017

 

$

1,965,000

 

1,958,111

 

1,961,070

 

ServiceMaster Company, The

 

Conglomerate

 

Tranche B Term Loan

 

Loan

 

4.45

%

1/31/2017

 

$

2,851,387

 

2,861,398

 

2,857,089

 

SI Organization, Inc., The

 

Aerospace and Defense

 

New Tranche B Term Loan

 

Loan

 

4.50

%

11/22/2016

 

$

3,920,000

 

3,895,621

 

3,906,946

 

Sonneborn, LLC

 

Chemicals/Plastics

 

Initial US Term Loan

 

Loan

 

6.50

%

3/30/2018

 

$

843,625

 

829,202

 

849,952

 

Sophia, L.P.

 

Electronics/Electric

 

Term B Loan

 

Loan

 

4.50

%

7/19/2018

 

$

969,244

 

954,866

 

976,310

 

SRA International Inc.

 

Aerospace and Defense

 

Term Loan

 

Loan

 

6.50

%

7/20/2018

 

$

3,268,571

 

3,165,384

 

3,154,171

 

SRAM, LLC

 

Industrial Equipment

 

Term Loan (First Lien)

 

Loan

 

4.77

%

6/7/2018

 

$

3,441,181

 

3,411,986

 

3,458,386

 

SS&C Technologies, Inc., /Sunshine Acquisition II, Inc.

 

Business Equipment and Services

 

Funded Term B-1 Loan

 

Loan

 

5.00

%

6/7/2019

 

$

811,071

 

803,796

 

817,138

 

SS&C Technologies, Inc., /Sunshine Acquisition II, Inc.

 

Business Equipment and Services

 

Funded Term B-2 Loan

 

Loan

 

5.00

%

6/7/2019

 

$

83,904

 

83,151

 

84,531

 

SunCoke Energy, Inc.

 

Nonferrous Metals/Minerals

 

Tranche B Term Loan

 

Loan

 

4.00

%

7/26/2018

 

$

1,367,311

 

1,357,359

 

1,370,729

 

SunGard Data Systems Inc (Solar Capital Corp.)

 

Conglomerate

 

Tranche B U.S. Term Loan

 

Loan

 

3.85

%

2/28/2016

 

$

4,253,748

 

4,184,167

 

4,260,086

 

SunGard Data Systems Inc (Solar Capital Corp.)

 

Conglomerate

 

Tranche C Term Loan

 

Loan

 

3.95

%

2/28/2017

 

$

497,687

 

493,012

 

500,544

 

SuperMedia Inc. (fka Idearc Inc.)

 

Publishing

 

Loan

 

Loan

 

11.00

%

12/31/2015

 

$

289,811

 

281,918

 

214,875

 

Syniverse Holdings, Inc.

 

Telecommunications

 

Initial Term Loan

 

Loan

 

5.00

%

4/23/2019

 

$

497,500

 

493,115

 

500,609

 

Taminco Global Chemical Corporation

 

Chemicals/Plastics

 

Tranche B-2 Dollar Term Loan

 

Loan

 

4.25

%

2/15/2019

 

$

1,488,750

 

1,478,991

 

1,498,859

 

Team Health, Inc.

 

Healthcare

 

Tranche B Term Loan

 

Loan

 

3.75

%

6/29/2018

 

$

4,432,500

 

4,415,534

 

4,432,500

 

TECTUM HOLDINGS INC

 

Industrial Equipment

 

Term Loan

 

Loan

 

7.50

%

12/3/2015

 

$

4,000,000

 

3,981,089

 

3,980,000

 

Texas Competitive Electric Holdings Company, LLC (TXU)

 

Utilities

 

2014 Term Loan (Non-Extending)

 

Loan

 

3.73

%

10/10/2014

 

$

5,580,862

 

5,527,535

 

4,012,249

 

Tomkins, LLC / Tomkins, Inc. (f/k/a Pinafore, LLC / Pinafore, Inc.)

 

Conglomerate

 

Term B-2 Loan

 

Loan

 

3.75

%

9/29/2016

 

$

2,431,854

 

2,437,744

 

2,450,093

 

TransDigm Inc.

 

Aerospace and Defense

 

Tranche C Term Loan

 

Loan

 

3.75

%

2/28/2020

 

$

4,945,974

 

4,955,789

 

4,955,587

 

Tricorbraun Inc. (fka Kranson Industries, Inc.)

 

Containers/Glass Products

 

Term Loan

 

Loan

 

5.50

%

5/3/2018

 

$

1,990,000

 

1,981,374

 

2,008,666

 

Truven Health Analytics Inc. (fka Thomson Reuters (Healthcare) Inc.)

 

Healthcare

 

New Tranche B Term Loan

 

Loan

 

5.75

%

6/6/2019

 

$

497,500

 

488,158

 

501,853

 

Tube City IMS Corporation

 

Steel

 

Term Loan

 

Loan

 

5.75

%

3/20/2019

 

$

992,500

 

983,864

 

1,001,184

 

U.S. Security Associates Holdings, Inc.

 

Business Equipment and Services

 

Delayed Draw Term Loan

 

Loan

 

6.00

%

7/28/2017

 

$

161,778

 

160,586

 

162,688

 

U.S. Security Associates Holdings, Inc.

 

Business Equipment and Services

 

Term Loan B

 

Loan

 

6.00

%

7/28/2017

 

$

123,747

 

123,243

 

124,444

 

U.S. Security Associates Holdings, Inc.

 

Business Equipment and Services

 

Term Loan B

 

Loan

 

6.00

%

7/28/2017

 

$

826,540

 

820,452

 

831,193

 

U.S. Silica Company

 

Nonferrous Metals/Minerals

 

Loan

 

Loan

 

4.75

%

6/8/2017

 

$

1,970,000

 

1,962,974

 

1,974,925

 

U.S. Xpress Enterprises, Inc.

 

Industrial Equipment

 

Extended Term Loan

 

Loan

 

9.00

%

11/13/2016

 

$

2,913,628

 

2,858,339

 

2,906,344

 

United Surgical Partners International, Inc.

 

Healthcare

 

New Tranche B Term Loan

 

Loan

 

6.00

%

4/3/2019

 

$

2,481,281

 

2,448,808

 

2,486,715

 

Univar Inc.

 

Chemicals/Plastics

 

Term B Loan

 

Loan

 

5.00

%

6/30/2017

 

$

3,924,924

 

3,924,007

 

3,902,670

 

Univision Communications Inc.

 

Telecommunications

 

2013 Converted Extended First-Lien Term Loan

 

Loan

 

4.75

%

3/1/2020

 

$

3,000,000

 

2,981,257

 

3,000,870

 

UPC Financing Partnership

 

Broadcast Radio and Television

 

Facility AF

 

Loan

 

4.00

%

1/31/2021

 

$

1,000,000

 

970,954

 

1,010,000

 

Valeant Pharmaceuticals International, Inc.

 

Drugs

 

Series D-1 Tranche B Term Loan

 

Loan

 

3.50

%

2/13/2019

 

$

2,985,000

 

2,972,608

 

3,006,462

 

 

28



Table of Contents

 

Vantiv, LLC (fka Fifth Third Processing Solutions, LLC)

 

Financial Intermediaries

 

Tranche B Term Loan

 

Loan

 

3.75

%

3/27/2019

 

$

1,063,393

 

1,058,765

 

1,065,520

 

Verint Systems Inc.

 

Business Equipment and Services

 

Term Loan 2011

 

Loan

 

4.50

%

10/27/2017

 

$

1,920,000

 

1,913,087

 

1,921,920

 

Vertafore, Inc.

 

Business Equipment and Services

 

Term Loan (First Lien)

 

Loan

 

5.25

%

7/29/2016

 

$

2,984,781

 

2,984,781

 

3,018,360

 

Visant Corporation (fka Jostens)

 

Leisure Goods/Activities/Movies

 

Tranche B Term Loan (2011)

 

Loan

 

5.25

%

12/22/2016

 

$

3,696,942

 

3,696,942

 

3,518,269

 

Washington Inventory Service

 

Business Equipment and Services

 

U.S. Term Loan (First Lien)

 

Loan

 

5.75

%

12/20/2018

 

$

2,000,000

 

2,029,513

 

2,007,500

 

Weight Watchers International, Inc.

 

Food Products

 

Term D Loan

 

Loan

 

2.56

%

6/30/2016

 

$

2,700,529

 

2,667,383

 

2,701,879

 

Wendy’s International, Inc

 

Food Services

 

Term Loan

 

Loan

 

4.75

%

5/15/2019

 

$

997,500

 

988,532

 

1,006,098

 

West Corporation

 

Telecommunications

 

Term B-8 Loan

 

Loan

 

4.25

%

6/30/2018

 

$

2,971,535

 

3,023,298

 

2,978,964

 

Wolverine World Wide, Inc.

 

Clothing/Textiles

 

Tranche B Term Loan

 

Loan

 

4.00

%

10/9/2019

 

$

854,821

 

846,633

 

861,233

 

Yankee Candle Company, Inc., The

 

Retailers (Except Food and Drugs)

 

Initial Term Loan

 

Loan

 

5.25

%

4/2/2019

 

$

2,256,466

 

2,236,833

 

2,268,876

 

BABSN 2007-1A

 

Financial Intermediaries

 

Floating - 01/2021 - D1 - 05617AAA9

 

ABS

 

3.55

%

1/18/2021

 

$

1,500,000

 

1,258,888

 

1,050,000

 

GALE 2007-3A

 

Financial Intermediaries

 

Floating - 04/2021 - E - 363205AA3

 

ABS

 

3.80

%

4/19/2021

 

$

4,000,000

 

3,386,571

 

2,800,000

 

KATO 2006-9A

 

Financial Intermediaries

 

Floating - 01/2019 - B2L - 486010AA9

 

ABS

 

3.80

%

1/25/2019

 

$

5,000,000

 

4,339,337

 

3,500,000

 

STCLO 2007-6A

 

Financial Intermediaries

 

Floating - 04/2021 - D- 86176YAG7

 

ABS

 

3.90

%

4/17/2021

 

$

5,000,000

 

4,054,241

 

3,500,000

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

$

379,843,341

 

$

374,419,979

 

 

29



Table of Contents

 

Note 5. Agreements

 

On July 30, 2010, the Company entered into an investment advisory and management agreement (the “Management Agreement”) with our Manager. The initial term of the Management Agreement was two years, with automatic, one-year renewals at the end of each year subject to certain approvals by our board of directors and/or our stockholders. On July 15, 2013, our board of directors approved the renewal of the Management Agreement for an additional one-year term. Pursuant to the Management Agreement, our Manager implements our business strategy on a day-to-day basis and performs certain services for us, subject to oversight by our board of directors. Our Manager is responsible for, among other duties, determining investment criteria, sourcing, analyzing and executing investments transactions, asset sales, financings and performing asset management duties. Under the Management Agreement, we have agreed to pay our Manager a management fee for investment advisory and management services consisting of a base management fee and an incentive fee.

 

The base management fee of 1.75% is calculated based on the average value of our gross assets (other than cash or cash equivalents, but including assets purchased with borrowed funds) at the end of the two most recently completed fiscal quarters, and appropriately adjusted for any share issuances or repurchases during the applicable fiscal quarter.

 

The incentive fee consists of the following two parts:

 

The first, payable quarterly in arrears, equals 20.0% of our pre-incentive fee net investment income, expressed as a rate of return on the value of our net assets at the end of the immediately preceding quarter, that exceeds a 1.875% quarterly (7.5% annualized) hurdle rate measured as of the end of each fiscal quarter, subject to a “catch-up” provision. Under this provision, in any fiscal quarter, our Manager receives no incentive fee unless our pre-incentive fee net investment income exceeds the hurdle rate of 1.875%. Our Manager will receive 100.0% of pre-incentive fee net investment income, if any, that exceeds the hurdle rate but is less than or equal to 2.344% in any fiscal quarter (9.376% annualized); and 20.0% of the amount of the our pre-incentive fee net investment income, if any, that exceeds 2.344% in any fiscal quarter (9.376% annualized).

 

The second part of the incentive fee is determined and payable in arrears as of the end of each fiscal year (or upon termination of the Management Agreement) and equals 20.0% of our “incentive fee capital gains,” which equals our realized capital gains on a cumulative basis from May 31, 2010 through the end of the year, if any, computed net of all realized capital losses and unrealized capital depreciation on a cumulative basis, less the aggregate amount of any previously paid capital gain incentive fee. Importantly, the capital gains portion of the incentive fee is based on realized gains and realized and unrealized losses from May 31, 2010. Therefore, realized and unrealized losses incurred prior to such time will not be taken into account when calculating the capital gains portion of the incentive fee, and our Manager will be entitled to 20.0% of incentive fee capital gains that arise after May 31, 2010. In addition, for the purpose of the “incentive fee capital gains” calculations, the cost basis for computing realized gains and losses on investments held by us as of May 31, 2010 will equal the fair value of such investments as of such date.

 

For the three months ended November 30, 2013 and 2012 we incurred $0.9 million and $0.5 million in base management fees, respectively. For the three months ended November 30, 2013 and 2012, we accrued $0.2 million, and $0.1 million in incentive fees related to pre-incentive fee net investment income. For the three months ended November 30, 2013 and 2012 there was a reduction of $0.8 million and $0.5 million in incentive management fees related to capital gains, respectively. For the nine months ended November 30, 2013 and 2012 we incurred $2.4 million and $1.5 million in base management fees, respectively. For the nine months ended November 30, 2013 and 2012, we accrued $1.0 million, and $0.4 million in incentive fees related to pre-incentive fee net investment income. For the nine months ended November 30, 2013 there was a reduction of $0.8 million in incentive management fees related to capital gains. For the nine months ended November 30, 2012, we accrued $0.5 million in incentive management fees related to capital gains. The accrual is calculated using both realized and unrealized capital gains for the period. The actual incentive fee related to capital gains will be determined and payable in arrears at the end of the fiscal year and will include only realized capital gains for the period. As of November 30, 2013, $0.9 million of base management fees and $2.7 million of incentive fees were accrued and included in management and incentive fees payable in the accompanying consolidated statements of assets and liabilities. As of February 28, 2013, $0.6 million of base management fees and $3.9 million of incentive fees were accrued and included in management and incentive fees payable in the accompanying consolidated statements of assets and liabilities.

 

On July 30, 2010, the Company entered into a separate administration agreement (the “Administration Agreement”) with our Manager, pursuant to which our Manager, as our administrator, has agreed to furnish us with the facilities and administrative services necessary to conduct our day-to-day operations and provide managerial assistance on our behalf to those portfolio companies to which we are required to provide such assistance. The initial term of the Administration Agreement was two years, with automatic, one-year renewals at the end of each year subject to certain approvals by our board of directors and/or our stockholders. The amount of expenses payable or reimbursable thereunder by the Company was capped at $1.0 million for the initial two year term of the administration agreement. On July 15, 2013, our board of directors approved the renewal of the Administration Agreement for an

 

30



Table of Contents

 

additional one-year term and determined to maintain the cap on the payment or reimbursement of expenses by the Company thereunder to $1.0 million for the additional one-year term.

 

For the three months ended November 30, 2013 and 2012, we recognized $0.3 million and $0.3 million in administrator expenses for the periods, pertaining to bookkeeping, record keeping and other administrative services provided to us in addition to our allocable portion of rent and other overhead related expenses, respectively. For the nine months ended November 30, 2013 and 2012, we recognized $0.8 million and $0.8 million in administrator expenses for the periods, pertaining to bookkeeping, record keeping and other administrative services provided to us in addition to our allocable portion of rent and other overhead related expenses, respectively. As of November 30, 2013, $0.3 million of administrator expenses were accrued and included in due to manager in the accompanying consolidated statements of assets and liabilities.

 

Note 6. Borrowings

 

Credit Facility

 

As a BDC, we are only allowed to employ leverage to the extent that our asset coverage, as defined in the 1940 Act, equals at least 200.0% after giving effect to such leverage. The amount of leverage that we employ at any time depends on our assessment of the market and other factors at the time of any proposed borrowing.

 

On April 11, 2007, we entered into a $100.0 million revolving securitized credit facility (the “Revolving Facility”). On May 1, 2007, we entered into a $25.7 million term securitized credit facility (the “Term Facility” and, together with the Revolving Facility, the “Facilities”), which was fully drawn at closing. In December 2007, we consolidated the Facilities by using a draw under the Revolving Facility to repay the Term Facility. In response to the marketwide decline in financial asset prices, which negatively affected the value of our portfolio, we terminated the revolving period of the Revolving Facility effective January 14, 2009 and commenced a two-year amortization period during which all principal proceeds from the collateral was used to repay outstanding borrowings. A significant percentage of our total assets had been pledged under the Revolving Facility to secure our obligations thereunder. Under the Revolving Facility, funds were borrowed from or through certain lenders and interest was payable monthly at the greater of the commercial paper rate and our lender’s prime rate plus 4.00% plus a default rate of 2.00% or, if the commercial paper market was unavailable, the greater of the prevailing LIBOR rates and our lender’s prime rate plus 6.00% plus a default rate of 3.00%.

 

In March 2009, we amended the Revolving Facility to increase the portion of the portfolio that could be invested in “CCC” rated investments in return for an increased interest rate and expedited amortization. As a result of these transactions, we expected to have additional cushion under our borrowing base under the Revolving Facility that would allow us to better manage our capital in times of declining asset prices and market dislocation.

 

On July 30, 2009, we exceeded the permissible borrowing limit under the Revolving Facility for 30 consecutive days, resulting in an event of default under the Revolving Facility. As a result of this event of default, our lender had the right to accelerate repayment of the outstanding indebtedness under the Revolving Facility and to foreclose and liquidate the collateral pledged thereunder. Acceleration of the outstanding indebtedness and/or liquidation of the collateral could have had a material adverse effect on our liquidity, financial condition and operations.

 

On July 30, 2010, we used the net proceeds from (i) the stock purchase transaction and (ii) a portion of the funds available to us under the $45.0 million senior secured revolving credit facility (the “Replacement Facility”) with Madison Capital Funding LLC, in each case, described in “Note 13. Recapitalization Transaction” below, to pay the full amount of principal and accrued interest, including default interest, outstanding under the Revolving Facility. As a result, the Revolving Facility was terminated in connection therewith. Substantially all of our total assets, other than those held by SBIC LP, have been pledged under the Replacement Facility to secure our obligations thereunder.

 

On February 24, 2012, we amended our senior secured revolving credit facility with Madison Capital Funding LLC to, among other things:

 

·                  expand the borrowing capacity under the credit facility from $40.0 million to $45.0 million;

 

·                  extend the period during which we may make and repay borrowings under the credit facility from July 30, 2013 to February 24, 2015 (the “Revolving Period”). The Revolving Period may be terminated at an earlier time upon the occurrence of an event of default by action of the lenders or automatically. All borrowings and other amounts payable under the credit facility are due and payable five years after the end of the Revolving Period; and

 

31



Table of Contents

 

·                  remove the condition that we may not acquire additional loan assets without the prior written consent of Madison Capital Funding LLC.

 

As of November 30, 2013, there was $4.0 million of outstanding borrowings under the Replacement Facility and the Company was in compliance with all of the limitations and requirements of the Replacement Facility. $2.3 million of financing costs related to the Replacement Facility have been capitalized and are being amortized over the term of the facility. For the three months ended November 30, 2013 and 2012, we recorded $0.1 million and $0.4 million of interest expense, respectively. For the three months ended November 30, 2013 and 2012, we recorded $0.1 million and $0.1 million of amortization of deferred financing costs related to the Replacement Facility, respectively. The interest rates during the nine months ended November 30, 2013 and 2012 on the outstanding borrowings under the Replacement Facility were 7.50% and 7.50%, respectively. For the nine months ended November 30, 2013 and 2012, we recorded $0.8 million and $1.5 million of interest expense, respectively. For the nine months ended November 30, 2013 and 2012, we recorded $0.3 million and $0.3 million of amortization of deferred financing costs related to the Replacement Facility, respectively.

 

The Replacement Facility contains limitations as to how borrowed funds may be used, such as restrictions on industry concentrations, asset size, weighted average life, currency denomination and collateral interests. The Replacement Facility also includes certain requirements relating to portfolio performance, the violation of which could result in the limit of further advances and, in some cases, result in an event of default, allowing the lenders to accelerate repayment of amounts owed thereunder. The Replacement Facility has an eight year term, consisting of a three year period (the “Revolving Period”), under which the Company may make and repay borrowings, and a final maturity five years from the end of the Revolving Period. Availability on the Replacement Facility will be subject to a borrowing base calculation, based on, among other things, applicable advance rates (which vary from 50.0% to 75.0% of par or fair value depending on the type of loan asset) and the value of certain “eligible” loan assets included as part of the Borrowing Base. Funds may be borrowed at the greater of the prevailing LIBOR rate or 2.00%, plus an applicable margin of 5.50%. At the Company’s option, funds may be borrowed based on an alternative base rate, which in no event will be less than 3.00%, and the applicable margin over such alternative base rate is 4.50%. In addition, the Company will pay the lenders a commitment fee of 0.75% per year on the unused amount of the Replacement Facility for the duration of the Revolving Period.

 

Our borrowing base under the Replacement Facility was $48.2 million subject to the Replacement Facility cap of $45.0 million at November 30, 2013. For purposes of determining the borrowing base, most assets are assigned the values set forth in our most recent Annual Report on Form 10-K or Quarterly Report on Form 10-Q filed with the SEC. Accordingly, the November 30, 2013 borrowing base relies upon the valuations set forth in the Annual Report on Form 10-K for the year ended February 28, 2013. The valuations presented in this Quarterly Report on Form 10-Q will not be incorporated into the borrowing base until after this Quarterly Report on Form 10-Q is filed with the SEC.

 

SBA Debentures

 

SBIC LP is able to borrow funds from the SBA against regulatory capital (which approximates equity capital) that is paid in and is subject to customary regulatory requirements including but not limited to an examination by the SBA. As of November 30, 2013, we have funded SBIC LP with $32.0 million of equity capital, and have $40.0 million of SBA-guaranteed debentures outstanding. SBA debentures are non-recourse to us, have a 10-year maturity, and may be prepaid at any time without penalty. The interest rate of SBA debentures is fixed at the time of issuance, often referred to as pooling, at a market-driven spread over 10-year U.S. Treasury Notes. SBA current regulations limit the amount that SBIC LP may borrow to a maximum of $150.0 million, which is up to twice its potential regulatory capital.

 

SBICs are designed to stimulate the flow of private equity capital to eligible small businesses. Under SBA regulations, SBICs may make loans to eligible small businesses and invest in the equity securities of small businesses. Under present SBA regulations, eligible small businesses include businesses that have a tangible net worth not exceeding $18.0 million and have average annual fully taxed net income not exceeding $6.0 million for the two most recent fiscal years. In addition, an SBIC must devote 25.0% of its investment activity to ‘‘smaller’’ concerns as defined by the SBA. A smaller concern is one that has a tangible net worth not exceeding $6.0 million and has average annual fully taxed net income not exceeding $2.0 million for the two most recent fiscal years. SBA regulations also provide alternative size standard criteria to determine eligibility, which depend on the industry in which the business is engaged and are based on such factors as the number of employees and gross sales. According to SBA regulations, SBICs may make long-term loans to small businesses, invest in the equity securities of such businesses and provide them with consulting and advisory services.

 

SBIC LP is subject to regulation and oversight by the SBA, including requirements with respect to maintaining certain minimum financial ratios and other covenants. Receipt of an SBIC license does not assure that SBIC LP will receive SBA guaranteed

 

32



Table of Contents

 

debenture funding, which is dependent upon SBIC LP continuing to be in compliance with SBA regulations and policies. The SBA, as a creditor, will have a superior claim to SBIC LP’s assets over our stockholders and debt holders in the event we liquidate SBIC LP or the SBA exercises its remedies under the SBA-guaranteed debentures issued by SBIC LP upon an event of default.

 

The Company received exemptive relief from the Securities and Exchange Commission to permit it to exclude the debt of SBIC LP guaranteed by the SBA from the definition of senior securities in the 200.0% asset coverage test under the 1940 Act. This allows the Company increased flexibility under the 200.0% asset coverage test by permitting it to borrow up to $150.0 million more than it would otherwise be able to absent the receipt of this exemptive relief.

 

As of November 30, 2013, there was $40.0 million outstanding of SBA debentures. The carrying amount of the amount outstanding of SBA debentures approximates its fair value. $1.5 million of financing costs related to the SBA debentures have been capitalized and are being amortized over the term of the commitment and drawdown. For the three and nine months ended November 30, 2013, the Company recorded $0.3 million and $0.9 million, respectively, of interest expense related to the SBA debentures. For the three and nine months ended November 30, 2012, the Company recorded $0.001 million and $0.001 million, respectively, of interest expense related to the SBA debentures. For the three and nine months ended November 30, 2013, the Company recorded $0.05 million and $0.2 million, respectively, of amortization of deferred financing costs related to the SBA debentures. For the three and nine months ended November 30, 2012, the Company recorded $0.03 million and $0.04 million, respectively, of amortization of deferred financing costs related to the SBA debentures. The weighted average interest rate during the nine months ended November 30, 2013 and 2012 on the outstanding borrowings of the SBA debentures was 2.99% and 1.47%, respectively.

 

Notes

 

On May 10, 2013, the Company issued $42.0 million in aggregate principal amount of 7.50% fixed-rate notes due 2020 (the “Notes”).  The Notes will mature on May 31, 2020, and may be redeemed in whole or in part at any time or from time to time at the Company’s option on or after May 31, 2016.  Interest will be payable quarterly beginning August 15, 2013.

 

On May 17, 2013, the Company closed an additional $6.3 million in aggregate principal amount of the Notes, pursuant to the full exercise of the underwriters’ option to purchase additional Notes.

 

As of November 30, 2013, the carrying amount and fair value of the Notes was $48.3 million and $49.3 million, respectively. The fair value of the Notes, which are publicly traded, is based upon closing market quotes as of the measurement date.  As of November 30, 2013, $2.5 million of financing costs related to the Notes have been capitalized and are being amortized over the term of the Notes.  For the three and nine months ended November 30, 2013, we recorded $0.9 million and $2.0 million, respectively, of interest expense and $0.09 million and $0.2 million, respectively, of amortization of deferred financing costs related to the Notes.

 

Note 7. Directors Fees

 

The independent directors receive an annual fee of $40,000. They also receive $2,500 plus reimbursement of reasonable out-of-pocket expenses incurred in connection with attending each board meeting and receive $1,000 plus reimbursement of reasonable out-of-pocket expenses incurred in connection with attending each committee meeting. In addition, the chairman of the Audit Committee receives an annual fee of $5,000 and the chairman of each other committee receives an annual fee of $2,000 for their additional services in these capacities. In addition, we have purchased directors’ and officers’ liability insurance on behalf of our directors and officers. Independent directors have the option to receive their directors’ fees in the form of our common stock issued at a price per share equal to the greater of net asset value or the market price at the time of payment. No compensation is paid to directors who are “interested persons” of the Company (as such term is defined in the 1940 Act). For the three months ended November 30, 2013 and 2012, we accrued $0.04 million and $0.05 million for directors’ fees expense, respectively. For the nine months ended November 30, 2013 and 2012, we accrued $0.1 million and $0.2 million for directors’ fees expense, respectively. As of November 30, 2013 and February 28, 2013, $0.02 million and $0.05 million in directors’ fees expense were unpaid and included in accounts payable and accrued expenses in the consolidated statements of assets and liabilities. As of November 30, 2013, we had not issued any common stock to our directors as compensation for their services.

 

Note 8. Stockholders’ Equity

 

On May 16, 2006, GSC Group, Inc. capitalized the LLC, by contributing $1,000 in exchange for 67 shares, constituting all of the issued and outstanding shares of the LLC.

 

On March 20, 2007, the Company issued 95,995.5 and 8,136.2 shares of common stock, priced at $150.00 per share, to GSC Group and certain individual employees of GSC Group, respectively, in exchange for the general partnership interest and a limited partnership interest in GSC Partners CDO III GP, LP, collectively valued at $15.6 million. At this time, the 6.7 shares owned by GSC Group in the LLC were exchanged for 6.7 shares of the Company.

 

33



Table of Contents

 

On March 28, 2007, the Company completed its IPO of 725,000 shares of common stock, priced at $150.00 per share, before underwriting discounts and commissions. Total proceeds received from the IPO, net of $7.1 million in underwriter’s discount and commissions, and $1.0 million in offering costs, were $100.7 million.

 

On November 13, 2009, we declared a dividend of $18.25 per share payable on December 31, 2009. Shareholders had the option to receive payment of the dividend in cash, shares of common stock, or a combination of cash and shares of common stock, provided that the aggregate cash payable to all shareholders was limited to $2.1 million or $2.50 per share. Based on shareholder elections, the dividend consisted of $2.1 million in cash and 864,872.5 of newly issued shares of common stock.

 

On July 30, 2010, our Manager and its affiliates purchased 986,842 shares of common stock at $15.20 per share. Total proceeds received from this sale were $15.0 million. See “Note 13. Recapitalization Transaction.”

 

On August 12, 2010, we effected a one-for-ten reverse stock split of our outstanding common stock. As a result of the reverse stock split, every ten shares of our common stock were converted into one share of our common stock. Any fractional shares received as a result of the reverse stock split were redeemed for cash. The total cash payment in lieu of shares was $230. Immediately after the reverse stock split, we had 2,680,842 shares of our common stock outstanding.

 

On November 12, 2010, we declared a dividend of $4.40 per share payable on December 29, 2010. Shareholders had the option to receive payment of the dividend in cash, shares of common stock, or a combination of cash and shares of common stock, provided that the aggregate cash payable to all shareholders was limited to approximately $1.2 million or $0.44 per share. Based on shareholder elections, the dividend consisted of approximately $1.2 million in cash and 596,235 shares of common stock.

 

On November 15, 2011, we declared a dividend of $3.00 per share payable on December 30, 2011. Shareholders had the option to receive payment of the dividend in cash, shares of common stock, or a combination of cash and shares of common stock, provided that the aggregate cash payable to all shareholders was limited to approximately $2.0 million or $0.60 per share. Based on shareholder elections, the dividend consisted of approximately $2.0 million in cash and 599,584 shares of common stock.

 

On November 9, 2012, the Company declared a dividend of $4.25 per share payable on December 31, 2012. Shareholders had the option to receive payment of the dividend in cash, shares of common stock, or a combination of cash and shares of common stock, provided that the aggregate cash payable to all shareholders was limited to approximately $3.3 million or $0.85 per share.  Based on shareholder elections, the dividend consisted of approximately $3.3 million in cash and 853,455 shares of common stock.

 

On October 30, 2013, the Company declared a dividend of $2.65 per share payable on December 27, 2013. Shareholders had the option to receive payment of the dividend in cash, shares of common stock, or a combination of cash and shares of common stock, provided that the aggregate cash payable to all shareholders was limited to approximately $2.5 million or $0.53 per share. Based on shareholder elections, the dividend consisted of approximately $2.5 million in cash and 649,500 shares of common stock.

 

Note 9. Earnings Per Share

 

In accordance with the provisions of FASB ASC 260, “Earnings per Share” (“ASC 260”), basic earnings per share is computed by dividing earnings available to common shareholders by the weighted average number of shares outstanding during the period. Other potentially dilutive common shares, and the related impact to earnings, are considered when calculating earnings per share on a diluted basis.

 

The following information sets forth the computation of the weighted average basic and diluted net increase in net assets per share from operations for the three and nine months ended November 30, 2013 and 2012 (dollars in thousands except share and per share amounts):

 

 

 

For the three months ended

 

For the nine months ended

 

Basic and diluted

 

November 30,
2013

 

November 30,
2012

 

November 30,
2013

 

November 30,
2012

 

Net increase in net assets from operations

 

$1,268

 

$746

 

$5,026

 

$8,807

 

Weighted average common shares outstanding

 

4,851,451

 

3,970,447

 

4,770,267

 

3,907,696

 

Earnings (loss) per common share-basic and diluted

 

$0.26

 

$0.19

 

$1.05

 

$2.25

 

 

Note 10. Dividend

 

On October 30, 2013, the Company declared a dividend of $2.65 per share payable on December 27, 2013. Shareholders had the option to receive payment of the dividend in cash, shares of common stock, or a combination of cash and shares of common stock, provided that the aggregate cash payable to all shareholders was limited to approximately $2.5 million or $0.53 per share.

 

34



Table of Contents

 

Based on shareholder elections, the dividend consisted of approximately $2.5 million in cash and 649,500 shares of common stock, or 13.7% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $15.439 per share, which equaled the volume weighted average trading price per share of the common stock on December 11, 14, and 16, 2013. The consolidated financial statements for the period ended November 30, 2013 have been retroactively adjusted to reflect the increase in common stock as a result of the dividend in accordance with the provisions of ASC 505-20-S50 regarding disclosure of a capital structure change after the interim balance sheet but before the release of the financial statements.

 

Note 11. Financial Highlights

 

The following is a schedule of financial highlights for the three months ended November 30, 2013 and 2012:

 

 

 

November
30, 2013

 

November
30, 2012

 

Per share data:

 

 

 

 

 

Net asset value at beginning of period

 

$

22.98

 

$

25.12

 

Net investment income(1) 

 

1.60

 

1.30

 

Net realized and unrealized gains and (losses) on investments and derivatives

 

(0.55

)

0.95

 

Net increase in net assets from operations

 

1.05

 

2.25

 

Distributions declared from net investment income

 

(2.65

)

(4.25

)

Other (2)

 

(0.71

)

(1.37

)

Net asset value at end of period

 

$

20.67

 

$

21.75

 

Net assets at end of period

 

$

111,206,093

 

$

102,892,221

 

Shares outstanding at end of period

 

5,379,616

 

4,730,116

 

Per share market value at end of period

 

$

15.64

 

$

15.70

 

Total return based on market value(3) 

 

7.66

%

26.07

%

Total return based on net asset value(4) 

 

5.40

%

10.43

%

Ratio/Supplemental data:

 

 

 

 

 

Ratio of net investment income to average, net assets(5) 

 

9.12

%

6.63

%

Ratio of operating expenses to average net assets(5) 

 

5.97

%

5.29

%

Ratio of incentive management fees to average net assets(5) 

 

0.26

%

1.16

%

Ratio of debt related expenses to average net assets(5) 

 

5.18

%

2.36

%

Ratio of total expenses to average net assets(5) 

 

11.42

%

8.81

%

Portfolio turnover rate(6) 

 

36.80

%

14.64

%

 


(1)                                 Net investment income per share is calculated using the weighted average shares outstanding during the period.

(2)                                 Represents the dilutive effect of issuing common stock below net asset value per share during the period.

(3)                                 Total investment return is calculated assuming a purchase of common shares at the current market value on the first day and a sale at the current market value on the last day of the periods reported. Dividends and distributions, if any, are assumed for purposes of this calculation to be reinvested at prices obtained under the Company’s dividend reinvestment plan. Total investment return does not reflect brokerage commissions. Total investment returns covering less than a full period are not annualized.

(4)                                 Total investment return is calculated assuming a purchase of common shares at the current net asset value on the first day and a sale at the current net asset value on the last day of the periods reported. Dividends and distributions, if any, are assumed for purposes of this calculation to be reinvested at prices obtained under the Company’s dividend reinvestment plan. Total investment return does not reflect brokerage commissions.

(5)                                 Ratios are annualized.

(6)                                 Portfolio turnover rate is calculated using the lesser of year-to-date sales or year-to-date purchases over the average of the invested assets at fair value.

 

Note 12. Recapitalization Transaction

 

In July 2010, we consummated a recapitalization transaction that was necessitated by the fact that we had exceeded permissible borrowing limits under the Revolving Facility in July 2009, which resulted in an event of default under the Revolving Facility. As a result of the event of default under the Revolving Facility, the lender had the right to accelerate repayment of the outstanding indebtedness under the Revolving Facility and to foreclose and liquidate the collateral pledged thereunder. We engaged the investment banking firm of Stifel, Nicolaus & Company to evaluate strategic transaction opportunities and consider alternatives for us in December 2008. On April 14, 2010, we entered into a stock purchase agreement with our Manager and certain of its affiliates and an assignment, assumption and novation agreement with our Manager, pursuant to which we assumed certain rights and

 

35



Table of Contents

 

obligations of our Manager under a debt commitment letter our Manager received from Madison Capital Funding LLC, indicating Madison Capital Funding’s willingness to provide us with the Replacement Facility, subject to the satisfaction of certain terms and conditions. In addition, we and GSCP (NJ), L.P., our then external investment adviser, entered into a termination and release agreement, to be effective as of the closing of the transaction contemplated by the stock purchase agreement, pursuant to which GSCP (NJ), L.P., among other things, agreed to waive any and all accrued and unpaid deferred incentive management fees up to and as of the closing of the transaction contemplated by the stock purchase agreement but continued to be entitled to receive the base management fees earned through the date of the closing of the transaction contemplated by the stock purchase agreement.

 

On July 30, 2010, the transactions contemplated by the stock purchase agreement with our Manager and certain of its affiliates was completed, and included the following actions:

 

·                  the private sale of shares of our common stock for $15.0 million in aggregate purchase price to our Manager and certain of its affiliates;

·                  the closing of the $40.0 million Replacement Facility with Madison Capital Funding;

·                  the execution of a registration rights agreement with the investors in the private sale transaction, pursuant to which we agreed to file a registration statement with the SEC to register for resale the shares of our common stock sold in the private sale transaction;

·                  the execution of a trademark license agreement with our Manager pursuant to which our Manager granted us a non-exclusive, royalty-free license to use the “Saratoga” name, for so long as our Manager or one of its affiliates remains our investment adviser;

·                  replacing GSCP (NJ), L.P. as our investment adviser and administrator with our Manager by executing an investment advisory and management agreement, which was approved by our stockholders, and an administration agreement with our Manager;

·                  the resignations of Robert F. Cummings, Jr. and Richard M. Hayden, both of whom are affiliates of GSCP (NJ) L.P., as members of the board of directors and the election of Christian L. Oberbeck and Richard A. Petrocelli, both of whom are affiliates of our Manager, as members of the board of directors;

·                  the resignation of all of our then existing executive officers and the appointment by our board of directors of Mr. Oberbeck as our chief executive officer and Mr. Petrocelli as our chief financial officer, secretary and chief compliance officer; and

·                  our name change from “GSC Investment Corp.” to “Saratoga Investment Corp.”

 

We used the net proceeds from the private sale transaction and a portion of the funds available to us under the Replacement Facility to pay the full amount of principal and accrued interest, including default interest, outstanding under Revolving Facility. The Revolving Facility with Deutsche Bank was terminated in connection with our payment of all amounts outstanding thereunder on July 30, 2010.

 

Note 13. Subsequent Events

 

Management has evaluated subsequent events through the date of issuance of the consolidated financial statements included herein. There have been no subsequent events that occurred during such period that would require disclosure in this Form 10-Q or would be required to be recognized in the consolidated financial statements as of and for the quarter ended November 30, 2013.

 

Item 2.  Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

The following discussion should be read in conjunction with our financial statements and related notes and other financial information appearing elsewhere in this Quarterly Report on Form 10-Q. In addition to historical information, the following discussion and other parts of this Quarterly Report contain forward-looking information that involves risks and uncertainties. Our actual results could differ materially from those anticipated by such forward-looking information due to the factors discussed under Part I, Item 1A in our Annual Report on Form 10-K for the fiscal year ended February 28, 2013.

 

The forward-looking statements are based on our beliefs, assumptions and expectations of our future performance, taking into account all information currently available to us. These beliefs, assumptions and expectations can change as a result of many possible events or factors, not all of which are known to us or are within our control. If a change occurs, our business, financial condition, liquidity and results of operations may vary materially from those expressed in our forward-looking statements.

 

The forward-looking statements contained in this Quarterly Report on Form 10-Q involve risks and uncertainties, including statements as to:

 

·                  our future operating results;

·                  our business prospects and the prospects of our portfolio companies;

·                  the impact of investments that we expect to make;

·                  our contractual arrangements and relationships with third parties;

 

36



Table of Contents

 

·                  the dependence of our future success on the general economy and its impact on the industries in which we invest;

·                  the ability of our portfolio companies to achieve their objectives;

·                  our expected financings and investments;

·                  our regulatory structure and tax treatment, including our ability to operate as a business development company, a small business investment company and a regulated investment company;

·                  the adequacy of our cash resources and working capital;

·                  the timing of cash flows, if any, from the operations of our portfolio companies; and

·                  the ability of our investment adviser to locate suitable investments for us and to monitor and effectively administer our investments.

 

You should not place undue reliance on these forward-looking statements. The forward-looking statements made in this Quarterly Report on Form 10-Q relate only to events as of the date on which the statements are made. We undertake no obligation to update any forward-looking statement to reflect events or circumstances occurring after the date of this Quarterly Report on Form 10-Q.

 

OVERVIEW

 

We are a Maryland corporation that has elected to be treated as a business development company (“BDC”) under the Investment Company Act of 1940 (the “1940 Act”). Our investment objective is to generate current income and, to a lesser extent, capital appreciation from our investments. We invest primarily in leveraged loans and mezzanine debt issued by private U.S. middle market companies, which we define as companies having EBITDA of between $5 million and $50 million, both through direct lending and through participation in loan syndicates. We may also invest up to 30.0% of the portfolio in opportunistic investments in order to seek to enhance returns to stockholders. Such investments may include investments in distressed debt, which may include securities of companies in bankruptcy, foreign debt, private equity, securities of public companies that are not thinly traded and structured finance vehicles such as collateralized loan obligation funds. We have elected and qualified to be treated as a regulated investment company (“RIC”) under Subchapter M of the Internal Revenue Code of 1986, as amended (the “Code”).

 

Corporate History and Recent Developments

 

We commenced operations, at the time known as GSC Investment Corp., on March 23, 2007 and completed an initial public offering of shares of common stock on March 28, 2007. Prior to July 30, 2010, we were externally managed and advised by GSCP (NJ), L.P., an entity affiliated with GSC Group, Inc. In connection with the consummation of a recapitalization transaction on July 30, 2010, we engaged Saratoga Investment Advisors (“SIA”) to replace GSCP (NJ), L.P. as our investment adviser and changed our name to Saratoga Investment Corp.

 

As a result of the event of default under a revolving securitized credit facility with Deutsche Bank we previously had in place, in December 2008 we engaged the investment banking firm of Stifel, Nicolaus & Company to evaluate strategic transaction opportunities and consider alternatives for us. On April 14, 2010, we entered into a stock purchase agreement with Saratoga Investment Advisors and certain of its affiliates and an assignment, assumption and novation agreement with Saratoga Investment Advisors, pursuant to which we assumed certain rights and obligations of Saratoga Investment Advisors under a debt commitment letter Saratoga Investment Advisors received from Madison Capital Funding LLC, indicating Madison Capital Funding’s willingness to provide us with a $40.0 million senior secured revolving credit facility, subject to the satisfaction of certain terms and conditions. In addition, we and GSCP (NJ), L.P. entered into a termination and release agreement, to be effective as of the closing of the transaction contemplated by the stock purchase agreement, pursuant to which GSCP (NJ), L.P., among other things, agreed to waive any and all accrued and unpaid deferred incentive management fees up to and as of the closing of the transaction contemplated by the stock purchase agreement but continued to be entitled to receive the base management fees earned through the date of the closing of the transaction contemplated by the stock purchase agreement.

 

On July 30, 2010, the transactions contemplated by the stock purchase agreement with Saratoga Investment Advisors and certain of its affiliates were completed, and included the following actions:

 

·                  the private sale of 986,842 shares of our common stock for $15.0 million in aggregate purchase price to Saratoga Investment Advisors and certain of its affiliates;

 

·                  the closing of the $40.0 million senior secured revolving credit facility with Madison Capital Funding;

 

·                  the execution of a registration rights agreement with the investors in the private sale transaction, pursuant to which, among other things, we agreed to file a registration statement with the SEC to register for resale the shares of our common stock sold in the private sale transaction, including any shares of common stock issued or issuable upon any stock split, dividend or other distribution, recapitalization or similar event relating thereto, and to use commercially reasonable efforts to cause such registration statement to be declared effective within 90 days after the date on which the registration statement was initially filed with the SEC;

 

37



Table of Contents

 

·                  the execution of a trademark license agreement with Saratoga Investment Advisors pursuant to which Saratoga Investment Advisors granted us a non-exclusive, royalty-free license to use the “Saratoga” name, for so long as Saratoga Investment Advisors or one of its affiliates remains our investment adviser; and

 

·                  replacing GSCP (NJ), L.P. as our investment adviser and administrator with Saratoga Investment Advisors by executing an investment advisory and management agreement, which was approved by our stockholders, and an administration agreement with Saratoga Investment Advisors;

 

·                  the resignations of Robert F. Cummings, Jr. and Richard M. Hayden, both of whom are affiliates of GSCP (NJ) L.P., as members of the board of directors and the election of Christian L. Oberbeck and Richard A. Petrocelli, both of whom are affiliates of Saratoga Investment Advisors, as members of the board of directors;

 

·                  the resignation of all of our then existing executive officers and the appointment by our board of directors of Mr. Oberbeck as our chief executive officer and Mr. Petrocelli as our chief financial officer, secretary and chief compliance officer; and

 

·                  our name change from “GSC Investment Corp.” to “Saratoga Investment Corp.”

 

We used the net proceeds from the private sale transaction and a portion of the funds available to us under the $40.0 million senior secured revolving credit facility with Madison Capital Funding to pay the full amount of principal and accrued interest, including default interest, outstanding under our revolving securitized credit facility with Deutsche Bank. The revolving securitized credit facility with Deutsche Bank was terminated in connection with our payment of all amounts outstanding thereunder on July 30, 2010.

 

On August 12, 2010, we effected a one-for-ten reverse stock split of our outstanding common stock. As a result of the reverse stock split, every ten shares of our common stock were converted into one share of our common stock. Any fractional shares received as a result of the reverse stock split were redeemed for cash. The total cash payment in lieu of shares was $230. Immediately after the reverse stock split, we had 2,680,842 shares of our common stock outstanding.

 

In January 2011, we registered for public resale the 982,842 shares of our common stock issued to Saratoga Investment Advisors and certain of its affiliates.

 

Critical Accounting Policies

 

Basis of Presentation

 

The preparation of financial statements in accordance with U.S. generally accepted accounting principles (“GAAP”) requires management to make certain estimates and assumptions affecting amounts reported in the Company’s consolidated financial statements. We have identified investment valuation, revenue recognition and the recognition of capital gains incentive fee expense as our most critical accounting estimates. We continuously evaluate our estimates, including those related to the matters described below. These estimates are based on the information that is currently available to us and on various other assumptions that we believe to be reasonable under the circumstances. Actual results could differ materially from those estimates under different assumptions or conditions. A discussion of our critical accounting policies follows.

 

Investment Valuation

 

The Company accounts for its investments at fair value in accordance with the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 820, Fair Value Measurements and Disclosures (“ASC 820”). ASC 820 defines fair value, establishes a framework for measuring fair value, establishes a fair value hierarchy based on the quality of inputs used to measure fair value and enhances disclosure requirements for fair value measurements. ASC 820 requires the Company to assume that its investments are to be sold at the statement of assets and liabilities date in the principal market to independent market participants, or in the absence of a principal market, in the most advantageous market, which may be a hypothetical market. Market participants are defined as buyers and sellers in the principal or most advantageous market that are independent, knowledgeable, and willing and able to transact.

 

Investments for which market quotations are readily available are fair valued at such market quotations obtained from independent third party pricing services and market makers subject to any decision by our board of directors to approve a fair value determination to reflect significant events affecting the value of these investments. We value investments for which market quotations are not readily available at fair value as approved, in good faith, by our board of directors based on input from Saratoga Investment Advisers, the audit committee of our board of directors and a third party independent valuation firm. Determinations of fair value may involve subjective judgments and estimates. The types of factors that may be considered in determining the fair value of our investments include the nature and realizable value of any collateral, the portfolio company’s ability to make payments, market yield trend analysis, the markets in which the portfolio company does business, comparison to publicly traded companies, discounted cash flow and other relevant factors.

 

We undertake a multi-step valuation process each quarter when valuing investments for which market quotations are not readily available, as described below:

 

38



Table of Contents

 

·                  Each investment is initially valued by the responsible investment professionals of Saratoga Investment Advisors and preliminary valuation conclusions are documented and discussed with our senior management; and

 

·                  An independent valuation firm engaged by our board of directors reviews approximately one quarter of these preliminary valuations each quarter so that the valuation of each investment for which market quotes are not readily available is reviewed by the independent valuation firm at least annually.

 

In addition, all our investments are subject to the following valuation process:

 

·                  The audit committee of our board of directors reviews each preliminary valuation and Saratoga Investment Advisors and independent valuation firm (if applicable) will supplement the preliminary valuation to reflect any comments provided by the audit committee; and

 

·                  Our board of directors discusses the valuations and approves the fair value of each investment, in good faith, based on the input of Saratoga Investment Advisors, the independent valuation firm (to the extent applicable) and the audit committee of our board of directors.

 

Our investment in Saratoga Investment Corp. CLO 2013-1, Ltd. (“Saratoga CLO”) is carried at fair value, which is based on a discounted cash flow model that utilizes prepayment, re-investment and loss assumptions based on historical experience and projected performance, economic factors, the characteristics of the underlying cash flow, and comparable yields for equity interests in collateralized loan obligation funds similar to Saratoga CLO, when available, as determined by SIA and recommended to our board of directors. Specifically, we use Intex cash flow models, or an appropriate substitute, to form the basis for the valuation of our investment in Saratoga CLO. The models use a set of assumptions including projected default rates, recovery rates, reinvestment rate and prepayment rates in order to arrive at estimated valuations. The assumptions are based on available market data and projections provided by third parties as well as management estimates. We use the output from the Intex models (i.e., the estimated cash flows) to perform a discounted cash flows analysis on expected future cash flows to determine a valuation for our investment in Saratoga CLO.

 

Revenue Recognition

 

Income Recognition

 

Interest income, adjusted for amortization of premium and accretion of discount, is recorded on an accrual basis to the extent that such amounts are expected to be collected. The Company stops accruing interest on its investments when it is determined that interest is no longer collectible. Discounts and premiums on investments purchased are accreted/amortized over the life of the respective investment using the effective yield method. The amortized cost of investments represents the original cost adjusted for the accretion of discounts and amortizations of premium on investments.

 

Loans are generally placed on non-accrual status when there is reasonable doubt that principal or interest will be collected. Accrued interest is generally reserved when a loan is placed on non-accrual status. Interest payments received on non-accrual loans may be recognized as a reduction in principal depending upon management’s judgment regarding collectability. Non-accrual loans are restored to accrual status when past due principal and interest is paid and, in management’s judgment, are likely to remain current, although we may make exceptions to this general rule if the loan has sufficient collateral value and is in the process of collection.

 

Interest income on our investment in Saratoga CLO is recorded using the effective interest method in accordance with the provisions of ASC Topic 325-40, Investments-Other, Beneficial Interests in Securitized Financial Assets, based on the anticipated yield and the estimated cash flows over the projected life of the investment. Yields are revised when there are changes in actual or estimated cash flows due to changes in prepayments and/or re-investments, credit losses or asset pricing. Changes in estimated yield are recognized as an adjustment to the estimated yield over the remaining life of the investment from the date the estimated yield was changed.

 

Paid-in-Kind Interest

 

The Company holds debt investments in its portfolio that contain a payment-in-kind (“PIK”) interest provision. The PIK interest, which represents contractually deferred interest added to the investment balance that is generally due at maturity, is generally recorded on the accrual basis to the extent such amounts are expected to be collected. We stop accruing PIK interest if we do not expect the issuer to be able to pay all principal and interest when due.

 

Capital Gains Incentive Fee

 

The Company records an expense accrual relating to the capital gains incentive fee payable by the Company to its investment adviser when the unrealized gains on its investments exceed all realized capital losses on its investments given the fact that a capital gains incentive fee would be owed to the investment adviser if the Company were to liquidate its investment portfolio at such time.  The actual incentive fee payable to the Company’s investment adviser related to capital gains will be determined and payable in arrears at the end of each fiscal year and will include only realized capital gains for the period.

 

39



Table of Contents

 

Revenues

 

We generate revenue in the form of interest income and capital gains on the debt investments that we hold and capital gains, if any, on equity interests that we may acquire. We expect our debt investments, whether in the form of leveraged loans or mezzanine debt, to have terms of up to ten years, and to bear interest at either a fixed or floating rate. Interest on debt will be payable generally either quarterly or semi-annually. In some cases, our debt investments may provide for a portion of the interest to be paid-in-kind (“PIK”). To the extent interest is paid-in-kind, it will be payable through the increase of the principal amount of the obligation by the amount of interest due on the then-outstanding aggregate principal amount of such obligation. The principal amount of the debt and any accrued but unpaid interest will generally become due at the maturity date. In addition, we may generate revenue in the form of commitment, origination, structuring or diligence fees, fees for providing managerial assistance or investment management services and possibly consulting fees. Any such fees will be generated in connection with our investments and recognized as earned. We may also invest in preferred equity securities that pay dividends on a current basis.

 

On January 22, 2008, we entered into a collateral management agreement with Saratoga CLO, pursuant to which we act as its collateral manager. The Saratoga CLO was refinanced in October 2013 and its reinvestment period ends in October 2016. The Saratoga CLO remains 100% owned and managed by Saratoga Investment Corp. We receive a senior collateral management fee of 0.25% and a subordinate collateral management fee of 0.25% of the outstanding principal amount of Saratoga CLO’s assets, paid quarterly to the extent of available proceeds. We are also entitled to an incentive management fee equal to 20.0% of excess cash flow to the extent the Saratoga CLO subordinated notes receive an internal rate of return equal to or greater than 12.0%.

 

We recognize interest income on our investment in the subordinated notes of Saratoga CLO using the effective interest method, based on the anticipated yield and the estimated cash flows over the projected life of the investment. Yields are revised when there are changes in actual or estimated cash flows due to changes in prepayments and/or re-investments, credit losses or asset pricing. Changes in estimated yield are recognized as an adjustment to the estimated yield over the remaining life of the investment from the date the estimated yield was changed.

 

Expenses

 

Our primary operating expenses include the payment of investment advisory and management fees, professional fees, directors and officers insurance, fees paid to independent directors and administrator expenses, including our allocable portion of our administrator’s overhead. Our investment advisory and management fees compensate our investment adviser for its work in identifying, evaluating, negotiating, closing and monitoring our investments. We bear all other costs and expenses of our operations and transactions, including those relating to:

 

·                  organization;

 

·                  calculating our net asset value (including the cost and expenses of any independent valuation firm);

 

·                  expenses incurred by our investment adviser payable to third parties, including agents, consultants or other advisers, in monitoring our financial and legal affairs and in monitoring our investments and performing due diligence on our prospective portfolio companies;

 

·                  interest payable on debt, if any, incurred to finance our investments;

 

·                  offerings of our common stock and other securities;

 

·                  investment advisory and management fees;

 

·                  fees payable to third parties, including agents, consultants or other advisers, relating to, or associated with, evaluating and making investments;

 

·                  transfer agent and custodial fees;

 

·                  federal and state registration fees;

 

·                  all costs of registration and listing our common stock on any securities exchange;

 

·                  federal, state and local taxes;

 

40



Table of Contents

 

·                  independent directors’ fees and expenses;

 

·                  costs of preparing and filing reports or other documents required by governmental bodies (including the SEC and the SBA);

 

·                  costs of any reports, proxy statements or other notices to common stockholders including printing costs;

 

·                  our fidelity bond, directors and officers errors and omissions liability insurance, and any other insurance premiums;

 

·                  direct costs and expenses of administration, including printing, mailing, long distance telephone, copying, secretarial and other staff, independent auditors and outside legal costs; and

 

·                  administration fees and all other expenses incurred by us or, if applicable, the administrator in connection with administering our business (including payments under the administration agreement based upon our allocable portion of the administrator’s overhead in performing its obligations under an administration agreement, including rent and the allocable portion of the cost of our officers and their respective staffs (including travel expenses)).

 

To the extent that any of our leveraged loans are denominated in a currency other than U.S. dollars, we may enter into currency hedging contracts to reduce our exposure to fluctuations in currency exchange rates. We may also enter into interest rate hedging agreements. Such hedging activities, which will be subject to compliance with applicable legal requirements, may include the use of interest rate caps, futures, options and forward contracts. Costs incurred in entering into or settling such contracts will be borne by us.

 

Portfolio and investment activity

 

Corporate Debt Portfolio Overview

 

 

 

At November 30,
2013

 

At February 28,
2013

 

 

 

($ in millions)

 

Number of investments(1)

 

57

 

44

 

Number of portfolio companies(1)

 

36

 

28

 

Average investment size(1)

 

$

3.2

 

$

2.9

 

Weighted average maturity(1)

 

4.6yrs

 

3.7yrs

 

Number of industries(1)

 

17

 

15

 

Average investment per portfolio company(1)

 

$

5.0

 

$

4.6

 

Non-performing or delinquent investments(1)

 

$

0.4

 

$

6.7

 

Fixed rate debt (% of interest bearing portfolio)(2)

 

$

64.2(37.5

)%

$

53.4(43.9

)%

Weighted average current coupon(2)

 

13.1

%

12.6

%

Floating rate debt (% of interest bearing portfolio)(2)

 

$

106.8(62.5

)%

$

68.2(56.1

)%

Weighted average current spread over LIBOR(2)

 

7.3

%

7.5

%

 


(1)                                 Excludes our investment in the subordinated notes of Saratoga CLO.

 

(2)                                 Excludes our investment in the subordinated notes of Saratoga CLO and investments in common stocks.

 

During the three months ended November 30, 2013, we made $22.3 million investments in new or existing portfolio companies and had $9.9 million in aggregate amount of exits and repayments resulting in net investments of $12.4 million for the period. During the three months ended November 30, 2012, we made $6.4 million investments in new or existing portfolio companies and had $1.5 million in aggregate amount of exits and repayments resulting in net investments of $4.9 million for the period.

 

During the nine months ended November 30, 2013, we made $110.1 million investments in new or existing portfolio companies and had $65.0 million in aggregate amount of exits and repayments resulting in net investments of $45.1 million for the period. During the nine months ended November 30, 2012, we made $34.7 million investments in new or existing portfolio companies and had $16.0 million in aggregate amount of exits and repayments resulting in net investments of $18.7 million for the period.

 

41



Table of Contents

 

Our portfolio composition based on fair value at November 30, 2013 and February 28, 2013 was as follows:

 

Portfolio composition

 

 

 

At November 30, 2013

 

At February 28, 2013

 

 

 

Percentage
of Total
Portfolio

 

Weighted
Average
Current
Yield

 

Percentage
of Total
Portfolio

 

Weighted
Average
Current
Yield

 

Middle market loans

 

18.8

%

6.4

%

%

%

First lien term loans

 

35.5

 

11.1

 

54.0

 

10.0

 

Second lien term loans

 

13.9

 

11.2

 

6.2

 

11.1

 

Senior secured notes

 

15.1

 

14.2

 

15.0

 

14.8

 

Unsecured notes

 

2.7

 

15.1

 

3.1

 

16.4

 

Saratoga CLO subordinated notes

 

9.6

 

11.7

 

16.5

 

27.1

 

Equity interests

 

4.4

 

N/A

 

5.2

 

N/A

 

Total

 

100.0

%

10.8

%

100.0

%

14.0

%

 

Our investment in the subordinated notes of Saratoga CLO represents a first loss position in a portfolio that, at November 30, 2013 and February 28, 2013, was composed of $300.6 million and $383.3 million, respectively, in aggregate principal amount of predominantly senior secured first lien term loans. This investment is subject to unique risks. (See “Risk Factors—Our investment in GSC Investment Corp. CLO 2013-1, LTD. constitutes a leveraged investment in a portfolio of predominantly senior secured first lien term loans and is subject to additional risks and volatility” in our Annual Report on Form 10-K for the fiscal year ended February 28, 2013). We do not consolidate the Saratoga CLO portfolio in our financial statements. However, at November 30, 2013, $298.1 million or 99.5% of the Saratoga CLO portfolio investments in terms of market value had a CMR (as defined below) color rating of green or yellow and three Saratoga CLO portfolio investments were in default with a fair value of $1.6 million. At February 28, 2013, $368.9 million or 98.5% of the Saratoga CLO portfolio investments in terms of market value had a CMR color rating of green or yellow and one Saratoga CLO portfolio investment was in default with a fair value of $1.0 million.

 

Saratoga Investment Advisors normally grades all of our investments using a credit and monitoring rating system (“CMR”). The CMR consists of a single component: a color rating. The color rating is based on several criteria, including financial and operating strength, probability of default, and restructuring risk. The color ratings are characterized as follows: (Green)—strong credit; (Yellow)—satisfactory credit; (Red)—payment default risk, in payment default and/or significant restructuring activity.

 

The CMR distribution of our investments at November 30, 2013 and February 28, 2013 was as follows:

 

Portfolio CMR distribution

 

 

 

At November 30, 2013

 

At February 28, 2013

 

Color
Score

 

Investments
at
Fair Value

 

Percentage
of
Total
Portfolio

 

Investments
at
Fair Value

 

Percentage
of
Total
Portfolio

 

 

 

($ in thousands)

 

Green

 

$

154,291

 

77.6

%

$

100,170

 

64.6

%

Yellow

 

15,479

 

7.8

 

8,143

 

5.3

 

Red

 

1,271

 

0.6

 

13,229

 

8.5

 

N/A(1)

 

27,738

 

14.0

 

33,538

 

21.6

 

Total

 

$

198,779

 

100.0

%

$

155,080

 

100.0

%

 


(1)                                 Comprised of our investment in the subordinated notes of Saratoga CLO and equity interests.

 

42



Table of Contents

 

The CMR distribution of Saratoga CLO investments at November 30, 2013 and February 28, 2013 was as follows:

 

Portfolio CMR distribution

 

 

 

At November 30, 2013

 

At February 28, 2013

 

Color
Score

 

Investments
at
Fair Value

 

Percentage
of
Total
Portfolio

 

Investments
at
Fair Value

 

Percentage
of
Total
Portfolio

 

 

 

($ in thousands)

 

Green

 

$

271,830

 

90.7

%

$

318,181

 

85.0

%

Yellow

 

26,320

 

8.8

 

50,677

 

13.5

 

Red

 

1,614

 

0.5

 

5,562

 

1.5

 

Total

 

$

299,764

 

100.0

%

$

374,420

 

100.0

%

 

Portfolio composition by industry grouping at fair value

 

The following table shows the portfolio composition by industry grouping at fair value at November 30, 2013 and February 28, 2013.

 

 

 

At November 30, 2013

 

At February 28, 2013

 

 

 

Investments
at
Fair Value

 

Percentage
of
Total
Portfolio

 

Investments
at
Fair Value

 

Percentage
of
Total
Portfolio

 

 

 

($ in thousands)

 

Business Services

 

$

57,347

 

28.8

%

$

22,155

 

14.3

%

Healthcare Services

 

23,329

 

11.7

 

12,400

 

8.0

 

Structured Finance Securities(1)

 

19,019

 

9.6

 

25,517

 

16.5

 

Software

 

17,833

 

9.0

 

 

 

Food and Beverage

 

17,196

 

8.7

 

18,199

 

11.7

 

Consumer Services

 

15,846

 

8.0

 

10,654

 

6.9

 

Automotive

 

10,462

 

5.3

 

14,805

 

9.5

 

Electronics

 

6,752

 

3.4

 

6,721

 

4.3

 

Metals

 

6,685

 

3.4

 

6,724

 

4.3

 

Consumer Products

 

5,981

 

3.0

 

13,727

 

8.9

 

Manufacturing

 

5,955

 

3.0

 

 

 

Logistics

 

5,056

 

2.5

 

11,181

 

7.2

 

Environmental

 

4,574

 

2.3

 

2,992

 

1.9

 

Publishing

 

1,180

 

0.6

 

5,631

 

3.6

 

Building Products

 

753

 

0.4

 

267

 

0.2

 

Homebuilding

 

376

 

0.2

 

315

 

0.2

 

Aerospace

 

344

 

0.1

 

3,500

 

2.3

 

Education

 

91

 

0.0

 

292

 

0.2

 

Total

 

$

198,779

 

100.0

%

$

155,080

 

100.0

%

 


(1)                                 Comprised of our investment in the subordinated notes of Saratoga CLO.

 

The following table shows the portfolio composition by industry grouping of Saratoga CLO at fair value at November 30, 2013 and February 28, 2013.

 

43



Table of Contents

 

 

 

At November 30, 2013

 

At February 28, 2013

 

 

 

Investments
at
Fair Value

 

Percentage
of
Total
Portfolio

 

Investments
at
Fair Value

 

Percentage
of
Total
Portfolio

 

 

 

($ in thousands)

 

Healthcare

 

$

35,971

 

12.0

%

$

40,502

 

10.8

%

Business Equipment and Services

 

28,492

 

9.5

 

28,300

 

7.6

 

Conglomerate

 

25,360

 

8.5

 

29,888

 

8.0

 

Chemicals/Plastics

 

24,037

 

8.0

 

28,817

 

7.7

 

Industrial Equipment

 

21,776

 

7.3

 

21,864

 

5.8

 

Aerospace and Defense

 

20,142

 

6.7

 

20,914

 

5.6

 

Drugs

 

17,688

 

5.9

 

18,226

 

4.9

 

Food Products

 

17,110

 

5.7

 

21,016

 

5.6

 

Electronics/Electric

 

13,193

 

4.4

 

26,321

 

7.0

 

Retailers (Except Food and Drugs)

 

10,699

 

3.6

 

19,050

 

5.1

 

Automotive

 

10,298

 

3.4

 

10,625

 

2.8

 

Leisure Goods/Activities/Movies

 

9,154

 

3.1

 

8,879

 

2.4

 

Financial Intermediaries

 

9,151

 

3.1

 

20,199

 

5.4

 

Brokers/Dealers/Investment Houses

 

6,752

 

2.2

 

3,311

 

0.9

 

Telecommunications

 

6,414

 

2.1

 

10,951

 

2.9

 

Utilities

 

5,859

 

1.9

 

9,932

 

2.6

 

Food Services

 

5,650

 

1.9

 

5,491

 

1.5

 

Insurance

 

5,613

 

1.9

 

6,648

 

1.8

 

Nonferrous Metals/Minerals

 

5,334

 

1.8

 

5,187

 

1.4

 

Publishing

 

3,156

 

1.1

 

5,657

 

1.5

 

Telecommunications/Cellular

 

3,037

 

1.0

 

3,076

 

0.8

 

Home Furnishings

 

2,874

 

1.0

 

2,984

 

0.8

 

Oil & Gas

 

2,741

 

0.9

 

 

 

Cable and Satellite Television

 

2,650

 

0.9

 

4,058

 

1.1

 

Food/Drug Retailers

 

2,461

 

0.8

 

4,329

 

1.1

 

Containers/Glass Products

 

1,903

 

0.6

 

2,009

 

0.5

 

Ecological Services and Equipment

 

1,245

 

0.4

 

753

 

0.2

 

Broadcast Radio and Television

 

1,004

 

0.3

 

1,010

 

0.3

 

Lodging and Casinos

 

 

 

7,400

 

2.0

 

Beverage and Tobacco

 

 

 

3,037

 

0.8

 

Building and Development

 

 

 

2,124

 

0.6

 

Steel

 

 

 

1,001

 

0.3

 

Clothing/Textiles

 

 

 

861

 

0.2

 

Total

 

$

299,764

 

100.0

%

$

374,420

 

100.0

%

 

Portfolio composition by geographic location at fair value

 

The following table shows the portfolio composition by geographic location at fair value at November 30, 2013 and February 28, 2013. The geographic composition is determined by the location of the corporate headquarters of the portfolio company.

 

 

 

At November 30, 2013

 

At February 28, 2013

 

 

 

Investments
at
Fair Value

 

Percentage
of
Total
Portfolio

 

Investments
at
Fair Value

 

Percentage
of
Total
Portfolio

 

 

 

($ in thousands)

 

Southeast

 

$

76,308

 

38.4

%

$

70,476

 

45.4

%

West

 

43,507

 

21.9

 

26,573

 

17.1

 

Midwest

 

38,379

 

19.3

 

18,469

 

11.9

 

Northeast

 

21,566

 

10.8

 

14,045

 

9.1

 

Other(1)

 

19,019

 

9.6

 

25,517

 

16.5

 

Total

 

$

198,779

 

100.0

%

$

155,080

 

100.0

%

 


(1)                                 Comprised of our investment in the subordinated notes of Saratoga CLO.

 

44



Table of Contents

 

Results of operations

 

Operating results for the three and nine months ended November 30, 2013 and 2012 are as follows:

 

 

 

For the three months ended

 

 

 

November 30,
2013

 

November 30,
2012

 

 

 

($ in thousands)

 

Total investment income

 

$

5,801

 

$

4,034

 

Total expenses, net

 

2,903

 

1,545

 

Net investment income

 

2,898

 

2,489

 

Net realized gains

 

83

 

95

 

Net unrealized losses

 

(1,713

)

(1,839

)

Net increase in net assets resulting from operations

 

$

1,268

 

$

745

 

 

 

 

For the nine months ended

 

 

 

November 30,
2013

 

November 30,
2012

 

 

 

($ in thousands)

 

Total investment income

 

$

17,206

 

$

11,816

 

Total expenses, net

 

9,567

 

6,740

 

Net investment income

 

7,639

 

5,076

 

Net realized gains

 

1,158

 

412

 

Net unrealized gains (losses)

 

(3,771

)

3,319

 

Net increase in net assets resulting from operations

 

$

5,026

 

$

8,807

 

 

Investment income

 

The composition of our investment income for the three and nine months ended November 30, 2013 and 2012 was as follows:

 

 

 

For the three months ended

 

 

 

November 30,
2013

 

November 30,
2012

 

 

 

($ in thousands)

 

Interest from investments

 

$

4,997

 

$

3,513

 

Management fee income from Saratoga CLO

 

421

 

500

 

Interest from cash and cash equivalents and other income

 

383

 

21

 

Total

 

$

5,801

 

$

4,034

 

 

 

 

For the nine months ended

 

 

 

November 30,
2013

 

November 30,
2012

 

 

 

($ in thousands)

 

Interest from investments

 

$

14,961

 

$

10,138

 

Management fee income from Saratoga CLO

 

1,400

 

1,501

 

Interest from cash and cash equivalents and other income

 

845

 

177

 

Total

 

$

17,206

 

$

11,816

 

 

For the three months ended November 30, 2013, total investment income increased $1.8 million, or 43.8% compared to the three months ended November 30, 2012. The increase in total investment income for the three months ended November 30, 2013 versus the three months ended November 30, 2012 was the result of a higher average portfolio for the three months ended November 30, 2013.

 

For the nine months ended November 30, 2013, total investment income increased $5.4 million, or 45.6% compared to the nine months ended November 30, 2012. The increase in total investment income for the nine months ended November 30, 2013 versus the nine months ended November 30, 2012 was the result of a higher average portfolio for the three and nine months ended November 30, 2013.

 

For the three and nine months ended November 30, 2013 and 2012, total PIK income was $0.2 million and $0.6 million, and $0.3 million and $0.8 million, respectively.

 

The Saratoga CLO was refinanced in October 2013. As a result, proceeds from principal payments in the loan portfolio of Saratoga CLO must now be used to paydown its outstanding notes. Thus, the management fee income and investment income that we will receive from Saratoga CLO will decline in future periods.

 

45



Table of Contents

 

Operating expenses

 

The composition of our expenses for the three and nine months ended November 30, 2013 and 2012 was as follows:

 

Operating Expenses

 

 

 

For the three months ended

 

 

 

November 30,
2013

 

November 30,
2012

 

 

 

($ in thousands)

 

Interest and debt financing expenses

 

$

1,611

 

$

530

 

Base management fees

 

876

 

529

 

Professional fees

 

313

 

347

 

Incentive management fees

 

(561

)

(413

)

Administrator expenses

 

250

 

250

 

Insurance expenses

 

118

 

129

 

Directors fees

 

36

 

54

 

General and administrative and other expenses

 

260

 

119

 

Total expenses

 

$

2,903

 

$

1,545

 

 

 

 

For the nine months ended

 

 

 

November 30,
2013

 

November 30,
2012

 

 

 

($ in thousands)

 

Interest and debt financing expenses

 

$

4,343

 

$

1,809

 

Base management fees

 

2,424

 

1,492

 

Professional fees

 

879

 

986

 

Incentive management fees

 

220

 

887

 

Administrator expenses

 

750

 

750

 

Insurance expenses

 

357

 

390

 

Directors fees

 

132

 

156

 

General and administrative and other expenses

 

462

 

270

 

Total expenses

 

$

9,567

 

$

6,740

 

 

For the three months ended November 30, 2013, total expenses increased $1.4 million, or 87.9%, compared to the three months ended November 30, 2012. For the nine months ended November 30, 2013, total expenses increased $2.8 million, or 41.9%, compared to the nine months ended November 30, 2012. The increase is primarily related an increase in interest and credit facility expense, base management fees and incentive management fees due to the growth in our portfolio and amount of our outstanding debt.

 

As discussed above, the increase in interest and debt financing expenses for the three and nine months ended November 30, 2013 is primarily attributable to an increase in the amount of outstanding debt as compared to the prior periods. For the nine months ended November 30, 2013 and 2012, the weighted average interest rate on the outstanding borrowings under the Replacement Facility was 7.50% and 7.50%, respectively. The weighted average interest rate during the nine months ended November 30, 2013 on the outstanding borrowings of the SBA debentures was 2.99%. The weighted average interest rate during the nine months ended November 30, 2013 on the Notes was 7.50%.

 

Net realized gains/losses on sales of investments

 

For the three months ended November 30, 2013, the Company had $9.9 million of sales, repayments, exits or restructurings resulting in $0.1 million of net realized gains.

 

For the nine months ended November 30, 2013, the Company had $65.0 million of sales, repayments, exits or restructurings resulting in $1.2 million of net realized gains.

 

For the three months ended November 30, 2012, we had $1.5 million of sales, repayments, exits and restructurings, resulting in $0.1 million of net realized gains.

 

For the nine months ended November 30, 2012, we had $16.0 million of sales, repayments, exits and restructurings, resulting in $0.5 million of net realized gains.

 

46



Table of Contents

 

Net unrealized appreciation/depreciation on investments

 

For the three months ended November 30, 2013, our investments had a decrease in net unrealized depreciation of $1.7 million versus a decrease in net unrealized depreciation of $1.8 million for the three months ended November 30, 2012. For the nine months ended November 30, 2013, our investments had a decrease in net unrealized depreciation of $3.8 million versus an increase in net unrealized appreciation of $3.2 million for the nine months ended November 30, 2012. The most significant cumulative changes in unrealized appreciation and depreciation for the nine months ended November 30, 2013, were the following:

 

Nine months ended November 30, 2013

 

Issuer

 

Asset Type

 

Cost

 

Fair
Value

 

Total
Unrealized
Appreciation

 

YTD Change
in Unrealized
Appreciation/
(Depreciation)

 

 

 

 

 

($ in thousands)

 

Elyria Foundry Company, LLC

 

Senior Secured Note

 

$

8,860

 

$

6,685

 

$

2,175

 

$

(2,174

)

Saratoga CLO

 

Other/ Structured Finance Securities

 

16,555

 

19,019

 

2,464

 

(4,109

)

USS Parent Holding Corp.

 

Voting Common Stock

 

3,026

 

4,381

 

1,355

 

1,515

 

 

The $2.2 million of unrealized depreciation in our investment in Elyria Foundry Company, LLC was due to a weakened demand in oil and gas end-markets.

 

The $4.1 million of unrealized depreciation in our investment in the Saratoga CLO subordinated notes was due to lower net present value of projected future cash flows due to a smaller total portfolio and higher financing costs.

 

The $1.5 million of unrealized appreciation in our investment in the common stock of USS Parent Holding Corp. was due to improved operating performance.

 

The most significant cumulative changes in unrealized appreciation for the nine months ended November 30, 2012 were the following:

 

Nine months ended November 30, 2012

 

Issuer

 

Asset Type

 

Cost

 

Fair Value

 

Total Unrealized
Appreciation/
(Depreciation)

 

YTD Change in
Unrealized
Appreciation

 

 

 

 

 

($ in thousands)

 

Targus Holdings, Inc.

 

Common Stock

 

$

567

 

$

3,732

 

$

3,165

 

$

1,056

 

Penton Media

 

First Lien Term Loan

 

4,442

 

4,285

 

(157

)

468

 

Saratoga CLO

 

Other/Structured Finance Securities

 

20,362

 

24,641

 

4,279

 

1,974

 

 

The $1.1 million of unrealized appreciation on our investment in Targus Holdings, Inc. resulted from its improved operating performance and improved trading multiples of comparable publicly traded companies.  In addition, the $0.5 million of unrealized appreciation on our investment in Penton Media resulted from its improved operating performance.

 

The $2.0 million of net unrealized appreciation in our investment in the Saratoga CLO subordinated notes was due to higher relative cash flow projections (based on an improvement in the overall portfolio, a decrease in the assumed portfolio default rate and a reduction in the CLO’s cost basis due to distributions during the year) offset by a higher discount rate used to present value the cash flows based on current market conditions.

 

Changes in net assets resulting from operations

 

For the three months ended November 30, 2013, we recorded a net increase in net assets resulting from operations of $1.3 million versus a net increase in net assets resulting from operations of $0.7 million for the three months ended November 30, 2012. Based on 4,851,451 and 3,970,447 weighted average common shares outstanding for the three months ended November 30, 2013 and November 30, 2012, respectively, our per share net increase in net assets resulting from operations was $0.26 for the three months ended November 30, 2013 versus a per share net increase in net assets from operations of $0.19 for the three months ended November 30, 2012.

 

47



Table of Contents

 

For the nine months ended November 30, 2013, we recorded a net increase in net assets resulting from operations of $5.0 million versus a net increase in net assets resulting from operations of $8.8 million for the nine months ended November 30, 2012. Based on 4,770,267 and 3,907,696 weighted average common shares outstanding for the nine months ended November 30, 2013 and November 30, 2012, respectively, our per share net increase in net assets resulting from operations was $1.05 for the nine months ended November 30, 2013 versus a per share net increase in net assets from operations of $2.25 for the nine months ended November 30, 2012.

 

FINANCIAL CONDITION, LIQUIDITY AND CAPITAL RESOURCES

 

We intend to continue to generate cash primarily from cash flows from operations, including interest earned from the temporary investment of cash in U.S. government securities and other high-quality debt investments that mature in one year or less, future borrowings and future offerings of securities.

 

Although we expect to fund the growth of our investment portfolio through the net proceeds from future equity offerings, including our dividend reinvestment plan, and issuances of senior securities or future borrowings, to the extent permitted by the 1940 Act, we cannot assure you that our plans to raise capital will be successful.  In this regard, because our common stock has historically traded at a price below our current net asset value per share and we are limited in our ability to sell our common stock at a price below net asset value per share, we have been and may continue to be limited in our ability to raise equity capital.  Our stockholders approved a proposal at our annual meeting of stockholders held on September 26, 2013 that authorizes us to sell shares of our common stock at an offering price per share to investors that is not less than 85% of our then current net asset value per share in one or more offerings for a period ending on the earlier of September 26, 2014 or the date of our next annual meeting of stockholders. We would need stockholder approval of a similar proposal to issue shares below net asset value per share at any time after the earlier of September 26, 2014 or our next annual meeting of stockholders.

 

In addition, we intend to distribute to our stockholders substantially all of our taxable income in order to satisfy the distribution requirement applicable to RICs under Subchapter M of the Code. In satisfying this distribution requirement, we have in the past relied on IRS issued private letter rulings concluding that a RIC may treat a distribution of its own stock as fulfilling its RIC distribution requirements if each stockholder may elect to receive his or her entire distribution in either cash or stock of the RIC subject to a limitation on the aggregate amount of cash to be distributed to all stockholders, which limitation must be at least 20% of the aggregate declared distribution.  We may rely on these IRS private letter rulings in future periods to satisfy our RIC distribution requirement.

 

Also, as a BDC, we generally are required to meet a coverage ratio of total assets, less liabilities and indebtedness not represented by senior securities, to total senior securities, which include all of our borrowings and any outstanding preferred stock, of at least 200%. This requirement limits the amount that we may borrow. Our asset coverage ratio, as defined in the 1940 Act, was 312.6% as of November 30, 2013 and 547.3% as of February 28, 2013. To fund growth in our investment portfolio in the future, we anticipate needing to raise additional capital from various sources, including the equity markets and other debt-related markets, which may or may not be available on favorable terms, if at all.

 

Consequently, we may not have the funds or the ability to fund new investments, to make additional investments in our portfolio companies, to fund our unfunded commitments to portfolio companies or to repay borrowings.  Also, the illiquidity of our portfolio investments may make it difficult for us to sell these investments when desired and, if we are required to sell these investments, we may realize significantly less than their recorded value.

 

Below is a summary of the terms of the senior secured revolving credit facility we entered into with Madison Capital Funding (the “Replacement Facility”) on June 30, 2010.

 

Availability.  The Company can draw up to the lesser of (i) $40.0 million (the “Facility Amount”) and (ii) the product of the applicable advance rate (which varies from 50.0% to 75.0% depending on the type of loan asset) and the value, determined in accordance with the Replacement Facility (the “Adjusted Borrowing Value”), of certain “eligible” loan assets pledged as security for the loan (the “Borrowing Base”), in each case less (a) the amount of any undrawn funding commitments the Company has under any loan asset and which are not covered by amounts in the Unfunded Exposure Account referred to below (the “Unfunded Exposure Amount”) and (b) outstanding borrowings. Each loan asset held by the Company as of the date on which the Replacement Facility was closed was valued as of that date and each loan asset that the Company acquires after such date will be valued at the lowest of its fair value, its face value (excluding accrued interest) and the purchase price paid for such loan asset. Adjustments to the value of a loan asset will be made to reflect, among other things, changes in its fair value, a default by the obligor on the loan asset, insolvency of the obligor, acceleration of the loan asset, and certain modifications to the terms of the loan asset.

 

48



Table of Contents

 

The Replacement Facility contains limitations on the type of loan assets that are “eligible” to be included in the Borrowing Base and as to the concentration level of certain categories of loan assets in the Borrowing Base such as restrictions on geographic and industry concentrations, asset size and quality, payment frequency, status and terms, average life, and collateral interests. In addition, if an asset is to remain an “eligible” loan asset, the Company may not make changes to the payment, amortization, collateral and certain other terms of the loan assets without the consent of the administrative agent that will either result in subordination of the loan asset or be materially adverse to the lenders.

 

Collateral.  The Replacement Facility is secured by substantially all of the assets of the Company (other than assets held by our SBIC subsidiary) and includes the subordinated notes (“CLO Notes”) issued by Saratoga CLO and the Company’s rights under the CLO Management Agreement (as defined below).

 

Interest Rate and Fees.  Under the Replacement Facility, funds are borrowed from or through certain lenders at the greater of the prevailing LIBOR rate and 2.00%, plus an applicable margin of 5.50%. At the Company’s option, funds may be borrowed based on an alternative base rate, which in no event will be less than 3.00%, and the applicable margin over such alternative base rate is 4.50%. In addition, the Company pays the lenders a commitment fee of 0.75% per year on the unused amount of the Replacement Facility for the duration of the Revolving Period (defined below). Accrued interest and commitment fees are payable monthly. The Company was also obligated to pay certain other fees to the lenders in connection with the closing of the Replacement Facility.

 

Revolving Period and Maturity Date.  The Company may make and repay borrowings under the Replacement Facility for a period of three years following the closing of the Replacement Facility (the “Revolving Period”). The Revolving Period may be terminated at an earlier time by the Company or, upon the occurrence of an event of default, by action of the lenders or automatically. All borrowings and other amounts payable under the Replacement Facility are due and payable in full five years after the end of the Revolving Period.

 

Collateral Tests.  It is a condition precedent to any borrowing under the Replacement Facility that the principal amount outstanding under the Replacement Facility, after giving effect to the proposed borrowings, not exceed the lesser of the Borrowing Base or the Facility Amount (the “Borrowing Base Test”). In addition to satisfying the Borrowing Base Test, the following tests must also be satisfied (together with Borrowing Base Test, the “Collateral Tests”):

 

·                  Interest Coverage Ratio.  The ratio (expressed as a percentage) of interest collections with respect to pledged loan assets, less certain fees and expenses relating to the Replacement Facility, to accrued interest and commitment fees and any breakage costs payable to the lenders under the Replacement Facility for the last 6 payment periods must equal at least 175.0%.

 

·                  Overcollateralization Ratio.  The ratio (expressed as a percentage) of the aggregate Adjusted Borrowing Value of “eligible” pledged loan assets plus the fair value of certain ineligible pledged loan assets and the CLO Notes (in each case, subject to certain adjustments) to outstanding borrowings under the Replacement Facility plus the Unfunded Exposure Amount must equal at least 200.0%.

 

·                  Weighted Average FMV Test.  The aggregate adjusted or weighted value of “eligible” pledged loan assets as a percentage of the aggregate outstanding principal balance of “eligible” pledged loan assets must be equal to or greater than 72.0% and 80.0% during the one-year periods prior to the first and second anniversary of the closing date, respectively, and 85.0% at all times thereafter.

 

The Replacement Facility also requires payment of outstanding borrowings or replacement of pledged loan assets upon the Company’s breach of its representation and warranty that pledged loan assets included in the Borrowing Base are “eligible” loan assets. Such payments or replacements must equal the lower of the amount by which the Borrowing Base is overstated as a result of such breach or any deficiency under the Collateral Tests at the time of repayment or replacement. Compliance with the Collateral Tests is also a condition to the discretionary sale of pledged loan assets by the Company.

 

Priority of Payments.  During the Revolving Period, the priority of payments provisions of the Replacement Facility require, after payment of specified fees and expenses and any necessary funding of the Unfunded Exposure Account, that collections of principal from the loan assets and, to the extent that these are insufficient, collections of interest from the loan assets, be applied on each payment date to payment of outstanding borrowings if the Borrowing Base Test, the Overcollateralization Ratio and the Interest Coverage Ratio would not otherwise be met. Similarly, following termination of the Revolving Period, collections of interest are required to be applied, after payment of certain fees and expenses, to cure any deficiencies in the Borrowing Base Test, the Interest Coverage Ratio and the Overcollateralization Ratio as of the relevant payment date.

 

49



Table of Contents

 

Reserve Account.  The Replacement Facility requires the Company to set aside an amount equal to the sum of accrued interest, commitment fees and administrative agent fees due and payable on the next succeeding three payment dates (or corresponding to three payment periods). If for any monthly period during which fees and other payments accrue, the aggregate Adjusted Borrowing Value of “eligible” pledged loan assets which do not pay cash interest at least quarterly exceeds 15.0% of the aggregate Adjusted Borrowing Value of “eligible” pledged loan assets, the Company is required to set aside such interest and fees due and payable on the next succeeding six payment dates. Amounts in the reserve account can be applied solely to the payment of administrative agent fees, commitment fees, accrued and unpaid interest and any breakage costs payable to the lenders.

 

Unfunded Exposure Account.  With respect to revolver or delayed draw loan assets, the Company is required to set aside in a designated account (the “Unfunded Exposure Account”) 100.0% of its outstanding and undrawn funding commitments with respect to such loan assets. The Unfunded Exposure Account is funded at the time the Company acquires a revolver or delayed draw loan asset and requests a related borrowing under the Replacement Facility. The Unfunded Exposure Account is funded through a combination of proceeds of the requested borrowing and other Company funds, and if for any reason such amounts are insufficient, through application of the priority of payment provisions described above.

 

Operating Expenses.  The priority of payments provision of the Replacement Facility provides for the payment of certain operating expenses of the Company out of collections on principal and interest during the Revolving Period and out of collections on interest following the termination of the Revolving Period in accordance with the priority established in such provision. The operating expenses payable pursuant to the priority of payment provisions is limited to $350,000 for each monthly payment date or $2.5 million for the immediately preceding period of twelve consecutive monthly payment dates. This ceiling can be increased by the lesser of 5.0% or the percentage increase in the fair market value of all the Company’s assets only on the first monthly payment date to occur after each one-year anniversary following the closing of the Replacement Facility. Upon the occurrence of a Manager Event (described below), the consent of the administrative agent is required in order to pay operating expenses through the priority of payments provision.

 

Events of Default.  The Replacement Facility contains certain negative covenants, customary representations and warranties and affirmative covenants and events of default. The Replacement Facility does not contain grace periods for breach by the Company of certain covenants, including, without limitation, preservation of existence, negative pledge, change of name or jurisdiction and separate legal entity status of the Company covenants and certain other customary covenants. Other events of default under the Replacement Facility include, among other things, the following:

 

·                  an Interest Coverage Ratio of less than 150.0%;

 

·                  an Overcollateralization Ratio of less than 175.0%;

 

·                  the filing of certain ERISA or tax liens;

 

·                  the occurrence of certain “Manager Events” such as:

 

·                  failure by Saratoga Investment Advisors and its affiliates to maintain collectively, directly or indirectly, a cash equity investment in the Company in an amount equal to at least $5,000,000 at any time prior to the third anniversary of the closing date;

 

·                  failure of the management agreement between Saratoga Investment Advisors and the Company to be in full force and effect;

 

·                  indictment or conviction of Saratoga Investment Advisors or any “key person” for a felony offense, or any fraud, embezzlement or misappropriation of funds by Saratoga Investment Advisors or any “key person” and, in the case of “key persons,” without a reputable, experienced individual reasonably satisfactory to Madison Capital Funding appointed to replace such key person within 30 days;

 

·                  resignation, termination, disability or death of a “key person” or failure of any “key person” to provide active participation in Saratoga Investment Advisors’ daily activities, all without a reputable, experienced individual reasonably satisfactory to Madison Capital Funding appointed within 30 days; or

 

·                  occurrence of any event constituting “cause” under the Collateral Management Agreement between the Company and Saratoga CLO (the “CLO Management Agreement”), delivery of a notice under Section 12(c) of

 

50



Table of Contents

 

the CLO Management Agreement with respect to the removal of the Company as collateral manager or the Company ceases to act as collateral manager under the CLO Management Agreement.

 

Conditions to Acquisitions and Pledges of Loan Assets.  The Replacement Facility imposes certain additional conditions to the acquisition and pledge of additional loan assets. Among other things, the Company may not acquire additional loan assets without the prior written consent of the administrative agent until such time that the administrative agent indicates in writing its satisfaction with Saratoga Investment Advisors’ policies, personnel and processes relating to the loan assets.

 

Fees and Expenses.  The Company paid certain fees and reimbursed Madison Capital Funding for the aggregate amount of all documented, out-of-pocket costs and expenses, including the reasonable fees and expenses of lawyers, incurred by Madison Capital Funding in connection with the Replacement Facility and the carrying out of any and all acts contemplated thereunder up to and as of the date of closing of the stock purchase transaction with Saratoga Investment Advisors and certain of its affiliates. These amounts totaled $2.0 million.

 

On February 24, 2012, we amended our senior secured revolving credit facility with Madison Capital Funding LLC to, among other things:

 

·                  expand the borrowing capacity under the credit facility from $40.0 million to $45.0 million;

 

·                  extend the Revolving Period from July 30, 2013 to February 24, 2015; and

 

·                  remove the condition that we may not acquire additional loan assets without the prior written consent of the administrative agent.

 

As of November 30, 2013, we had $4.0 million of outstanding balance under the Replacement Facility and our borrowing base under the Replacement Facility was $48.2 million.

 

Our asset coverage ratio, as defined in the 1940 Act, was 312.6% as of November 30, 2013 and 547.3% as of February 28, 2013.

 

In addition, we, through a wholly-owned subsidiary, sought and obtained a license from the SBA to operate an SBIC.  In this regard, on March 28, 2012, our wholly-owned subsidiary, Saratoga Investment Corp. SBIC, LP, received a license from the SBA to operate as an SBIC under Section 301(c) of the Small Business Investment Act of 1958. SBICs are designated to stimulate the flow of private equity capital to eligible small businesses. Under SBA regulations, SBICs may make loans to eligible small businesses and invest in the equity securities of small businesses.

 

The SBIC license allows our SBIC subsidiary to obtain leverage by issuing SBA-guaranteed debentures. SBA-guaranteed debentures are non-recourse, interest only debentures with interest payable semi-annually and have a ten year maturity. The principal amount of SBA-guaranteed debentures is not required to be paid prior to maturity but may be prepaid at any time without penalty. The interest rate of SBA-guaranteed debentures is fixed on a semi-annual basis at a market-driven spread over U.S. Treasury Notes with 10-year maturities.

 

SBA regulations currently limit the amount that our SBIC subsidiary may borrow to a maximum of $150 million when it has at least $75 million in regulatory capital, receives a capital commitment from the SBA and has been through an examination by the SBA subsequent to licensing. As of November 30, 2013, our SBIC subsidiary had $32 million in regulatory capital and $40.0 million SBA-guaranteed debentures outstanding.

 

We received exemptive relief from the Securities and Exchange Commission to permit us to exclude the debt of our SBIC subsidiary guaranteed by the SBA from the definition of senior securities in the 200% asset coverage test under the 1940 Act. This allows us increased flexibility under the 200% asset coverage test by permitting us to borrow up to $150 million more than we would otherwise be able to absent the receipt of this exemptive relief.

 

In May 2013, we issued $48.3 million in aggregate principal amount of our 7.50% unsecured notes due 2020 for net proceeds of $46.1 million after deducting underwriting commissions of $1.9 million and offering costs of $0.3 million. The proceeds included the underwriters’ full exercise of their overallotment option. Interest on these notes is paid quarterly in arrears on February 15, May 15, August 15 and November 15, at a rate of 7.5% per year, beginning August 15, 2013. The notes mature on May 31, 2020 and may be redeemed in whole or in part at any time or from time to time at our option on or after May 31, 2016.  In connection with the issuance of the notes, we agreed to the following covenants for the period of time during which the notes are outstanding:

 

51



Table of Contents

 

·                  we will not violate (whether or not we are subject to) Section 18(a)(1)(A) as modified by Section 61(a)(1) of the 1940 Act or any successor provisions, but giving effect to any exemptive relief granted to us by the SEC. Currently, these provisions generally prohibit us from making additional borrowings, including through the issuance of additional debt or the sale of additional debt securities, unless our asset coverage, as defined in the 1940 Act, equals at least 200% after such borrowings.

 

·                  we will not violate (regardless of whether we are subject to) Section 18(a)(1)(B) as modified by Section 61(a)(1) of the 1940 Act or any successor provisions, but giving effect to (i) any exemptive relief granted to us by the SEC and (ii) no-action relief granted by the SEC to another BDC (or to the Company if it determines to seek such similar no-action or other relief) permitting the BDC to declare any cash dividend or distribution notwithstanding the prohibition contained in Section 18(a)(1)(B) as modified by Section 61(a)(1) of the 1940 Act in order to maintain the BDC’s status as a regulated investment company under Subchapter M of the Internal Revenue Code of 1986. Currently these provisions generally prohibit us from declaring any cash dividend or distribution upon any class of our capital stock, or purchasing any such capital stock if our asset coverage, as defined in the 1940 Act, is below 200% at the time of the declaration of the dividend or distribution or the purchase and after deducting the amount of such dividend, distribution or purchase.

 

The notes are listed on the NYSE under the trading symbol “SAQ” with a par value of $25.00 per share.

 

Contractual obligations

 

The following table shows our payment obligations for repayment of debt and other contractual obligations at November 30, 2013:

 

 

 

 

 

Payment Due by Period

 

 

 

Total

 

Less Than
1 Year

 

1 - 3
Years

 

3 - 5
Years

 

More Than
5 Years

 

 

 

($ in thousands)

 

 

 

 

 

 

 

 

 

Long-Term Debt Obligations

 

$

92,300

 

$

 

$

4,000

 

$

 

$

88,300

 

 

Off-balance sheet arrangements

 

At November 30, 2013 and February 28, 2013, we did not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that are material to investors.

 

Item 3.        Quantitative and Qualitative Disclosures about Market Risk

 

Our market risks have not changed materially from the risks reported in our Form 10-K for the year ended February 28, 2013.

 

52



Table of Contents

 

Item 4.        Controls and Procedures

 

(a)                                 As of the end of the period covered by this report, we carried out an evaluation, under the supervision and with the participation of our management, including our chief executive officer and our chief financial officer, of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rule 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934).  Based on that evaluation, our chief executive officer and our chief financial officer have concluded that our current disclosure controls and procedures are effective in facilitating timely decisions regarding required disclosure of any material information relating to us that is required to be disclosed by us in the reports we file or submit under the Securities Exchange Act of 1934.

 

(b)                                 There have been no changes in our internal control over financial reporting that occurred during the quarter ended November 30, 2013 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

PART II.  OTHER INFORMATION

 

Item 1. Legal Proceedings

 

On August 31, 2012, a complaint was filed in the United States Bankruptcy Court for the Southern District of New York by GSC Acquisition Holdings, LLC against us to recover, among other things, approximately $2.6 million for the benefit of the estates and the general unsecured creditors of GSC Group, Inc. and its affiliates, including the Company’s former investment adviser, GSCP (NJ), L.P.  The complaint alleges that the former investment adviser made a constructively fraudulent transfer of $2.6 million in deferred incentive fees by waiving them in connection with the termination of an investment advisory and management agreement with us, and that the termination of the investment advisory and management agreement was itself a fraudulent transfer.  These transfers, the complaint alleges, were made without receipt of reasonably equivalent value and while the former investment adviser was insolvent.  The complaint has not yet been served, and the plaintiff’s motion for authority to prosecute the case on behalf of the estates was taken under advisement by the court on October 1, 2012. We opposed that motion.  We believe that the claims in this lawsuit are without merit and, if the plaintiff is authorized to proceed, intend to vigorously defend against this action.

 

Except as discussed above, neither we nor our wholly-owned subsidiaries, Saratoga Investment Funding LLC and Saratoga Investment Corp. SBIC LP, are currently subject to any material legal proceedings.

 

Item 1A. Risk Factors

 

Other than as set forth below, there have been no material changes from the risk factors set forth in our annual report on Form 10-K for the year ended February 28, 2013.

 

Our independent auditors have not assessed our internal control over financial reporting. If our internal control over financial reporting is not effective, it could have a material adverse effect on our stock price and our ability to raise capital.

 

Because we are a “non-accelerated filer” within the meaning of Rule 12b-2 under the Securities Exchange Act of 1934, our independent auditors are not required to assess our internal control over financial reporting or to provide a report thereon.  Although our management determined that our internal control over financial reporting was effective at February 28, 2013 (the last dated that such determination was required to be made by us), there can be no assurance that our independent auditors would agree with our management’s conclusion.  Furthermore, if our market capitalization, excluding affiliated stockholders, at August 31 of any fiscal year is greater than $75 million, then we will be required to obtain independent auditor certification on the adequacy of our internal control over financial reporting for that fiscal year.  If our internal control over financial reporting is determined in the future to not be effective, whether by our management or by our independent auditors, there could be an adverse reaction in the financial markets due to a loss of confidence in the reliability of our financial statements, which could materially adversely affect our stock price and our ability to raise capital necessary to operate our business.  In addition, we may be required to incur costs in improving our internal control system and hiring additional personnel.

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

 

Not applicable.

 

Item 3. Defaults upon Senior Securities

 

Not applicable.

 

53



Table of Contents

 

Item 4. Mine Safety Disclosures

 

Not applicable.

 

Item 5. Other Information

 

Not applicable.

 

Item 6. Exhibits

 

Listed below are the exhibits which are filed as part of this report (according to the number assigned to them in Item 601 of Regulation S-K):

 

Exhibit
Number

 

Description of Document

 

 

 

31.1*

 

Certification of Chief Executive Officer Pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934

 

 

 

31.2*

 

Certification of Chief Financial Officer Pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934

 

 

 

32.1*

 

Certification of Chief Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. 1350)

 

 

 

32.2*

 

Certification of Chief Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. 1350)

 


*                          Submitted herewith.

 

54



Table of Contents

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 

SARATOGA INVESTMENT CORP.

 

 

 

Date: January 14, 2014

By

/s/ Christian L. Oberbeck

 

 

Christian L. Oberbeck

 

 

Chief Executive Officer

 

 

 

 

By

/s/ Richard A. Petrocelli

 

 

Richard A. Petrocelli

 

 

Chief Financial Officer, Chief Compliance Officer and Secretary

 

55


Exhibit 31.1

 

CERTIFICATION PURSUANT TO

RULE 13a-14(a) and 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED

 

I, Christian L. Oberbeck, certify that:

 

1.                                      I have reviewed this Quarterly Report on Form 10-Q of Saratoga Investment Corp.;

 

2.                                      Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.                                      Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the company as of, and for, the periods presented in this report;

 

4.                                      The company’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the company and have:

 

(a)                                 Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the company, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b)                                 Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c)                                  Evaluated the effectiveness of the company’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d)                                 Disclosed in this report any change in the company’s internal control over financial reporting that occurred during the company’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the company’s internal control over financial reporting; and

 

5.                                      The company’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the company’s auditors and the audit committee of the company’s board of directors (or persons performing the equivalent functions):

 

(a)                                 All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the company’s ability to record, process, summarize and report financial information; and

 

(b)                                 Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: January 14, 2014

 

 

 

 

/s/ CHRISTIAN L. OBERBECK

 

Christian L. Oberbeck

 

Chief Executive Officer

 


Exhibit 31.2

 

CERTIFICATION PURSUANT TO

RULE 13a-14(a) and 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED

 

I, Richard A. Petrocelli, certify that:

 

1.                                      I have reviewed this Quarterly Report on Form 10-Q of Saratoga Investment Corp.;

 

2.                                      Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.                                      Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the company as of, and for, the periods presented in this report;

 

4.                                      The company’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the company and have:

 

(a)                                 Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the company, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b)                                 Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c)                                  Evaluated the effectiveness of the company’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d)                                 Disclosed in this report any change in the company’s internal control over financial reporting that occurred during the company’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the company’s internal control over financial reporting; and

 

5.                                      The company’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the company’s auditors and the audit committee of the company’s board of directors (or persons performing the equivalent functions):

 

(a)                                 All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the company’s ability to record, process, summarize and report financial information; and

 

(b)                                 Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: January 14, 2014

 

 

 

 

/s/ RICHARD A. PETROCELLI

 

Name: Richard A. Petrocelli

 

Chief Financial Officer, Chief Compliance Officer and Secretary

 


Exhibit 32.1

 

CERTIFICATION PURSUANT TO

SECTION 1350, CHAPTER 63 OF TITLE 18, UNITED STATES CODE,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

The certification set forth below is being submitted in connection with the accompanying Quarterly Report of Saratoga Investment Corp. on Form 10-Q (the “Report”) for the purpose of complying with Rule 13a-14(b) or Rule 15d-14(b) of the Securities Exchange Act of 1934 (the “Exchange Act”) and Section 1350 of Chapter 63 of Title 18 of the United States Code.

 

Christian L. Oberbeck, the Chief Executive Officer, certifies that, to the best of his knowledge:

 

1.                                      the Report fully complies with the requirements of Section 13(a) or 15(d) of the Exchange Act; and

 

2.                                      the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Saratoga Investment Corp.

 

Date: January 14, 2014

 

 

 

 

/s/ CHRISTIAN L. OBERBECK

 

Name: Christian L. Oberbeck

 

Chief Executive Officer

 


Exhibit 32.2

 

CERTIFICATION PURSUANT TO

SECTION 1350, CHAPTER 63 OF TITLE 18, UNITED STATES CODE,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

The certification set forth below is being submitted in connection with the accompanying Quarterly Report of Saratoga Investment Corp. on Form 10-Q (the “Report”) for the purpose of complying with Rule 13a-14(b) or Rule 15d-14(b) of the Securities Exchange Act of 1934 (the “Exchange Act”) and Section 1350 of Chapter 63 of Title 18 of the United States Code.

 

Richard A. Petrocelli, the Chief Financial Officer, Chief Compliance Officer and Secretary of Saratoga Investment Corp., certifies that, to the best of his knowledge:

 

1.                                      the Report fully complies with the requirements of Section 13(a) or 15(d) of the Exchange Act; and

 

2.                                      the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Saratoga Investment Corp.

 

Date: January 14, 2014

 

 

 

 

/s/ RICHARD A. PETROCELLI

 

Name: Richard A. Petrocelli

 

Chief Financial Officer, Chief Compliance Officer and Secretary